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Background: Anxiety during pregnancy is a strong predictor of postnatal depression and 
can negatively impact on a range of child developmental outcomes. Recent reviews highlight 
the lack of anxiety measures with robust psychometric properties for screening use in 
pregnancy. 
Aim: This research aimed to develop a brief self-report scale specifically constructed to 
identify problematic anxiety symptoms in pregnant women, and conduct preliminary 
psychometric testing of the scale.  
Method: The development and psychometric validation of the SAAS (Stirling Antenatal 
Anxiety Scale) was informed by five studies. A systematic review of the psychometric 
literature and interviews with women with experience of problematic anxiety symptoms in 
pregnancy both contributed to the generation of an initial item pool for the assessment of the 
target construct. This was subsequently refined and reduced, using a Delphi technique 
involving key informants (i.e. expert opinion and target population). The screening accuracy 
of the final, 10-item version of the scale was subsequently tested against a diagnostic 
interview, and compared to the NICE-recommended screening scales for antenatal anxiety 
(GAD-2/7). The internal consistency, factor structure and construct validity of the SAAS 
were also assessed.  
Results: 174 women completed the SAAS, GAD-2/7 and Edinburgh Postnatal Depression 
Scale (EPDS). The SAAS was found to have excellent sensitivity (91%) and very good 
specificity (85%) at its optimal cut-off score of ≥ 8. It also showed a superior screening 
performance when compared to both the GAD-2 and the GAD-7 at their NICE-
recommended cut-off scores. Its internal consistency was close to excellent (α = 0.88), and 
the scale exhibited a single-factor structure. The SAAS was also considered highly 
acceptable to pregnant women (mean score = 9.48; range 1-10).  
Conclusion: The SAAS shows promise as a brief, acceptable and effective screening tool 
for antenatal anxiety, which may improve identification and aid appropriate targeting of 
resources and care.  





This work has resulted in one research paper at the time of submission of the thesis. Chapter 
4 is a partial reproduction of this paper, which was published in January 2019. The paper is 
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Chapter 1   Introduction and overview of the thesis 
 
1.1  Introduction   
While the physical care of women during pregnancy and in the months after giving birth has 
substantially improved over the course of the last century, it is only in recent decades that 
their emotional care has received some attention in clinical practice and research (Glover, 
2014). The perinatal period, which includes pregnancy and the first postnatal year (Milgrom 
& Gemmill, 2015), is a major time of transition for women, and is often characterised by 
substantial physiological, psychological and social changes (Grant, McMahon, & Austin, 
2008).  It is thus perhaps not surprising that a considerable proportion of women experience 
increased psychological vulnerability and morbidity at this time ((Heron, O’Connor, Evans, 
Golding, & Glover, 2004; Goodman, Watson, & Stubbs, 2016). Among the mental health 
difficulties that women can experience during pregnancy and in the first year after giving 
birth, a growing body of research has indicated that women experiencing elevated levels of 
anxiety during pregnancy are at increased risk of developing postnatal depression (Lee et al., 
2007; Verreault et al., 2014). Maternal antenatal anxiety has also been found to be associated 
with a number of adverse obstetric and birth outcomes, including low birth weight and 
premature birth (Ding et al., 2014). In addition, evidence now exists suggesting that 
clinically significant anxiety during pregnancy increases the risk of a range of negative child 
developmental outcomes (Talge et al., 2007; O’Donnell, Glover, Barker, & O’Connor, 
2014). In Chapter 2, which is specifically focused on antenatal anxiety, current evidence in 
relation to its potential negative impact on mother and child is reviewed and discussed in 
detail. In conclusion of this overview of antenatal anxiety, a rationale for the need to develop 
a new screening scale for the identification of pregnant women experiencing problematic 
anxiety symptoms is also presented.  
This brief, introductory chapter aims to introduce the reader to the area of perinatal mental 
health research and clinical practice. The chapter initially provides an overview of perinatal 
mental health problems, their prevalence and common assessment methods. The issue of 
under-recognition of common mental health problems in routine maternity care is also 
briefly discussed. In 1.3, the study aims and research questions are presented, while the final 
section (1.4) provides a brief summary of the nine chapters included in the thesis.  
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1.2   Setting the context  
1.2.1  An overview of perinatal mental health problems 
Perinatal mental health problems and perinatal mental illness are general terms commonly 
used to refer to the range of mental health difficulties that women can experience during 
pregnancy and in the first postnatal year (Austin, 2004; Glover, 2014). These range from 
moderate symptoms of depression or anxiety to more severe conditions such as postpartum 
psychosis. Overall, perinatal mental health problems are estimated to affect between 10 and 
20% of women (Gavin et al., 2005; Dennis, Falah-Hassani, & Shiri, 2017; Howard et al., 
2018). Historically, the majority of research studies in the area of perinatal mental health 
have focused on the postnatal period (i.e. the first year after giving birth), and in particular 
on postnatal depression (Cox, Holden, & Sagovsky, 1987; Goodman et al., 2016). 
Consequently, much less attention has been devoted to other forms of psychological distress 
that women experience during the perinatal period (Tebbe, Terluin, & Koelewijn, 2013). 
The reasons for the historical emphasis on postnatal depression, both in research and clinical 
settings, are likely to be varied. Some authors have suggested that the lack of attention 
towards the antenatal period (i.e. pregnancy) may have resulted from the incorrect 
assumption that women are somewhat hormonally protected from poor mental health at this 
time (Lee et al., 2007; Biaggi, Conroy, Pawlby, & Pariante, 2016). Others have argued that 
during the antenatal period the clinical focus is predominantly on the physical health of the 
woman and the fetus, and psychological complaints may be dismissed or attributed to the 
physiological changes occurring during gestation (Talge et al., 2007). As a result, clinical 
symptoms of anxiety and depression in the antenatal period were, until recent years, 
neglected by the research literature on perinatal mental health (Martin, 2012).  
However, a growing body of literature has emerged over the course of the last two decades 
documenting the common occurrence of mental health problems other than postnatal 
depression, both in pregnancy and postnatally (Olde, van der Hart, Kleber, & van Son, 2006; 
Spinelli, 2009; Rubertsson, Hellström, Cross, & Sydsjö, 2014). A considerable body of 
evidence now exists indicating that during pregnancy women have an increased 
susceptibility to poor mental health compared to the general population (Grant et al., 2008; 
Dennis et al., 2017), and a number of studies and systematic reviews have shown that the 
prevalence of perinatal mental health problems may in fact be higher in pregnancy than 
during the postnatal period (Heron et al., 2004, Goodman et al., 2016). The majority of these 
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studies also appear to indicate that anxiety disorders and self-reported symptoms of anxiety 
have higher prevalence than any other mental health problem during the perinatal period 
(Ross & McLean, 2006; Lee et al., 2007; Rubertsson et al., 2014; Fairbrother, Janssen, 
Antony, Tucker, & Young, 2016), as detailed later in the chapter. As a result, a conceptual 
shift has occurred in the area of perinatal mental health research and clinical practice, from 
the traditional emphasis on postnatal depression to an increased attention to the whole 
spectrum of mental health problems that women can experience during pregnancy and in the 
first postnatal year (Austin, Tully, & Parker, 2007; Glover; 2014).  
Identifying women who experience poor mental health at this time is the first, crucial step 
in order to provide them with effective and timely support and treatment (Colin, 2012; Nath 
et al., 2018). Different assessment methods currently used in research and clinical settings 
are discussed in the following section.  
 
1.2.2  Assessment methods of perinatal mental health problems 
In research, the ‘gold standard’ method of assessment of psychological morbidity is a 
structured diagnostic interview conducted by a mental health professional or a trained 
researcher (DeVellis, 2012; Tolin et al., 2018). These clinical interviews are commonly 
based on diagnostic guidelines such as the Diagnostic and Statistical Manual of Mental 
Disorders (DSM–5: American Psychiatric Association [APA], 2013) or the ICD-10 
Classification of Mental and Behavioural Disorders (ICD-10: World Health Organization 
[WHO], 1992). However, this type of assessment is time-consuming, potentially expensive 
and therefore often impractical in studies conducted in maternity care settings. 
Consequently, a substantial proportion of studies have used self-report rating scales such as 
the Edinburgh Postnatal Depression Scale (EPDS: Cox et al., 1987) and the State-Trait 
Anxiety Inventory (STAI: Spielberger et al., 1983) for the assessment of common mental 
health problems in perinatal populations.  
With regard to perinatal depression, when this is assessed with a clinical diagnostic interview 
the occurrence of depressive symptomatology is commonly determined by meeting 
diagnostic criteria for Major Depressive Disorder or a Depressive Episode (Scottish 
Intercollegiate Guidelines Network [SIGN], 2012; Gavin, Meltzer-Brody, Glover, & 
Gaynes, 2015). In cases when a self-report scale is used, the Edinburgh Postnatal Depression 
Scale is by far the most widely used and well-validated measure available (O’Connor, 
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Rossom, Henninger, Groom, & Burda, 2016), and it is also used to assess antenatal 
depression (Matthey, Fisher, & Rowe, 2013). Another ultra-brief screening tool which has 
recently been used in research settings (Howard et al., 2018) is the Patient Health 
Questionnaire-2 (PHQ-2), sometimes referred to as the Whooley questions (Kroenke, 
Spitzer, & Williams, 2003; Bosanquet et al., 2015).    
In contrast to depression, which is a well-defined and somewhat unitary construct (Widiger 
& Clark, 2000), various anxiety disorders exist according to formal diagnostic criteria 
(WHO, 1992; APA, 2013). An overview of the various anxiety disorders is provided in 
Chapter 2. Here it is important to highlight that assessing and screening for clinically 
significant symptoms of anxiety during the perinatal period is more complicated than 
screening for perinatal depression, as observed by various authors (Meades & Ayers, 2011; 
Evans, Spiby, & Morrell, 2015). Perinatal anxiety has been assessed with a range of self-
report rating scales, including measures of general state and trait anxiety, scales assessing 
specific anxiety disorders and other self-report measures which focus on pregnancy-specific 
anxiety and worries. Some investigators would appear to use the term anxiety and stress 
interchangeably in perinatal mental health research (Van Den Bergh, Mulder, Mennes, & 
Glover, 2005; Dunkel Schetter & Tanner, 2012), thus adding to the uncertainty about how 
perinatal anxiety should be conceptualised and measured (Grant et al., 2008). Moreover, the 
majority of scales used have no or very limited evidence of their psychometric properties in 
perinatal populations (Evans et al, 2015; Brunton, Dryer, Saliba, & Kohlhoff, 2015). These 
significant limitations are also explored in more detail in Chapter 4.   
In the UK, the National Institute for Health and Care Excellence regularly publishes 
recommendations for the identification and management of antenatal and postnatal mental 
health problems (NICE, 2007; NICE, 2014). As part of general screening procedures, NICE 
recommends that all women should be asked at the first antenatal assessment visit (also 
known as the booking visit) about family history and their own past and present experience 
of severe mental illness. In relation to screening for more common mental health problems 
such as perinatal anxiety and depression, a significant change in the most recent version of 
the NICE guidance (2014) was the introduction, for the first time, of two screening questions 
to assess the presence of perinatal anxiety (GAD-2: Generalised Anxiety Disorder-2, 
Kroenke et al., 2007). The previous guidelines (NICE, 2007) only included two screening 
questions for depressive symptoms (PHQ-2: Kroenke et al., 2003). An overview of the 
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NICE-recommended screening questions that health professionals should consider asking at 
each antenatal appointment and early in the postnatal period is presented below in Table 1.    
 


























 During the past month have you 
often been bothered by feeling down, 
depressed, or hopeless? 
 
 During the past month have you 
often been bothered by having little 
interest or pleasure in doing things? 
 
 
If positive answer to one 
or both questions, 
consider:  
 
-Using other validated 
measures such as the 
PHQ-9 or EPDS 
- Referral to GP/mental 
health professional,  
















 During the past month have you 
been feeling nervous, anxious, or on 
edge? 
 
 During the past month have you not 
been able to stop or control 
worrying? 
 
If score is 3 or more on 
the GAD-2 scale, 
consider: 
 
- Using the GAD-7 for 
further assessment 
- Referral to GP/mental 
health professional, 
depending on severity of 
problems 
 
With the recommendation to use the GAD-2 as part of standard screening procedures, NICE 
thus appears to acknowledge the clinical importance of identifying and providing support to 
women experiencing problematic anxiety symptoms during the perinatal period. Critically, 
however, the GAD-2 has no evidence to recommend its use in perinatal populations, and in 
particular during the antenatal period. This key limitation is considered in detail in Chapter 






1.2.3 The prevalence of perinatal mental health problems  
The bulk of the evidence on the prevalence of perinatal mental health problems is available 
for perinatal anxiety and depression, with other disorders such as eating disorder and 
postpartum psychosis receiving considerable less attention in the research literature (Howard 
et al., 2014). In relation to perinatal depression, a meta-analysis which only included studies 
using formal diagnostic criteria reported a period prevalence (i.e. the rate over a defined 
period of time) of  12.7% during pregnancy and 5.7% over the first two postnatal months 
(Gavin et al., 2005). The authors, however, specified that for the postpartum period only a 
small number of high-quality studies were available. A large American study (n > 10,000) 
using DSM-IV diagnoses (APA, 2000) reported that 9.1% of women during pregnancy and 
10.2% postnatally met the diagnostic criteria for a Major Depressive Episode (Hoertel et al., 
2015). More recently, a systematic review and meta-analysis of the global prevalence of 
perinatal depression was conducted by Woody and colleagues (Woody, Ferrari, Siskind, 
Whiteford, & Harris, 2017). The authors reported an overall pooled prevalence of 11.9% 
(95% CI: 11.4–12.5%) for perinatal depression, with prevalence being slightly higher 
postpartum compared to the antenatal period. Overall, the studies discussed above appear to 
indicate a prevalence of perinatal depression of 10-12%, with comparable rates in the 
antenatal and postnatal period. This is consistent with other recent, methodologically robust, 
studies (Howard et al., 2018) and reviews (Schmied et al., 2013). Higher prevalence 
estimates are usually found in low and middle income countries and when depression is 
assessed with a self-report scale (Fisher et al., 2011; Woody et al., 2017).    
As noted earlier, anxiety in the perinatal period has become the focus of growing research 
and clinical attention over the last two decades (Brouwers, van Baar, & Pop, 2001; Lee et 
al., 2007; Goodman, Chenausky, & Freeman, 2014). In relation to anxiety during pregnancy, 
Chapter 2 presents numerous studies examining the prevalence of general antenatal anxiety 
and specific anxiety disorders, as well as the risk factors and potential detrimental effects of 
antenatal anxiety on mother and child. Here only one systematic review is discussed, which 
arguably provides the most comprehensive and up-to-date evidence available on the 
prevalence of antenatal and postnatal anxiety (Dennis et al., 2017). This thorough review 
and meta-analysis of the literature examined over 100 studies from 34 countries and included 
both research using anxiety scales and studies employing structured diagnostic interviews. 
The review indicated that between 15 and 23% of women experience problematic anxiety 
symptoms during pregnancy. The prevalence of women with significant self-reported 
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anxiety symptoms (i.e. scoring above a predefined cut-off score on an anxiety scale) was 
found to be 18.2% in the first trimester, increasing to 24.6% in the third trimester. The pooled 
prevalence across trimesters was 22.9%. For anxiety disorders based on formal diagnostic 
criteria (WHO, 1992; APA, 2013), the overall prevalence during pregnancy was 15.2% (95% 
CI: 9.0%-21.4%). In the postnatal period, the overall prevalence of self-reported anxiety 
symptoms over the first 6 months after giving birth was 15.0%. Anxiety disorders meeting 
diagnostic criteria over the same period were estimated to have a prevalence of 9.9%. This 
recent review clearly illustrates that problematic anxiety symptoms are common throughout 
the perinatal period, and in particular during pregnancy. As noted above, other psychological 
disorders that women can experience during the perinatal period include eating disorder 
(Meltzer-Brody et al., 2011), posttraumatic stress disorder (Ayers, Bond, Bertullies, & 
Wijma, 2016) and postpartum psychosis. Postpartum psychosis is a particularly severe 
condition that can affect women in the weeks following childbirth, with symptoms such as 
thought disorganisation, memory loss and delusional or suicidal ideation (Sit, Rothschild, & 
Wisner, 2006). It is relatively rare, estimated to occur in 1-2 cases per 1,000 births (Spinelli 
et al., 2009).  
The prevalence of perinatal mental health problems discussed above refer to those found in 
research settings. However, in routine maternity care detection rates are significantly lower 
(Bauer, Parsonage, Knapp, Iemmi, & Adelaja, 2014), especially for the most common 
mental health problems such as perinatal anxiety and depression (NICE, 2014). This has 
been identified as a major issue in recent clinical guidelines (SIGN, 2012; NICE, 2014), and 
the under-recognition of perinatal mental health problems in the UK has been indicated as a 
clinical priority to be urgently addressed by the Royal College of General Practitioners 
(RCGP, 2017). The lack of identification of women experiencing poor mental health in the 
perinatal period thus currently remains a significant problem.  
This brief overview of perinatal mental health problems, their prevalence and common 
assessment methods aimed to provide a brief introduction to to this area of research and 
clinical practice. As noted in 1.1, the reasons and rationale for focusing specifically on the 
development of a screening scale for antenatal anxiety are discussed extensively in Chapter 





1.3   Study aim and research questions 
The primary aim of the programme of work presented in this thesis was to develop a brief 
and psychometrically robust self-report scale to screen for a range of problematic anxiety 
symptoms in pregnancy, and conduct a preliminary psychometric validation of the scale.  
Since the early phases of this programme of work, the aim was also to develop a scale that 
was feasible to use both in research settings and in routine antenatal care. For this reason, 
the target was to produce a final version of the scale which contained less than 12 items (i.e. 
questions). NICE, in its most recent guidance on perinatal mental health clearly indicates 
that this is a prerequisite for self-report scales to be considered for use as a screening tool in 
maternity care in the UK (NICE, 2014).  
 
The development and psychometric validation of the screening scale for antenatal anxiety 
presented in this thesis was guided by five main research questions, as listed below:  
 Research question 1: What should a construct definition of antenatal anxiety include 
in order to cover the core domains of problematic anxiety symptoms in pregnancy? 
 
 Research question 2: Which items are the most appropriate to operationalise the 
proposed construct of antenatal anxiety into a self-report rating scale? 
 
 Research question 3: Which items are considered clear, relevant and acceptable by 
the target population and experts, and can thus be used to create a short and 
psychometrically robust self-report scale for the assessment of antenatal anxiety?  
 
 Research question 4: What is the evidence in relation to the convergent and 
discriminant validity, internal consistency and factor structure of the final version of 
the scale?  
 
 Research question 5: How does the new scale perform when compared to the measure 
currently recommended by NICE (GAD-2/7), and to expert assessment using a 
structured diagnostic interview; and what are the optimised cut-off points for 




1.4   Overview of the thesis  
The organisation of the thesis is presented here. Chapter 1 has provided a brief overview of 
the prevalence and assessment methods of common perinatal mental health problems. The 
study aim and research questions were also presented.  
Chapter 2, following an introduction to the construct of general anxiety and anxiety 
disorders, focuses entirely on antenatal anxiety.  Evidence with regard to its prevalence at 
different stages of pregnancy and its role in increasing the risk for adverse maternal and child 
outcomes in the postnatal period is discussed.  The second part of the chapter examines the 
current issues in screening for antenatal anxiety and makes the case for the need for early 
identification and support. The chapter concludes with a rationale for the development of a 
new screening scale for the assessment of problematic anxiety symptoms in pregnant 
women. 
Chapter 3 begins with the presentation of a number of theoretical and methodological 
considerations related to scale development and psychometric testing. The chapter then 
describes the research methodology and the specific research methods that were used to 
develop and conduct preliminary psychometric testing of the scale, and concludes by 
examining the potential ethical issues arising from the research.  
Chapters 4 and 5 presents the two studies that were conducted to inform the initial phase of 
scale development and generation of an initial item pool. A systematic review of the 
psychometric literature of anxiety scales used in pregnancy is reported in Chapter 4. The 
findings from this study were complemented by qualitative interviews with women with 
experience of problematic anxiety symptoms during pregnancy (Chapter 5). 
In Chapter 6, based on the findings of the previous two chapters, a conceptual and an 
operational definition of the construct of antenatal anxiety are proposed. The pool of items 
generated to operationalise the proposed construct is subsequently presented, including a 
preliminary phase of item refinement through the contribution of key informants. Finally, a 
Delphi study is presented in which expert opinion was used to reduce the initial number of 
items from 59 to 30.  
Chapter 7 presents the pilot psychometric testing of the preliminary, 30-item version of the 
scale using a cross-sectional survey. This survey, which aimed to reduce further the number 
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of items through a process of item analysis, resulted in a final, 10-item version of the scale 
named as the Stirling Antenatal Anxiety Scale (SAAS).   
Chapter 8 presents the preliminary psychometric validation of the SAAS. A second cross-
sectional survey conducted in a larger sample of pregnant women is described, in which a 
range of psychometric properties of the new scale were assessed. Its screening performance 
was evaluated against a structured clinical interview, and it was also compared to the GAD-
2/7. 
In the Discussion (Chapter 9), the study aim and research questions are re-examined in light 
of the findings. The strength and limitations of the research are critically discussed, and the 
potential implications for policy and clinical practice are examined. The thesis concludes by 
indicating possible directions for future research, and briefly highlighting the original 







Chapter 2   Perinatal mental health problems: the case of 
antenatal anxiety 
 
2.1  Introduction  
As noted in the introductory chapter, Chapter 2 is almost entirely focused on problematic 
anxiety symptoms during pregnancy (i.e. antenatal anxiety). First, however, it was 
considered appropriate to define and briefly discuss the general construct of anxiety, and 
provide an overview of the most common anxiety disorders. This chapter thus initially 
presents a brief introduction to the construct of anxiety and anxiety disorders (2.2). In 2.3 
several key studies documenting the prevalence of antenatal anxiety, and indicating specific 
groups of women which may be at increased risk, are reviewed. A specific type of anxiety 
that women can experience during the antenatal period (pregnancy-related anxiety) is also 
discussed. Subsequently, a number of studies which examined the potential detrimental 
effects of antenatal anxiety on mother and child are summarised (2.4), and the importance 
of early identification and support is highlighted (2.5). The chapter continues with a 
discussion on the current issues in screening for clinically significant anxiety symptoms in 
pregnant women (2.6), and concludes by providing a rationale for developing a self-report 











2.2 A brief overview of anxiety and anxiety disorders 
Anxiety has been described as a universal human emotion (Simpson, Neria, Lewis-
Fernandez, & Schneier, 2010). It is commonly characterised by a set of physiological, 
affective, behavioural, and cognitive responses to internal or external stimuli which are 
perceived as potentially dangerous or threatening (Barlow, 2002). Its evolutionary 
advantages are well documented in the literature, and it is now clear that anxiety has evolved 
primarily as a defence mechanism to alert us to react promptly to imminent or future dangers 
(Simpson et al., 2010). It is thus a common and normal emotion that serves important signal 
functions (Vanin, 2008). However, when feelings of anxiety become frequent, pervasive, or 
chronic regardless of the presence of an imminent or future threat, they can have a 
considerable negative impact on an individual’s psychological wellbeing and daily 
functioning (APA, 2013). Anxiety symptoms can include excessive worry, heightened 
vigilance, a feeling of pervasive uneasiness, intense fear, physiological arousal, muscle 
tension and behavioural avoidance of stimuli perceived as potentially dangerous (Remes, 
Brayne, van der Linde, & Lafortune, 2016). In this thesis, when the general term “anxiety” 
is used, this will refer to the broad definition provided by the American Psychiatric 
Association (2013) indicating that anxiety is an emotion characterised by feelings of tension, 
worried thoughts, and physical changes like increased blood pressure. With regard to the 
diagnostic approach to anxiety, when anxiety symptoms cause significant distress or become 
chronic they are typically categorised as one of a range of anxiety disorders, according to 
the classifications provided by the DSM (APA, 2013) or the ICD (WHO, 1992). The most 
prevalent and well-known anxiety disorders are Generalised Anxiety Disorder (GAD), 
Social Anxiety Disorder, Panic Disorder, Agoraphobia and Specific Phobia (Remes et al., 
2016). For reasons of brevity, an overview of the core symptoms associated with different 


















 Excessive worry and anxiety related to a range of 
situations/activities 
 Difficulty controlling the worry 






(Social phobia in ICD-10 
classification) 
 
 Marked worry or fear about being the focus of 
attention/acting in a way that may be embarrassing in one 
or more social situations 
 Exposure to social situations invariably causes marked 






 Unexpected and recurrent panic attacks, characterised by 
intense fear or discomfort (physical symptoms may 
include pounding heart, sweating, difficulty breathing).  





 Marked and disproportionate fear in situations such as 
public transport and open spaces 
 Exposure to the feared situation provokes almost 
invariably a panic attack 
 Avoidance behaviours or anticipatory anxiety with 






 Intense anxiety or fear related to a specific situation or 
object, which is disproportionate to the actual danger 
 Exposure to the feared stimuli provokes almost invariably 
a panic attack 
 The anxiety-provoking object or situation is avoided or 





(Included in the ‘Trauma and 
Stressor-Related Disorders’ 
chapter in DSM-5) 
 
 Personal or indirect exposure to traumatic situation such as 
death, threatened death or severe injury 
 Trauma-related flashbacks, nightmares or physical 
reactivity following exposure to stimuli reminding the 
trauma 
 Negative affect, loss of interest in activities 






(Included in the ‘Obsessive-
Compulsive and Related 
Disorders’ chapter in DSM-5) 
 
 Obsessions - Presence of recurrent and unwanted thoughts 
that cause marked anxiety or distress and that the 
individual tries to ignore or suppress with some specific 
thought or action 
                                   AND / OR  
Compulsions – Presence of repetitive behaviours or mental 
acts, such as checking or ordering that are performed in 
response to an obsession or following particular rules.  
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By examining the core symptoms of the anxiety disorders summarised in Table 2, it is 
evident that many common features are shared by the majority of the anxiety disorders. 
While the distinction of anxiety disorders in a number of different diagnostic categories is 
useful for clinical purposes, in recent years a trans-diagnostic approach to the classification 
and treatment of anxiety disorders is emerging in the literature (Norton & Paulus, 2017). 
Notably, Obsessive-Compulsive Disorder (OCD) and Posttraumatic Stress Disorder 
(PTSD), which were classified as anxiety disorders in the DSM-IV-TR (APA, 2000), are no 
longer considered as such in the DSM-V. However, the clinical utility of this reclassification 
has been questioned as OCD and PTSD share many distinctive features of other anxiety 
disorders (Emmelkamp & Ehring, 2014). In this thesis OCD and PTSD will be considered 
under the umbrella of the anxiety disorders, consistently with the ICD-10 classification 
which includes all the anxiety disorders under the same category of Neurotic, stress-related 
and somatoform disorders, and in consideration of the clinical importance of these 
conditions in perinatal women (Chaudron & Nirodi, 2010; Ayers, Meades, & Matthey 
(2015).  
Global epidemiological evidence in the general population indicates that anxiety disorders 
are the most common class of psychiatric disorders worldwide (Kessler et al., 2005; Remes 
et al., 2016). One of the most rigorous systematic reviews of prevalence studies of anxiety 
disorders to date indicated a lifetime prevalence of 28.8% worldwide (Kessler et al., 2005). 
In an epidemiological review of reviews (Remes et al., 2016), women were found to have 
an almost two-fold increased risk of experiencing an anxiety disorder compared to men, with 
a female-to-male ratio of 1.9: 1. This observation is supported by other recent data indicating 
a global time-point prevalence of 4.6% for women compared to 2.6% for men (WHO, 2017). 
Moreover, anxiety disorders are particularly prevalent under 35 years of age (Baxter, Scott, 
Vos, & Whiteford, 2013), with onset of symptoms typically occurring in early adulthood 
(Kessler et al., 2012). In relation to specific anxiety disorders, the highest prevalence is found 
for Generalised Anxiety Disorder and Specific Phobia, both with a lifetime prevalence of 
approximately 6% (Remes et al., 2016). It is also important to note that comorbidity of 
anxiety and depressive disorders is not uncommon, both in the general population (Haug, 
Mykletun, & Dahl, 2004; WHO, 2017) and in perinatal women (Goodman et al., 2014; 
Staneva, Bogossian, Pritchard, & Wittkowski, 2015). This is consistent with the widely 
influential tripartite model of anxiety and depression proposed by Clark and Watson (1991). 
This model postulates that, while some of the core symptoms of anxiety and depressive 
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symptomatology are clearly distinct (i.e. physiological arousal in anxiety and absence of 
positive affect in depression), anxiety and depressive disorders also share a common 
component of general distress that the authors named negative affect (Clark & Watson, 
1991). Following this brief overview of anxiety and anxiety disorders, the rest of the chapter 
is specifically focused on discussing anxiety during pregnancy, which will be mostly referred 

















2.3 Antenatal anxiety 
In the following pages, the term antenatal anxiety will be used to refer to problematic anxiety 
symptoms experienced during pregnancy. This will include both women meeting diagnostic 
criteria for one or more anxiety disorders (WHO, 1992; APA, 2013) during the antenatal 
period, as well as pregnant women scoring above a predefined cut-off on a self-report 
measure of anxiety. A more detailed definition of antenatal anxiety will be provided later in 
this chapter, based on recent evidence that anxiety disorders are only one of the types of 
problematic anxiety symptoms that women can experience during pregnancy. A formal 
definition of the construct of antenatal anxiety is subsequently proposed in Chapter 6.  
 
2.3.1 Antenatal anxiety: common but under-recognised  
As noted in the previous chapter, antenatal anxiety appears to be more common than 
antenatal depression (Grant et al., 2008). The systematic review on the global prevalence of 
antenatal anxiety reported earlier indicated prevalence ranging from 15 to 23%, for 
diagnosed anxiety disorders and self-reported anxiety symptoms respectively (Dennis et al., 
2017). Although accurate prevalence estimates for antenatal anxiety remain challenging 
because of a number of factors, including the heterogeneity of assessment methods used and 
timing of assessment (i.e. different trimesters), the largest longitudinal study (n > 8000) 
conducted in the UK on the prevalence of self-reported symptoms of anxiety and depression 
in the perinatal period found that approximately 14% of women experience elevated levels 
of anxiety during pregnancy (Heron et al., 2004), with similar prevalence at 18 and 32 
gestational weeks. This study also provided strong evidence for the relative stability of 
anxiety symptoms across the perinatal period, as illustrated by the fact that two-thirds of 
women reporting significant anxiety symptoms in the postpartum period had already 
experienced anxiety during pregnancy. A number of other studies have reported similar 
prevalence, indicating that problematic anxiety symptoms affect approximately 15% of 
women, both in early pregnancy (Rubertsson et al., 2014) and in later stages (Lee et al., 
2007; Grant et al., 2008; Goodman et al., 2014). The well-documented high prevalence of 
antenatal anxiety is of particular concern when its significant under-recognition in routine 
maternity care is considered. Both NICE (2014) and SIGN (2012) guidance on perinatal 
mental health have observed that common perinatal mental health problems, and in particular 
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anxiety disorders, often go unrecognised and thus untreated throughout pregnancy and the 
postnatal period. This is certainly due to a combination of factors, but it has been suggested 
that the traditional emphasis on depression in perinatal mental health care and a hierarchical 
diagnostic custom in clinical practice may lead to prioritise depressive over anxiety 
symptomatology (Matthey et al., 2013a; Dennis et al., 2017). It is also important to note that 
there is evidence indicating that a proportion of women experiencing mental health 
difficulties during pregnancy are likely to present with comorbid disorders (Grant et al., 
2008; Fairbrother et al., 2016).  
In relation to specific groups of women at higher risk of antenatal anxiety, the research 
literature has identified a number of obstetric, psychosocial and contextual factors that 
increase the risk of experiencing antenatal anxiety. The most commonly reported include a 
previous history of mental health problems (Rubertsson et al., 2014; Marchesi et al., 2014; 
Bayrampour, McDonald, Fung, & Tough, 2015), low educational level (Glazier, Elgar, Goel, 
& Holzapfel, 2004; Bodecs et al., 2013), lack of perceived social support (Lee et al., 2007; 
Grant et al., 2008; Martini et al., 2015), a history of domestic abuse (Fisher et al., 2011)  and 
a past experience of pregnancy loss or obstetric complications (Armstrong, 2004M; Waqas 
et al., 2015). There is also evidence, although more limited, for other variables to be 
predictive of antenatal anxiety, including low income (Prady et al., 2013) and being a single 
mother (Faisal-Cury & Rossi Menezes, 2007). Contradictory findings have been reported in 
relation to other factors such as age (Biaggi et al., 2016), with some studies indicating that 
younger women are at higher risk (Lee et al., 2007; Rubertsson et al., 2014) and others 
reporting that women over 35 years of age are more likely to experience antenatal anxiety 
(Nasreen, Kabir, Forsell, & Edhborg, 2011; Fisher et al., 2011). The observation that women 
who have experienced a miscarriage and those with a present or past history of obstetric 
complications are at higher risk of clinically significant anxiety during pregnancy is 
significant. Considering that approximately 10 to 15% of pregnant women have at least one 
experience of previous miscarriage (Royal College of Obstetricians and Gynaecologists 
[RCOG], 2017), these women could be specifically targeted with regular monitoring of their 
emotional wellbeing throughout pregnancy. Pregnant women can obviously experience any 
of the anxiety disorders that are also found in the general population. However, anxiety 
disorders are not the only type of problematic anxiety that women can experience during 




2.3.2 The case of pregnancy-related anxiety   
During the antenatal period, women can experience significant worries and fears that are 
specific to pregnancy (Blackmore, Gustafsson, Gilchrist, Wyman, & O’Connor, 2016). The 
occurrence of pregnancy-related anxiety has been proposed as a specific and distinct 
syndrome (Huizink, Mulder, Robles De Medina, Visser, & Buitelaar, 2004) and a growing 
body of empirical evidence, briefly discussed below, would appear to support its clinical 
distinction from other forms of anxiety that women can experience during pregnancy 
(Brunton et al., 2015; Blackmore et al., 2016; Witteveen et al., 2016). Pregnancy-related 
anxiety (hereafter often referred to as PrA) can be defined as a particular anxiety response 
in which symptoms of anxiety are specifically focused on pregnancy and childbirth, and may 
include persistent worries regarding the health of the woman and fetus, fear around labour 
and delivery and concerns around physical appearance and future parenting (Orr, Blazer, 
James, & Reiter, 2007; Dunkel Schetter & Tanner, 2012). It is reasonable to expect that most 
expectant women will experience a level of worry and anxiety regarding these aspects of 
pregnancy and childbirth, which are also thought to serve important functions in protecting 
the fetus from potential harm and preparing for parenthood (Haines et al., 2015). It is thus 
particularly important not to consider these common and normal concerns as indicators of 
pathological or problematic anxiety. However, similarly to anxiety disorders, if these fears 
and worries become persistent or particularly distressing they can have a detrimental impact 
on a woman’s psychological wellbeing over the course of pregnancy (Wijma & Wijma, 
2017). While this anxiety type is not covered by standard diagnostic classifications, it is of 
clinical significance as it can lead to negative outcomes for mother and child, as discussed 
later in this section.  
Initial psychometric evidence of PrA as a psychological construct that can be distinguished 
from general antenatal anxiety was provided by Huizink and colleagues (2004) who 
developed a self-report scale, the Pregnancy-Related Anxiety Questionnaire – Revised 
(PRAQ-R), based on previous attempts at measuring PrA (Levin, 1991). The scale was tested 
on nulliparous women (i.e. in their first pregnancy), who completed both the PRAQ-R and 
a measure of general anxiety (STAI: Spielberger et al., 1983). The authors found that the 
STAI and factors of the PRAQ-R only shared low to moderate variance (8-27%), and 
interpreted this as an indication that PrA should be considered as a distinct syndrome, which 
can be reliably distinguished from general anxiety and anxiety disorders during pregnancy. 
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Comparable findings, indicating only a moderate overlap between PrA and general antenatal 
anxiety using the PRAQ-R, were replicated in some other studies, both in nulliparous and 
multiparous women (Arch, 2013; Westerneng, de Cock, Spelten, Honig, & Hutton, 2015). 
Several other scales to measure PrA have been developed, including the Pregnancy-Specific 
Anxiety Scale (PSAS: Roesch et al., 2004) and the Wijma Delivery Expectancy/Experience 
Questionnaire (W-DEQ: Wijma, Wijma, & Zar 1998), the latter specifically focused on fear 
of childbirth as a domain of PrA. Other authors have, however, argued that while PrA 
describes worries specifically related to pregnancy and childbirth, the nature of the 
symptoms (e.g. excessive worrying) closely resembles anxiety symptoms as experienced in 
the general population, and consequently that pregnancy-related anxiety should not be 
conceptualised as a distinct syndrome (Bar-Shai, Gott, Kreinin, & Marmor, 2015). In sum, 
although the literature on PrA is still relatively limited, several authors have proposed that 
the psychological construct of PrA is at least partially distinct from general anxiety during 
pregnancy (Blackmore et al., 2016). An important implication of this is that women 
experiencing problematic PrA symptoms may not meet diagnostic ICD or DSM criteria for 
an anxiety disorder or score above cut-off point on a measure of general anxiety (Meades & 
Ayers, 2011; Brunton et al., 2015), and consequently go unrecognised in routine antenatal 
care.  
 
Fear of childbirth 
Within the research literature on pregnancy-related anxiety, fear of childbirth has been 
recognised as an important dimension of PrA (Heimstad, Dahloe, Laache, Skogvoll, & 
Schei, 2006; Rubertsson et al., 2014). Fear of childbirth (FoC), sometimes also referred to 
as tokophobia, can be defined as intense anxiety or fear related to the expectation of giving 
birth (Heimstad et al., 2006; Lukasse, Schei, & Ryding, 2014). It may include fears about 
uncontrollable pain during labour and medical interventions, and intense anxiety that the 
woman or baby may die during delivery (Klabbers, 2016). FoC is estimated to affect 
approximately 10% of pregnant women when measured with specific scales such as the W-
DEQ (Wijma et al., 1998), and it has been documented that at least 5-6% of all pregnant 
women experience fear related to childbirth that is severe or disabling (Heimstad et al., 2006; 
Lukasse et al., 2014). The increased interest towards FoC is mainly due to the observation 
that FoC appears to increase significantly the chance of a woman opting for an elective 
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caesarean section (elective C-section), when there is no medical indication to support this 
choice (Handelzalts et al., 2012). Lukasse and colleagues (2014) used the W-DEQ to conduct 
a large study aimed to examine the prevalence of FoC in six European countries and found 
that severe fear of childbirth affected between 4.5% and 15.2% of women (respectively in 
Belgium and Sweden). Evidence that FoC increases the risk of elective C-section deserves 
particular attention, considering that C-sections are known to increase the risk of negative 
health outcomes for women and babies (RCOG, 2012). Rates of caesarean sections in the 
Western world have consistently risen over the last few decades (Betran et al., 2018). In the 
UK, figures published by the UK National Maternity and Perinatal Audit (RCOG, 2017) and 
referring to the period 2015-2016 show that the mode of birth was caesarean in 25% of cases. 
10.8% of women opted for an elective C-section (emergency 14.2%), compared to 
approximately 4% of women in 1980. If women who are experiencing moderate or severe 
FoC were identified at the earliest opportunity during pregnancy and given the appropriate 
support to manage these fears and worries related to giving birth, this could arguably result 
in a reduction of women opting for an elective C-section, with a considerable potential for 
improved birth and postnatal outcomes for mother and child. However, no measures of PrA 
or fear of childbirth are currently used in routine antenatal care in the UK.  
 
2.3.3 A construct in search of a definition 
It is evident from the above that the current research on antenatal anxiety is characterised by 
the use of a considerable variety of anxiety scales, including measures of general anxiety, 
specific anxiety disorders (e.g. GAD-7) and pregnancy-related anxiety. This heterogeneity 
of screening scales appears to reflect substantial differences in how researchers have defined 
and conceptualised the psychological construct of anxiety during the antenatal period (Grant 
et al., 2008; Brunton et al., 2015).  
Based on the body of literature reported above and in Chapter 1 in relation to different types 
of clinically significant anxiety symptoms that pregnant women can experience, antenatal 
anxiety will be used in the following chapters to refer to pregnant women who meet at least 
one of these criteria:  
 Diagnosed with one or more anxiety disorders, based on standard diagnostic 
classification 
 Scoring above a validated cut-off score on a self-report anxiety measure 
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 Experiencing pregnancy-related anxiety or fear of childbirth as assessed by a PrA 
measure  
 
Each of the criteria above is related to problematic anxiety symptoms during pregnancy. It 
is thus important to consider that anxiety in the antenatal period may present in different 
forms, all of which can cause significant distress to women and deserve clinical attention 
(Ayers et al., 2015). The general term antenatal anxiety will thus be used here to refer to the 
range of problematic anxiety symptoms that women can experience during pregnancy. When 
pregnancy-related anxiety is specifically discussed, this will be specified in the text. A more 

















2.4 Antenatal anxiety and the risk of negative outcomes for mother and 
child 
The following sections provide a brief summary of the growing body of evidence which has 
examined the short- and long-terms effects of antenatal anxiety on a range of maternal and 
child outcomes.  
 
2.4.1 Maternal postnatal disorders 
Antenatal anxiety has been consistently found to be an important predictor of postnatal 
anxiety and depression in numerous studies conducted over the last two decades (Sutter-
Dallay, Giaconne-Marcesche, Glatigry-Dallay, & Verdoux, 2004; Austin et al., 2007; 
Milgrom et al. 2008; Grant et al., 2008; Verreault et al., 2014). A large prospective study 
conducted in the UK by Heron and colleagues (2004), which was briefly discussed earlier, 
examined the patterns of self-reported anxiety and depressive symptoms from the second 
trimester of pregnancy up to eight months postnatally. The authors found that a considerable 
proportion of cases of postnatal anxiety and depression could be predicted antenatally. In 
particular, almost half (47%) of women experiencing postnatal depression had already 
reported elevated depressive symptoms in pregnancy. Anxiety in the perinatal period was 
even more stable, with 64% of women reporting elevated levels of anxiety symptoms both 
in pregnancy and in the postpartum period. A further, significant finding from this large 
study (n > 8000) was that antenatal anxiety predicted not only postnatal anxiety but also 
postnatal depression, both at 8 weeks and 8 months postpartum. Women who experienced 
anxiety at 32 weeks gestation had a more than three-fold increased risk to experience 
persistent postnatal depression (Odds ratio [OR] = 3.22), even after accounting for antenatal 
depression (Heron et al, 2004).  
Antenatal anxiety as a predictor of postnatal depression 
While there is evidence of antenatal anxiety as a risk factor for both postnatal anxiety and 
depressive symptoms, evidence regarding the association between antenatal anxiety and 
postnatal depression is particularly robust. A considerable number of studies have 
consistently indicated that women experiencing antenatal anxiety have a three- to five-fold 
increased risk of developing postnatal depression (Lee et al., 2007; Verreault et al., 2014; 
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Norhayati et al., 2015). Antenatal anxiety appears to predict postpartum depression both 
when measured with a self-report rating scale and when formal diagnostic criteria are used 
to determine the presence of an anxiety disorder in pregnancy. For example, Grant and 
colleagues (2008) found that symptoms of anxiety in pregnancy meeting diagnostic criteria 
led to significantly greater odds (OR: 4.97) of experiencing a depressive or anxiety disorder 
in the months following childbirth. A recent systematic review has confirmed that antenatal 
anxiety is an important risk factor for the development of postpartum depression (Goodman 
et al., 2014). The authors of this review found a significant association in all of the reviewed 
studies investigating the role played by antenatal anxiety symptoms in predicting maternal 
postnatal problems. While most of the studies discussed above used general anxiety 
measures, when pregnancy-related anxiety scales were employed, they were also predictive 
of postnatal depression (Blackmore et al., 2016). A somewhat surprising finding in a number 
of studies is that antenatal anxiety appears to predict postpartum depression more accurately 
than antenatal depression (Matthey, Barnett, Howie, & Kavanagh, 2003; Heron et al., 2004; 
Verreault et al., 2014). The combination of these findings would appear to indicate that 
screening for antenatal anxiety provides a key opportunity for targeting in pregnancy, 
through early identification and support, women at risk of postnatal mental health disorders.  
 
2.4.2 The effects on child: Possible mechanisms of transmission  
Before discussing the range of negative birth and child developmental outcomes found to be 
associated with antenatal anxiety, it is important to briefly outline the main hypothesis that 
has been proposed to explain the mechanisms by which maternal antenatal anxiety can 
negatively affect fetal development, birth outcomes and child developmental trajectories. 
Gestation is a time of rapid cell division and organ development for the fetus, which during 
this period is particularly sensitive to both beneficial and detrimental influences from the 
maternal environment, with potential consequences on health outcomes across the lifespan 
(Davis & Sandman, 2012; Cao-Lei, Laplante & King, 2016). This is commonly known as 
the fetal programming hypothesis (Barker, 1998), which postulates that fetal development is 
strongly influenced by responses of the fetus to intrauterine conditions throughout the 
prenatal period (Hocher, 2014). Maternal physiological responses to anxiety or significant 
stressors can affect the release of specific hormones which can, in turn, alter the fetal 
environment (Aizer, Stroud, & Buka, 2009; Dunkel-Schetter & Lobel, 2011; Staneva et al., 
2015; Van den Bergh, 2016).  
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Glucocorticoids, and in particular cortisol, have been indicated as primary candidates for 
fetal programming in the context of maternal antenatal anxiety (Wadhva, 2005; Blair, Glynn, 
Sandman, & Davis, 2011). Cortisol is secreted by the hypothalamic-pituitary-adrenal (HPA) 
axis, and a large body of evidence exists indicating the association between exposure to 
stressors or persistent anxiety and increased levels of this glucocorticoid (Kirschbaum et al., 
1995; Hunter, Minnis, & Wilson, 2011). It is estimated that approximately 40% of in-utero 
levels of cortisol are determined by concentration levels of maternal cortisol (Gitau et al., 
2001). This is of particular importance as there is now evidence that in utero exposure to 
elevated levels of glucocorticoids, including cortisol, can have detrimental effects on the 
fetus and on brain development (Reynolds, 2013). One of the mechanisms by which 
excessive levels of fetal cortisol may have a detrimental effect on the developing fetus is by 
affecting fetal growth, thus increasing the risk of premature birth and lower birth weight 
(Goodman et al., 2014), with potentially poorer short- and long-term health outcomes 
(Barker, 1998; Dueker, Chen, Cowling, & Haskin, 2016).  
It has been suggested that the detrimental effects on the fetus and the developing child are 
also likely to be mediated by timing and length of exposure to maternal prenatal distress 
(Stein et al. 2014). In the context of antenatal anxiety, this hypothesis is supported by a 
number of studies, which found that maternal anxiety is a better predictor of adverse birth 
outcomes when it is prolonged during pregnancy, as well as in the third trimester of gestation 
(DiPietro, Hilton, Hawkins, Costigan, & Pressman, 2002; Lobel et al., 2008; Blair et al., 
2011). This observation is of critical importance, as it suggests that early identification and 
treatment of women experiencing antenatal anxiety might considerably increase the chance 
to prevent, or at least reduce, the risk of poorer fetal and child developmental outcomes. 
In sum, it has thus been proposed that the potential detrimental effects of maternal antenatal 
anxiety on the child may begin in utero (Staneva et al., 2015). Although the specific 
mechanisms in action to explain the underlying association between prenatal exposure to 
maternal anxiety and negative birth and child outcomes remain uncertain, evidence now 
exists documenting the specific association between antenatal anxiety and increased risk for 
a range of adverse neonatal and child developmental outcomes. A brief overview of this 





2.4.3 Obstetric and birth outcomes 
In recent years, an increasing number of studies have investigated the association between 
antenatal anxiety and a range of fetal and neonatal outcomes (O’Connor, Heron, Golding, & 
Glover, 2002; Heron et al., 2004; Dunkel Schetter et al., 2012). The research literature has 
focused mainly on two neonatal outcomes: gestational age at birth and infant birth weight.  
Gestational age at birth is an important indicator of neonatal wellbeing (Tucker & McGuire, 
2004). Premature birth, commonly defined as birth before the completion of the 37th 
gestational week (RCOG, 2017), is a well-known risk factor for subsequent health problems 
throughout the lifespan (Barker et al., 1998; Hagberg & Wennerholm, 2000). The association 
between maternal antenatal anxiety and greater risk of premature birth has been examined 
in numerous studies ((Mancuso, Schetter, Rini, Roesch, & Hobel, 2004; Berle et al., 2005; 
Dunkel-Schetter and Lobel, 2011, Ibanez et al., 2015). In a systematic review and meta-
analysis of the effects of maternal anxiety in pregnancy on length of gestation (Ding et al., 
2014), twelve studies were reviewed and a statistically significant, although modest, 
association was found between antenatal anxiety and preterm delivery, with a pooled risk 
ratio = 1.50. On the other hand, the authors of a narrative summary of the literature conducted 
in the same year argued that the evidence regarding the association between antenatal anxiety 
and premature birth is still inconclusive, because of the small number of studies and the 
frequent comorbidity of depressive and anxiety symptoms which may be a confounding 
factor (Stein et al., 2014). However, a more recent systematic review (Staneva et al., 2015) 
reported consistent associations between elevated levels of anxiety in pregnancy and preterm 
birth, with the majority of reviewed studies supporting this hypothesis.    
There is also evidence suggesting an association between elevated anxiety in pregnancy and 
lower birth weight. Low weight at birth, similarly to premature birth, is a significant 
predictor of poorer short- and long-term health outcomes (Phillips, 2002). Two recent 
systematic reviews investigated the effects of maternal anxiety during pregnancy on birth 
weight. A study by Ding and colleagues (2014) reviewed six studies and concluded that there 
was evidence to indicate that exposure to maternal anxiety in pregnancy increases the risk 
of low birth weight (pooled risk ratio = 1.76). A second review (Goodman et al., 2014) 
applied more stringent inclusion criteria, by examining only studies in which the presence 
of antenatal anxiety was established according to formal diagnostic criteria (WHO, 1992; 
APA, 2013). Three studies found that infants of mothers who had experienced specific 
anxiety disorders, namely specific phobia, PTSD and panic disorder, were more likely to 
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have lower birth weight when compared to infants of women in a control group. In contrast, 
three other investigations did not show any significant association between lower weight at 
birth and Generalised Anxiety Disorder or any anxiety disorder. These two reviews indicate 
that a modest association between antenatal anxiety and lower birth weight may exist, 
although mixed findings were reported.  
In conclusion to this brief overview of the effects of antenatal anxiety on neonatal outcomes, 
the body of research discussed above would appear to support the hypothesis that maternal 
anxiety during pregnancy is associated with higher risk for negative fetal and birth outcomes. 
Despite the relative paucity of studies which have examined these adverse neonatal 
outcomes in the context of antenatal anxiety, the overall evidence shows the potential 
detrimental effects of antenatal anxiety, particularly on length of gestation. The next section 
summarises the literature on the effects of antenatal anxiety later in life, from the early years 
up to late adolescence.  
 
2.4.4   Association with child development outcomes  
If antenatal anxiety can negatively affect fetal development and birth outcomes, it may also 
have an adverse impact on child development outcomes. A growing body of research has 
emerged in recent years investigating this potential association, and numerous studies have 
been conducted to examine a range of neurodevelopmental, cognitive, affective, and 
behavioural outcomes for children whose mothers had experience of anxiety in pregnancy 
(Van den Bergh et al., 2005; Talge et al., 2007; Glover, 2016). An investigation conducted 
on Australian women in their third trimester of pregnancy (Austin, Hadzi-Pavlovic, Leader, 
Saint, & Parker, 2005) indicated that elevated maternal anxiety at this time predicts difficult 
infant temperament, an index of emotional reactivity, at 4 and 6 months of age (OR = 2.56). 
Importantly, antenatal depression was not found to be a risk factor for problematic infant 
temperament. An American cohort of women and their babies were assessed from pregnancy 
up to twelve months postpartum to examine the effects of antenatal anxiety on cognitive 
functioning and fine and gross motor skills (Keim et al., 2011), and found that elevated levels 
of anxiety in pregnancy were associated with poorer overall infant cognition, after 
controlling for a number of other variables. Early cognitive and motor development was also 
recently investigated in a French study conducted with over 1300 mother-baby dyads (Ibanez 
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et al., 2015). The researchers found strong associations between maternal anxiety assessed 
at 24-28 weeks gestation and poorer developmental trajectories at two and three years of 
age, particularly in the domains of communication, fine motor and personal-social skills as 
measured by the Ages and Stages questionnaire. Once again, this association was not found 
to be significant for antenatal depression. This appears to highlight the crucial and specific, 
adverse role played by antenatal anxiety on child developmental outcomes. Similar findings 
were reported in other recent studies (Glover et al., 2016; Lin et al., 2017). 
A number of studies have also shown significant associations between antenatal anxiety and 
behavioural and affective problems during childhood and pre-adolescence. Van den Bergh 
and colleagues (2004) showed that antenatal anxiety during the late first trimester and second 
trimester was predictive of ADHD symptoms and poorer emotional regulation in 8- and 9-
year olds, with 22% of the variance in these symptoms explained by maternal antenatal 
anxiety. The significant association remained even when a range of factors, including 
postnatal maternal mental health problems and parental educational level, were controlled 
for. In another investigation, 7-year olds of mothers who experienced anxiety during 
pregnancy had a two-fold increased risk for emotional and behavioural problems (O’Connor 
et al., 2003). A modest association between antenatal anxiety and poorer behavioural and 
affective outcomes in children aged 10 and 11, as reported by mothers and teachers, was also 
found by Leis and colleagues (2014).  
Several large, longitudinal studies have also reported poorer developmental outcomes and 
worse self-reported mental health during adolescence, up to age 18. These investigations are 
commonly based on large cohorts, as in the example of the ALSPAC (Avon Longitudinal 
Study of Parents and Children) study, a prospective cohort study which recruited pregnant 
women in the Avon region (UK) during 1992 and followed up their children for an extended 
period of time to investigate the association between maternal characteristics and a wide 
range of health and social outcomes. Capron and colleagues (2015), analysing data from a 
subset of over 4000 adolescents from the ALSPAC population cohort, showed that maternal 
anxiety in pregnancy increases the risk of self-reported anxiety or depression at 18 years of 
age (adjusted odds ratio = 1.39). Other studies have indicated an association between anxiety 
during pregnancy and increased risk for poorer outcomes in adolescence, including higher 
impulsivity (Van den Bergh et al., 2005) and higher risk of experiencing anxiety or 
depression (Betts, Williams, Najman, & Alati, 2014). A criticism that could be raised 
regarding the body of research discussed above relates to the potential role of a wide range 
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of confounders in determining child developmental trajectories. However, at least one study 
based on a large dataset from the ALSPAC cohort showed that, even when a variety of 
potential confounders such as maternal postnatal mental health problems, socio-economic 
status, and level of education were controlled for, the negative effects of antenatal anxiety 
on offspring persisted (O’Donnell et al., 2014).  
Some authors have suggested that, based on a review of the literature, antenatal anxiety 
appears to account for approximately 10-15% of adverse developmental outcomes (Glover, 
2014). It could thus be argued that, although uncertainty remains about the real magnitude 
of the effects of antenatal anxiety on child development, the relatively common occurrence 
of antenatal anxiety and the consequent high number of children potentially affected imply 
that even a relatively small negative effect on birth and child developmental outcomes can 
still result in a considerable impact on public health (Ding et al., 2014; Bauer et al., 2014). 
In sum, an increasing body of literature documenting the negative impact of antenatal 
anxiety on maternal postnatal mental health and on a range of offspring outcomes now exists. 
Early recognition and timely treatment of women experiencing antenatal anxiety may thus 
have significant, beneficial effects in preventing a wide range of negative outcomes for 












2.5 The importance of early identification and support  
The findings presented above have important clinical implications. First, there is substantial 
evidence documenting the association between antenatal anxiety and postnatal depression 
and anxiety (Verreault et al., 2014; Goodman et al., 2014). Maternal antenatal anxiety can 
thus be considered an early marker that health professionals could use to identify during 
pregnant women at higher risk of poor mental health in the postnatal period (Grant, 2008). 
This is also true for the negative impact that antenatal anxiety, probably through the 
mechanism of fetal programming, can have on birth and child developmental outcomes. 
While further research is needed to improve our understanding of the interplay of a range of 
biological, psychological and contextual factors in determining adverse birth and 
developmental outcomes, the evidence reviewed above clearly indicates that antenatal 
anxiety is at least moderately associated with potentially serious consequences for the child, 
both short- and long-term. Of particular importance is the observation of the cumulative 
effect of antenatal anxiety in predicting child outcomes, with some studies showing that 
prolonged periods of exposure to maternal antenatal anxiety are associated with worse 
outcomes for the child (Lobel et al., 2008; Blair et al., 2011). These adverse effects are, 
however, not inevitable. The antenatal period, with its frequent contacts between women and 
healthcare professionals, provides important opportunities for prevention. If women 
experiencing problematic anxiety in pregnancy are identified early, they can be offered the 
appropriate support which is likely to result in a reduction of symptoms and improved 
outcomes, given that evidence-based interventions and forms of treatment exist (Marchesi 
et al., 2016). At a time when public funds for health services are under restraint, prevention 
is recognised by the NHS as a strategic objective, with the NHS Five-year Forward View 
(NHS England, 2014) emphasising the need for “a radical upgrade in prevention and public 
health” (p. 9). Perinatal mental health care is arguably one of the rare clinical areas in which 
preventative strategies and interventions can potentially improve outcomes in two 
individuals at the same time, and reduce the significant health, social and economic costs 
associated with perinatal mental health problems. This was clearly illustrated in a report 
published by the London School of Economics (Bauer et al., 2014), which estimated the 
costs for healthcare services and the wider society of neglecting perinatal mental health 
problems in the UK. This analysis was the first of its kind, as it estimated the economic costs 
of perinatal depression, anxiety and postpartum psychosis, taking into account the adverse 
effects of maternal mental health problems on children as well as women. The report 
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indicated a staggering figure of approximately £8.1 billion as the total cost of the impact of 
untreated perinatal mental health problems for each one-year cohort of births in the UK, with 
nearly three-quarters (72%) of this cost related to adverse impact on the child rather than the 
mother (Bauer et al., 2014). 
A strong economic argument thus also exists to promote the early assessment and treatment 
of perinatal mental health problems. However, as previously discussed, under-recognition 
of mental health problems throughout the perinatal period remains a major issue. This is 
particularly true for common mental health difficulties such as perinatal anxiety and 
depression (NICE, 2104), with a recent report from the Centre of Mental Health estimating 
that in the UK only half of all cases of perinatal depression and anxiety are identified, and 
even less receive evidence-based forms of treatment. (Khan, 2015). In the context of 
antenatal anxiety, while the introduction of the GAD-2 as a brief screening measure is 
certainly a positive step, this scale and many other anxiety scales currently used in research 
and clinical settings have a number of important limitations when used to assess specifically 













2.6   Issues in screening for antenatal anxiety 
The assessment and identification of women experiencing antenatal anxiety is problematic 
for a number of reasons. As noted in the first chapter, both in research settings and in busy 
clinical practice self-report scales are commonly favoured over clinical diagnostic 
interviews, which are time-consuming and require specific training. In the vast majority of 
cases, self-report scales used to assess antenatal anxiety were originally developed for use 
in the general population (Meades & Ayers, 2011). This is also the approach adopted by 
NICE (2014) to identify women experiencing poor mental health during the perinatal period 
in routine antenatal care, with the recommendation to use brief screening tools developed 
for the general population such as the PHQ-2 and the GAD-2 to screen for perinatal 
depression and anxiety respectively. It was also noted earlier that the GAD-2 consists of two 
questions (“During the past month have you been feeling nervous, anxious, or on edge?” 
and “During the past month have you not been able to stop or control worrying?”), with 
scores ranging from 0 = ‘not at all’ to 3 = ‘nearly every day’. A cut-off score of 3 or above 
is recommended by NICE to screen for problematic anxiety symptoms. By examining the 
content of these two questions, it could be argued that while women with more severe anxiety 
symptoms are likely to score ≥ 3, this cut-off may not be appropriate to discriminate reliably 
between the common feelings of anxiety that can be experienced during pregnancy, and 
problematic anxiety symptoms that would require appropriate support. The GAD-2 consists 
of the initial two questions of the GAD-7, which was developed to assess specifically 
Generalised Anxiety Disorder. NICE recommends use of the longer GAD-7 for further 
assessment, or referral to a GP or mental health practitioner, if a woman scores ≥ 3 on the 
GAD-2 (NICE, 2014). However, perhaps surprisingly, at the time of the publication of the 
guidelines no studies on the screening accuracy of the GAD-2 in pregnant or perinatal 
populations existed. Since then, very limited psychometric evidence for the GAD-7 (Zhong 
et al., 2015) and the GAD-2 (Nath et al., 2018) has been published. The NICE Guideline 
Development Group in the full version of the guideline commented that, considering the 
inadequate evidence on the screening accuracy of case identification tools specific to the 
assessment of perinatal anxiety, the recommendation to use the GAD-2/7 drew heavily on 
the evidence base from other guidelines for screening tools in non-pregnant populations 
(NICE, 2011).  
Over the course of the last decade, three systematic reviews have examined the psychometric 
properties of anxiety scales used in pregnant or perinatal populations (Meades & Ayers, 
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2011, Evans et al., 2015, Brunton et al., 2015). Meades and Ayers (2011) reviewed general 
anxiety measures with published psychometric data in the perinatal period, while Evans and 
colleagues (2015) examined both general anxiety and pregnancy-related anxiety measures, 
but limited their review to the antenatal period. On the other hand, Brunton and colleagues 
(2015) focused exclusively on PrA scales. Two findings, common to all these reviews, are 
of particular relevance here. First, the authors of the three reviews highlighted the general 
lack of satisfactory psychometric properties (i.e. indexes of scale reliability and validity, 
discussed in Chapter 3) of anxiety scales used in the antenatal period, as well as the lack of 
measures which take into account both general antenatal anxiety and PrA. In second place, 
the reviews revealed the considerable variety of anxiety scales used to assess antenatal 
anxiety which, as previously observed, would seem to reflect substantial differences in how 
researchers have defined and conceptualised this psychological construct (Meades & Ayers, 
2011; Brunton et al., 2015). It has also been observed that in numerous cases researchers 
have opted for a specific anxiety scale primarily because of its good psychometric properties 
in the general population (Grant et al., 2008). However, an anxiety scale developed for use 
in other populations may not retain its psychometric properties when used to assess anxiety 
in pregnant women, for a number of reasons which are briefly discussed here.  
 
Confounding role of physical symptoms  
One of the main limitation of numerous anxiety scales developed for the general population 
relates to their emphasis on physical symptoms and their potential confounding role when 
questions on somatic symptoms are used to screen for anxiety during pregnancy (Biaggi et 
al., 2016). Physical complaints such as dizziness, sleep problems or difficulty to relax can 
be relatively common experiences in pregnancy, without necessarily being indicators of poor 
mental health (Tebbe et al., 2013). Some of these symptoms, however, resemble closely 
symptoms of anxiety disorders and are thus included in many anxiety scales. This can 
potentially lead to inflated scores and high numbers of false positives when these scales are 
used to screen for anxiety in pregnant women (Lee et al., 2007; Ayers, Coates & Matthey, 
2015).    
Inaccurate cut-off scores 
A further, significant issue in the use of general anxiety measures to identify women 
experiencing antenatal anxiety is that cut-off scores validated for other populations to 
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distinguish ‘cases’ from ‘non-cases’ might not be accurate when used in the antenatal period. 
The body of literature on antenatal anxiety provides numerous examples of studies in which 
researchers have used a specific cut-off score simply based on its widespread use in the 
general population, without further psychometric testing specific to pregnant women (Lee et 
al., 2007; Rubertsson et al., 2014). However, cut-off scores require recalibration when they 
are used in populations with substantial differences from the one they were originally 
validated for (Jomeen & Martin, 2005a). Meades and Ayers (2011), for instance, observed 
that the STAI has been used in different studies on antenatal anxiety with cut-off scores 
ranging from >40 to >48 (Grant et al., 2008; Field et al., 2010), without any prior validation 
of these cut-offs in pregnant populations. This can lead to inaccurate prevalence estimates, 
as in the case of Lee and colleagues (2007) who used the Hospital Anxiety and Depression 
Scale (HADS) with the cut-off validated in the general population (> 7 for the anxiety 
subscale) and found that over 35% of women in their sample experienced antenatal anxiety 
based on this measurement. In sum, anxiety scales developed for the general population 
require further psychometric testing and validation when used in the antenatal period. 
However, only a paucity of studies have provided any evidence of the measurement 
properties of scales when they are used to measure antenatal anxiety, and this can lead to 
misinterpretation of scores and inaccuracy of findings (Evans et al., 2015). The use of the 
GAD-2 as recommended by NICE (2014) is thus only one of various examples of the 
application of scales developed for the general population to the perinatal period. While in 
research studies this choice may lead to inaccurate findings, the implications of using a 
potentially inaccurate measure in clinical settings are obviously more problematic.  
General antenatal anxiety vs pregnancy related anxiety scales 
There is also uncertainty in relation to whether to use measures for anxiety disorders or scales 
developed to assess specifically pregnancy-related anxiety (Meades & Ayers, 2011) to 
identify women experiencing problematic anxiety symptoms during pregnancy. Symptoms 
related to pregnancy-specific anxiety and worries may not be detected by general anxiety 
measures. Conversely, PrA instruments developed exclusively to identify anxiety symptoms 
related to a current pregnancy will not identify women experiencing different anxiety 
disorders (e.g. Social Anxiety). However, as discussed previously in this chapter, both 
anxiety disorders and pregnancy-related anxiety are of clinical importance and deserve 
attention. While the screening accuracy of the GAD-2 in identifying women experiencing 
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general antenatal anxiety still needs to be established, this brief measure certainly does not 
appear to be appropriate to screen for pregnancy-related anxiety.  
To conclude this section, it would appear clear from the above that current assessment 
methods of antenatal anxiety, including the one currently recommended by NICE (2014), 
are not evidence-based and may thus lead to incorrect identification, potentially creating 
unmotivated worry and anxiety. Following this overview of the current issues in screening 
for antenatal anxiety, this chapter concludes by providing a brief rationale for the 



















2.7 The development of a screening scale for antenatal anxiety 
The lack of self-report scales with an adequate evidence base to assess antenatal anxiety 
documented above constitutes a significant barrier to the recognition of women experiencing 
problematic anxiety symptoms during pregnancy, and a number of authors in recent years 
have advocated the use of a brief scale for the universal screening of antenatal anxiety 
(Rubertsson et al., 2014; Brunton et al., 2015; Biaggi et al., 2016). It could be argued that, 
ideally, such a scale should be developed specifically for the antenatal period and take into 
account symptoms of both general antenatal anxiety and PrA. NICE, in its review of scales 
to be considered for the identification of perinatal mental health problems which informed 
the most recent guidelines (2014), only considered brief scales as potentially feasible to 
implement in maternity care settings. As observed in Chapter 1, brief scales were defined as 
those containing less than 12 items (NICE, 2014).  
Timely and effective screening procedures for antenatal anxiety are crucial in order to 
identify women who would benefit from monitoring, and where appropriate, early 
intervention, with a high potential for prevention. However, recent reviews on the topic 
(Meades & Ayers, 2011; Brunton et al., 2015) have showed a general lack of satisfactory 
psychometric properties for screening tools currently used to assess anxiety in pregnancy. 
Therefore, the availability of a short, reliable, and easy-to-complete screening scale for 
significant antenatal anxiety is pivotal in order to improve the detection of pregnant women 
experiencing various forms of problematic anxiety symptoms.  
The PhD programme of work discussed in this thesis aimed to contribute to fill this gap by 
developing a self-report measure of anxiety specifically constructed to be used with pregnant 
women in research and clinical settings. The rest of this thesis will be devoted to report on 
the methods used to develop this measure and on the different stages of scale development 
and preliminary psychometric testing. The experimental chapters conclude with Chapter 8, 
which presents a psychometric validation study in which the new antenatal anxiety screening 




Chapter 3   Methodology  
The main aim of the research documented in this thesis was the development and initial 
psychometric validation of a self-report scale to screen for antenatal anxiety. In this chapter, 
the initial sections discuss a number of theoretical and methodological considerations in 
scale development and psychometric testing, including the important role of psychometric 
properties in the evaluation of the quality and accuracy of a scale. The chapter continues by 
providing an overview of the research methods and study design of this programme of work, 
and a rationale is given for the choice of Classical Test Theory as the guiding theoretical 
framework of the research. The chapter concludes by discussing the potential ethical issues 
arising from the research in relation to the participation of pregnant women as study subjects, 
and how these were addressed to minimise any potential discomfort or distress for study 
















3.1 Theoretical and methodological considerations in psychometrics and 
scale development 
3.1.1 The measurement of psychological constructs 
Measurement is a central component of scientific research (Kline, 2005). In its simplest 
form, measurement involves the collection of data and the assignment of a numerical value 
to a characteristic or attribute of the phenomenon under investigation (Furr, 2011). In the 
natural sciences, techniques and instruments to measure physical quantities have become 
extremely accurate over the centuries. However, in the fields of social, behavioural and 
psychological sciences, many of the phenomena of interest are often intangible and elusive 
(DeVellis, 2012). This is also at least partly true for healthcare research and clinical practice, 
in which the measurement of intangible phenomena such as quality of life, depression or 
stress has received increasing attention over the last decades and has become an important 
aspect of providing evidence-based and patient-centred care (Stewart, 2001; Rattray & 
Jones, 2005).  
In social and psychological research, intangible phenomena that cannot be directly observed 
are commonly referred to as constructs (Messick, 1995; Streiner & Norman, 2008). These 
include phenomena as varied as emotional states (e.g. anxiety), personality characteristics 
(e.g. introversion), personal needs (e.g. autonomy) and many others (Atkinson et al., 2004). 
In this thesis the term ‘construct’ will be used specifically in the context of psychological 
research to indicate phenomena such as cognitive or emotional states (e.g. symptoms of 
anxiety or depression) that cannot be observed or measured directly. Other interchangeable 
terms such as latent construct or variable, target construct or underlying construct (DeVellis, 
2012) are also used in the literature, and at times in this thesis, to highlight the intangible 
and variable (i.e. not stable) nature of constructs.  
The field of psychometrics has emerged over the course of the last century to provide 
standardised and objective ways of assessing psychological constructs. While a range of 
measures can be used to assess constructs, including clinician-based behavioural 
observations, psychophysiological devices, and structured diagnostic interviews, it has been 
indicated that the most common method of assessment and measurement of psychological 
constructs is the self-report rating scale (Simms, 2008). This type of scale is the focus for 
the remainder of this chapter.   
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Although several approaches exist within the field of psychometrics, the theoretical 
framework that has dominated scale development and psychometrics until recently is 
Classical Test Theory (Loevinger, 1957; Kline, 2005). The research presented in this thesis 
was based on this theory, and consequently the following section is mainly focused on the 
key principles and assumptions of this approach. In more recent years, Item Response 
Theory (IRT) has also been used as a somewhat different approach to scale development and 
validation. A brief description of IRT is provided later in the chapter (3.3.1), which also 
discusses the strengths and limitations of both approaches and provides a rationale for the 
choice of Classical Test Theory as the overarching theoretical framework of this programme 
of work.  
 
3.1.2 Classical Test Theory and the use of self-report rating scales 
One of the key assumptions of Classical Test Theory (CTT) is that although constructs 
cannot be directly observed, they can be assessed and measured by means of effect indicators 
(Streiner & Norman, 2008). Effect indicators are essentially behavioural, cognitive or 
affective manifestations of the latent construct (DeVellis, 2012). For example, when 
assessing depression, self-reported hopelessness and loss of interest in activities are often 
used by clinicians as effect indicators of the underlying construct of depression. Similarly, 
self-report measurement instruments (i.e. scales) consisting of a number of effect indicators 
can be used to measure levels of a latent construct in an individual. In CTT, effect indicators 
are thus considered to share a common, underlying cause (i.e. the latent construct) and are 
used to identify and quantify the experience of a subject in relation to the target construct 
(Rattray & Jones, 2005). Self-report rating scales have become increasingly popular over the 
course of the last decades and have been extensively used in both research and clinical 
settings to assess a wide range of constructs. Their simplicity, speed of completion, and the 
fact that they can be administered to large numbers of individuals at a relatively low cost, 
are all likely to have contributed to their popularity (Clark & Watson, 2003).  
While a variety of terms have been used for instruments measuring constructs, including 
rating scale, inventory, screening tool, and patient-reported outcome measure (PROM), in 
this thesis the term scale will be generally used to refer to self-report measurement 
instruments used to assess and measure levels of a latent construct. In a scale, effect 
indicators take the form of statements or questions (e.g. “I feel tense”) which are typically 
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referred to as scale items or more simply items. Respondents are asked to score each item 
(i.e. assign a numerical value to it based on a specific attribute such as its frequency or 
severity) and a total score is produced by summing the scores of all items as a measure of 
the overall level of the target construct. A scale can thus be broadly defined as “a collection 
of items combined into a composite score and intended to reveal levels of theoretical 
variables not readily observable by direct means” (DeVellis, 2012, p11). This type of scale, 
also typically known as a ‘summated rating scale’ or ‘Likert scale’ is by far the most 
commonly used in research and clinical settings (Simms, 2008), and its properties are further 
discussed below and in Chapter 6. Other types of scales also exist, such as visual analogue 
scales (a graphic rating method) or Guttman scales (a hierarchical type of scale typically 
used in achievement tests). This thesis will make use of the ‘summated rating scale’. The 
focus will also be on self-report scales as opposed to observer-based or clinician-
administered scales.  
A further key concept in CTT is the distinction between observed score and true score, which 
is particularly relevant to summated rating scales. CTT postulates that an individual’s 
observed score on an item or a full scale is the result of two components: the true score plus 
some random error of measurement (Netemeyer, Bearden, & Sughash, 2003; Streiner & 
Norman, 2008). This can be simply illustrated by the formula below:  
O (observed score) = T (true score) + E (random error) 
As unsystematic errors in observed scores are assumed to be random and normally 
distributed, CTT implies that multiple observations of the construct (e.g. as tested by 
different items in a summated rating scale) will result in a reduction of the overall error 
component (Spector, 1992). Many efforts in CTT have been devoted to develop techniques 
to minimise the random error component of the observed score. The reliability of a scale, for 
instance, can be seen as an index of the proportion of variance of the observed score that is 
attributable to the true score (Tavakol & Dennick, 2011). A scale that is perfectly reliable 
would thus be purely a reflection of the true score and would not be influenced by 
measurement error (DeVellis, 2012). Scale reliability is only one of a range of measurement 
properties, also commonly known as psychometric properties, which are used to evaluate 
the accuracy and overall quality of a scale. A brief overview of different forms of 




3.1.3 Psychometric properties: the important role of reliability and validity 
Psychometric theory is specifically concerned with the assessment of the psychometric 
properties of scales of latent constructs (Bowling, 2014). Evaluating the psychometric 
properties of a scale is a crucial aspect of scale development and validation. Psychometric 
properties, in fact, indicate the extent to which a scale measures what it purports to measure 
(validity) in a consistent and reproducible fashion (reliability) (Cook & Beckman, 2006). 
Reliability and validity are the two main types of psychometric properties that can be 
evaluated in a scale. In turn, different forms of reliability and validity exist. In general terms, 
reliability refers to the consistency, stability or repeatability of scale scores (Kumar, 2015). 
Validity is a broader concept consisting of multiple and somewhat different lines of 
evidence, all contributing to support claims that a scale measures what is intended to measure 
(Tavakol & Dennick, 2011). A brief outline and definition of different psychometric 
properties commonly evaluated in a scale is provided below. Throughout the thesis, 
psychometric properties will be further discussed in relation to the development and 
validation of a screening scale for antenatal anxiety, and the procedures that were used to 
construct a psychometrically robust scale will be described.  
 
Reliability 
As noted above, scale reliability refers to the consistency and repeatability of scale 
measurements (Kline, 2005; DeVellis, 2012). Scale reliability is an important psychometric 
property and a necessary prerequisite for scale validity. A scale thus cannot be considered 
valid unless its reliability has also been established (Tavakol & Dennick, 2011; Furr, 2011). 
Different forms of scale reliability exist, which include internal consistency (consistency of 
items within a scale), inter-rater reliability (scale consistency when used by multiple raters) 
and test-retest reliability (scale consistency over time). The relative importance of these 
different forms of reliability depends on the type of scale and its intended purpose (Cook & 
Beckman, 2006).  The most commonly examined and reported form of reliability is internal 
consistency reliability (Abell, Springer, & Kamata, 2009). Internal consistency is essentially 
an index of inter-item correlations within a scale, and it can be formally defined as the degree 
to which the scale score is free from measurement errors (APA, 2000). DeVellis (2012) 
explains clearly the rationale behind internal consistency by observing that if items 
composing a scale all have a strong relationship to the latent construct, they will also have a 
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strong relationship to one another. A scale is thus considered to be internally consistent when 
inter-item correlations are robust, indicating that all items within the scale are measuring the 
same underlying construct. This is commonly determined by calculating Cronbach’s Alpha 
(Cronbach, 1951), a widely used measure of scale reliability expressed as a number between 
0 and 1, with 1 indicating perfect internal consistency. This important index of internal 
consistency is discussed further in Chapter 7 and 8.  
Two other forms of reliability mentioned above, namely inter-rater and test-retest reliability, 
are not directly relevant to a self-report scale which aims to assess the construct of antenatal 
anxiety at a fixed moment in time and were thus not considered in the present research. Inter-
rater reliability is commonly examined when an observer-based scale is used, and the 
agreement between different raters is calculated as a measure of the consistency of scale 
scores among different observers (Kline, 2005). This index is, however, clearly not 
applicable to self-report scales. Test-retest reliability examines the consistency of scale 
scores when a scale is completed by the same individual at least two times following an 
intervening period of time (DeVellis, 2012), and should only be measured when the target 
construct is considered to be stable over time (e.g. trait anxiety, extroversion, intelligence). 
In the case of antenatal anxiety, Chapter 2 documented that fluctuations in anxiety levels 
typically occur throughout pregnancy and thus it was considered not appropriate to examine 
the consistency over time of the scale as it would be incorrect to assume that scores should 
remain stable over consecutive administrations.  
 
Validity  
Establishing validity is a crucial step in scale development and psychometric validation. 
While internal consistency indicates the degree to which items in a scale are all measuring 
the same construct, it does not provide any indication of whether the construct measured is 
in fact the latent construct that the scale developers originally intended to measure 
(Netemeyer et al., 2003). This is the role of validity estimates, which overall can be described 
as the degree to which scale scores can be confidently interpreted as a reflection of the true 
level of the target construct (Norman & Streiner, 2008). This makes validity arguably the 
most important form of psychometric robustness of a measure (Furr, 2011). As previously 
noted, several different types of validity exist, and no single form of validity is sufficient to 
determine whether a scale can be considered a valid measure of the construct of interest. It 
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follows that scale validity is a matter of degree rather than an “all-or-none” property of a 
scale (Furr, 2011). Traditionally, a distinction between three different types of validity, 
namely content, construct and criterion validity, was made by different scholars (Landy, 
1986). In more recent decades, a number of other forms of scale validity have been proposed, 
as in the case of construct validity which some authors suggested should be based on 
evidence of both convergent and discriminant validity (DeVellis, 2012). Others have argued 
that the various types of validity are all essentially forms of construct validity (Abell et al., 
2009; Streiner & Kottner, 2014). This thesis follows the approach indicated by Streiner & 
Norman (2008) who note that, while it is important to evaluate different aspects of validity, 
the terminology used to describe different forms of validity is somewhat secondary. The key 
consideration is that scale validity should be established through a process of hypothesis 
testing which is performed through a number of procedures, each dealing with different 
aspects of scale validity. For clarity of exposition, a brief outline of different types of validity 
is provided here, and each of these different forms of validity is discussed further in this and 
subsequent chapters of the thesis.  
Face validity: This is arguably the simplest form of scale validity, and it refers to whether a 
set of items appears to be measuring the construct of interest “on the face of it” (Streiner & 
Norman, 2008, p5) as judged by experts or the intended respondents. This intuitive form of 
validity is rarely evaluated through empirical approaches, and has thus been criticised as 
superficial and subjective (Cook & Beckman, 2006). Some, however, have argued that scales 
composed of items that are clear and open regarding what they asses are more likely to 
increase motivation and cooperation of respondents to complete the scale (DeVellis, 2012).  
Content validity: This type of validity is strongly linked to the definition of the target 
construct articulated by the scale developers, and is concerned with evaluating whether a set 
of items composing a scale collectively reflect the target construct and are all relevant to its 
measurement (Netemeyer et al., 2003; Furr, 2011). Content validity is typically established 
by consulting experts in the area of the construct of interest, who can judge whether they 
consider the items to reflect the construct of interest. In order to make this process more 
objective, it is recommended that the feedback of experts is subject to some form of 
quantification (Abell et al., 2009). Experts can also identify content areas of the construct 
that have been omitted in a scale (i.e. that are not represented by any items) and potentially 
suggest further items for inclusion (Watson & Clark, 2003; Hunsley & Mash, 2008).  
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Construct validity: Construct validity is commonly evaluated by testing whether a scale 
sufficiently correlates with other scales measuring theoretically similar constructs and is 
relatively independent from scales purported to measure different constructs (DeVellis, 
2012). As noted above, however, some authors have suggested that the construct validity of 
a scale should be evaluated more broadly, by examining and considering the procedures used 
throughout the scale construction process. The two following forms of validity are often both 
considered as types of construct validity (DeVellis, 2012):  
Convergent validity: The degree of correlation of a scale with existing scales measuring 
constructs that are theoretically related to the target construct (Furr, 2011) is calculated to 
determine convergent validity. Correlation indexes are used (Pearson’s r or Spearman’s rho, 
depending on whether the assumption of normal distribution is met), with the hypothesis that 
the scales will exhibit moderately large to large correlations.   
Discriminant validity: The degree of correlation of a scale with other scales which measure 
constructs that are anticipated to be relatively or entirely unrelated to the target construct is 
calculated to establish discriminant validity. Similarly to convergent validity, Pearson’s r or 
Spearman’s rho are used, and small to moderate correlations are used as evidence of the 
discriminant validity of a scale.  
Structural validity: This type of validity refers to the factor structure of a scale and is 
determined by administering the scale to a validation sample and conducting Principal 
Component Analysis, Exploratory Factor Analysis or Confirmatory Factor Analysis on scale 
scores. Factor analysis is commonly used to reduce variables (i.e. single items) that share 
common variance into set of clusters (i.e. factors) (Bartholomew et al., 2011). Factors can 
thus be described in terms of percentage of the total variance explained by each factor 
(Netemeyer et al., 2003). Examining the factor structure of a scale is an important aspect of 
validity, as it provides evidence of whether a scale is unidimensional (i.e. measures a single 
factor or latent construct) or multidimensional.   
Criterion validity: As the name suggests, criterion validity is concerned with the correlation 
of a scale with a criterion measure or ‘gold standard’ of the target construct (Streiner & 
Norman, 2008). In psychological scale validation, the gold or reference standard is generally 
considered to be a clinical diagnostic interview based on well-established diagnostic criteria 
(Gibson, McKenzie-McHarg, Shakespeare, Price, & Gray, 2009), such as DSM or ICD 
criteria (WHO, 1992; APA, 2013). It is important to note that, although diagnostic interviews 
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are commonly regarded as an accurate method of assessment of psychological morbidity 
(Reed et al., 1998), they are not perfect diagnostic tools and may be affected by issues of 
inter-rater reliability (Pinninti, Madison, Musser, & Rissmiller, 2003). Despite this 
observation, diagnostic interviews are typically considered the best available approximation 
to a ‘gold standard’. Criterion validity is arguably the most powerful indicator of scale 
validity for scales assessing psychological disorders, as it describes how precise the scale 
score is in distinguishing between individuals with the target condition and those without 
the target condition. Various statistical indexes can be used to evaluate criterion validity, as 



















3.2 Processes and stages in scale development and validation 
The development of a self-report scale for the assessment of a psychological construct is a 
sequential process and a number of steps and procedures are required in order to develop a 
scale with robust psychometric properties (Kline, 2005; DeVaus, 2014). In this section, the 
key principles and techniques of scale development and validation recommended by various 
scholars are discussed and an overview of different factors that should be taken into account 
when developing a self-report rating scale is provided. Although no universally 
recommended procedures exist for scale development, a number of guidelines and 
frameworks are available to guide investigators in the construction of a psychometrically 
sound scale (Nunnally & Bernstein, 1994; Kline, 2005; Streiner & Norman, 2008; Abell et 
al., 2009; National Institutes of Health [NIH], 2012: DeVellis, 2012). Consistently with the 
view that scale validity is established through the accumulation of different lines of evidence, 
ideally a number of sources should be consulted during the scale development phase. These 
can include, among others, the research literature related to the construct of interest, 
members of the target population and individuals with specific expertise in the area of the 
construct. An overview of the main stages in the development and psychometric testing of a 
scale, as recommended by both DeVellis (2012) and Streiner & Norman (2008), is 
summarised in the next page in Figure 1 and each stage is discussed in further detail in the 












Figure 1 – Key stages in scale development and psychometric validation, based on 






      
 










Definition of the construct: The initial stage in the development of a scale is to clearly define 
the construct that the scale intends to measure (Netemeyer et al., 2003; Kline; 2005; Streiner 
& Norman, 2008). Although it may appear obvious that a scale needs to be unambiguous 
with regard to what it purports to measure, it has been indicated that it is not uncommon for 
scale developers to underestimate the importance of a a clear definition of the target construct 
(Abell et al., 2009; DeVellis, 2012). The validity of a scale, however, cannot be accurately 
assessed unless the nature of the construct is delineated and its boundaries are clarified 
(Keedwell & Snaith, 1996). A definition of the phenomenon of interest (i.e. the target 
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construct) serves a number of purposes. First, it informs and guides the generation and 
selection of an initial pool of items for potential inclusion in the scale. Without a well-defined 
construct, it is difficult to develop good items to measure it, with the potential risk that the 
scale will have poor reliability and validity (DeVellis, 2012). Second, defining the construct 
is useful in clarifying its boundaries, thus making it clear not only what the scale intends to 
measure, but also what it should not measure (Clark & Watson, 2003). Furthermore, once a 
final version of the scale is developed, a number of validation hypotheses can be tested with 
regard to the relation of the target construct to other scales, thus contributing to establish the 
construct validity of the scale. The research literature on the construct of interest is often 
recommended as a starting point that can guide the conceptualisation of the target construct 
(Kline, 2005; Streiner & Norman, 2008). Theories related to the construct of interest, prior 
conceptual definitions and empirical evidence regarding the nature of the construct can all 
provide a foundation to define the phenomenon that the scale developer wants to measure 
(Spector, 1992). In the case of psychological traits or disorders, individuals with direct 
experience of the condition of interest can also be consulted and contribute to determine 
which domains (i.e. content areas) should be included in the construct definition.  
Item generation and format of measurement: The second stage of scale development is the 
generation of items (i.e. questions or statements) that reflect the construct of interest. This 
phase is commonly referred to as the operationalisation of the construct (Streiner & Norman, 
2008), which essentially corresponds to the translation of the construct definition into an 
initial item pool for potential inclusion in the scale (Kline, 2005). While the key aim is to 
formulate items that accurately reflect the proposed construct, in scale development it is 
desirable to start with a large pool of items which is initially over-inclusive, by also including 
items that are only tangentially related to the target construct (Netemeyer et al., 2003; Furr, 
2011). By allowing some items with marginal content, scale developers improve the chance 
that all domains of the target construct are represented in the initial item pool (Abell et al., 
2009). A second, important consideration in item generation is that, at this stage, item 
redundancy (i.e. items with similar or overlapping content) is also a desirable characteristic 
of the initial item pool (Clark & Watson, 2003; Furr, 2011; DeVellis, 2012). In particular, 
for domains that are deemed to be central in the construct definition, multiple items can be 
generated which tap into the same content area in slightly different ways (e.g. minor 
differences in wording). At later stages of scale development, quantitative analyses and 
inputs from experts and potential respondents regarding the relevance, wording and clarity 
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of individual items can be used to determine which version of the item can be considered 
superior. In order to ensure that items in the initial item pool have good face and content 
validity, they can be generated from a number of sources. The scale developer can formulate 
items de novo based on the construct definition, and draw on specific items from extant 
scales with demonstrated psychometric properties for the assessment of the construct of 
interest (Netemeyer et al., 2003; Kline, 2005; Bowling, 2014). Key informants such as 
individuals from the target population and experts in the field can also be consulted as 
sources for the generation of items (Spector, 1992; Rattray & Jones, 2007; Streiner & 
Norman, 2008; DeVellis, 2012). Norman & Streiner (2008) point out that these different 
potential sources for the generation of items, and the corresponding methods used to gather 
relevant information, are not mutually exclusive. Rather, different sources can all contribute 
to enhance item clarity and relevance to the target construct and consequently the 
psychometric properties of the final scale.  
During the stage of item generation, the scale developers also need to make a number of 
decisions regarding the format of measurement, including the type of response format (e.g. 
Likert scale, Guttman scale), the stem question, the number of response categories and how 
they are worded, and the timeframe assessed by the scale (e.g. past week, past month). These 
decisions should be taken at the same time of item generation, and need to be guided by 
carefully considering both the target population and those who will typically score and 
interpret the measure (e.g. health professionals) (Kline, 2005; Abell et al., 2009). These 
aspects of scale design are discussed in detail in Chapter 6, which documents the item 
formulation phase and the decisions taken in relation to these more practical aspects of scale 
development.   
Item reduction and refinement: Once a comprehensive, initial item pool is generated, an 
assessment of the relevance of items to the target construct and a refinement of their quality 
can be carried out through qualitative and quantitative procedures. Problematic items can be 
identified at this stage and they can either be modified or discarded (DeVellis, 2012). One 
key objective in this phase is to reduce the number of items in the initial item pool to a scale 
of reasonable length before preliminary psychometric testing on a validation sample 
(Streiner & Norman, 2008; Furr, 2011). This is typically achieved by discarding items that 
are considered to be less relevant to the assessment of the construct of interest. Various 
authors recommend that all items are reviewed by ‘judges’ with specific expertise in the area 
of the target construct in order to make this process as objective and rigorous as possible 
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(Clark & Watson, 2003; Abell et al., 2009; DeVellis, 2012). In the case of psychological 
constructs, health professionals with clinical expertise of the condition of interest are clearly 
well-placed to assess the appropriateness and relevance of specific questions (i.e. items) to 
assess the condition of interest.  
Potential issues related to the wording and clarity of items can also be addressed at this stage. 
It is crucial that scale items need are not only relevant and accurate indicators of the target 
construct, but also comprehensible and acceptable to the population of respondents (Clark 
& Watson, 2003). The readability of scale items is a key aspect that must be taken into 
account by scale developers. In this regard, a useful rule of thumb is thus to keep items as 
short and simple as possible, as length and complexity tend to negatively impact on item 
clarity (Netemeyer et al., 2003; DeVellis, 2012).  For example, Streiner & Norman (2008) 
recommend that scales aimed at groups whose educational level is unknown should require 
reading skills that are not beyond the level of a 12-year old. In addition, well-written items 
should be unambiguous and designed to be interpreted by respondents in the same way (Furr, 
2011). Moreover, the use of jargon, technical terms and double-barrelled items (i.e. asking 
more than one question at the same time) should all be avoided (Kline, 2005). While scale 
developers should attempt to address all these potential issues at the initial stage of item 
writing, further quality checks can be conducted at this stage. Individuals from the target 
population can be asked to pre-pilot scale items and provide feedback and comments on item 
clarity, wording, and acceptability, so that problematic items can be modified or dismissed.  
Preliminary psychometric testing: Once scale developers have established which items show 
sufficient face and content validity and discarded or modified problematic items, ideally 
based on a number of sources, it is considered best practice to administer the obtained 
preliminary version of the scale to a small sample of individuals from the target population 
for preliminary psychometric testing (Rattray & Jones, 2007; DeVellis, 2012). This 
administration of a pilot version of the scale is mostly concerned with addressing any issues 
with the internal consistency reliability of the scale and selecting items for the final version 
of the scale. As discussed earlier, internal consistency is an essential psychometric property 
as a high internal consistency provides evidence that all scale items are measuring the same 
construct. At this stage, the contribution of individual items to the overall scale can thus be 
statistically analysed, and items that do not contribute significantly to the internal 
consistency of the scale can be considered for deletion. Different item and scale statistics 
can be examined (e.g. item response distributions, item-total correlations, inter-item 
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correlations) for this purpose (Streiner & Norman, 2008; Tavakol & Dennick, 2011). This 
procedure typically results in a shorter, final version of the scale that has good preliminary 
evidence of internal consistency. Two other important forms of validity, specifically 
construct and criterion validity, are commonly tested on a larger validation sample, in the 
final phase of the initial psychometric validation of a scale.  
Psychometric validation: As noted earlier, criterion validity refers to the correlation of a 
scale with a criterion measure or reference standard of the target construct (Streiner & 
Norman, 2008). For scales that intend to measure a psychological trait or disorder, this 
corresponds to establishing the accuracy of the scale in discriminating between individuals 
with the condition of interest and those who do not have the condition of interest (i.e. cases 
and non-cases) at the optimal threshold or cut-off score (Kline, 2005). This is typically 
examined by conducting a specific type of psychometric validation study, commonly 
referred to as a study of diagnostic or screening accuracy in the medical and psychological 
sciences. In this type of study, subjects are asked to complete the scale under scrutiny, and 
are also assessed using the clinical “gold standard”. A range of statistical indexes of 
screening accuracy, including sensitivity, specificity and positive and negative predictive 
values can be subsequently calculated. This procedure is discussed in detail in Chapter 7. 
While the main focus of a psychometric validation study is typically to evaluate the criterion 
validity of a scale, at this stage it is also considered best practice to evaluate other 
psychometric properties of the scale, which can include its factor structure, construct validity 
(i.e. by testing the correlation of the scale with other measures of related or unrelated 
constructs) and internal consistency as index of scale reliability. The next section discusses 
the rationale for the choice of CTT as the underpinning theoretical framework of this 









3.3  Research methodology  
3.3.1  Theoretical framework and rationale for research methodology  
The overall aim of the programme of work presented in this thesis was the development and 
initial psychometric validation of a self-report rating scale to screen for antenatal anxiety. 
This was conducted using the theoretical framework of Classical Test Theory, whose key 
principles and assumptions were presented above. As noted earlier, over the last few decades 
Item Response Theory (IRT) models have provided an alternative to the CTT approach 
(Rose & Devine, 2014). CTT and IRT share the assumption that, when assessing a latent 
construct, every person can be described in terms of the true level of the latent variable, 
called theta in IRT models (Hambleton, Swaminathan, & Rogers, 1991). However, the focus 
of IRT models is at the item-level rather than at the scale-level as in CTT, and a set of 
mathematical equations are used to predict the probability of choosing a specific response to 
an item as a function of theta (Embretson & Reise, 2000). CTT was preferred to IRT as the 
overarching framework of the present research for a number of reasons, some related to 
theoretical considerations and others essentially pragmatic. First, as different authors have 
observed, while techniques based on IRT have become well established in the field of 
education, as they lend themselves particularly well to the testing of knowledge or abilities 
(Simms, 2008), CTT remains the dominant paradigm in the construction of scales measuring 
psychological traits or disorders (DeVellis, 2012; Petrillo, Cano, McLeod, & Coon, 2015). 
Kline (2005), for instance, notes that a number of psychometrically excellent scales in use 
in healthcare research and clinical settings were designed and validated based on the 
principles of Classical Test Theory. This may also be partly due to the fact that the theoretical 
assumptions and statistical techniques of CTT are somewhat more accessible to health 
researchers compared to IRT, which uses complex mathematical modelling to describe and 
analyse the relations between the latent construct and item responses in order to inform scale 
development (Simms, 2008). A further disadvantage of IRT is that it typically requires 
considerably large samples, with a number of authors indicating that at least 500 subjects 
are required for statistical analyses based on IRT models (Hambleton et al., 1991; DeVellis, 
2012; Kean & Reilly, 2014). Considering the practical limitations and the relatively limited 
timeframe of a PhD, the recruitment of such a large number of subjects would have been 
highly challenging and probably unrealistic. In contrast, the principles of CTT enable scale 
developers to conduct initial psychometric validation of a newly developed scale with 
relatively smaller sample sizes (Clark & Watson, 2003; Abell et al., 2009). Moreover, 
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DeVellis (2012) argues that in most cases CTT and IRT produce relatively comparable scales 
when scale developers carefully consider issues related to the reliability and validity of the 
final scale at all stages of scale development and validation.    
With regard to the study design, a sequential mixed-method design was used to achieve the 
research aim and objectives presented in Chapter 1. Mixed-method research can be broadly 
defined as the integration of quantitative and qualitative research methods (Wilson & 
MacLean, 2011). Traditionally, quantitative and qualitative approaches were characterised 
by considerable differences in relation to their epistemological paradigms, with quantitative 
methods commonly based on positivist paradigms and qualitative methods typically drawing 
on the philosophical assumptions of constructivism (Pluye & Hong, 2014). The use of 
mixed-method research has been consequently at times criticised for combining approaches 
derived from somewhat opposing epistemological backgrounds (Doyle, Brady, & Byrne, 
2009). However, it has been proposed that mixed-method research provides a “third 
paradigm”, in which the combination of quantitative and qualitative methods can lead to a 
more thorough and elaborated understanding of the phenomenon under investigation, thus 
enhancing the credibility and validity of the findings (Johnson, Onwuegbuzie, & Turner, 
2007; Bowling et al., 2014). While the theoretical principles of CTT underpinned the 
psychometric aspects of scale development and validation in this study, the philosophical 
stance of pragmatism informed the mixed-method design and guided the choice of specific 
research methods used at different stages of the research. Pragmatism rejects the argument 
that quantitative and qualitative research methods are incompatible (Reichardt & Rallis, 
1994; Bowling et al., 2014) and its epistemological foundations are based on the idea that a 
researcher should choose “the combination or mixture of methods and procedures that works 
best for answering your research questions” (Johnson et al., 2004, p17). The philosophical 
approach of pragmatism is particularly well-suited to scale developers and consistent with 
the theoretical framework of CCT, in which issues related to different forms of reliability 
and validity are typically addressed by using different research methods, with each stage of 
the research building on previous steps to maximise the psychometric properties of the final 
scale (DeVellis, 2012). This is clearly illustrated in the next section of this chapter, which 
provides an outline of the phases of the present research and the range of research methods 




3.3.2 Summary of research design  
The present research is broadly based on the guidelines for scale development and validation 
proposed by DeVellis (2012), who provides clear guidance on the development and 
psychometric testing of scales to measure social and psychological constructs, and Streiner 
& Norman (2008), who in their book focus specifically on the development and use of health 
measurement scales. Whereas these two sources served as the basis for designing the study 
presented here, specific techniques and procedures used also drew on numerous other 
guidelines and psychometric textbooks (Spector, 1992; Nunnally & Bernstein, 1994; 
Netemeyer et al., 2003; Kline, 2005; Simms, 2008; Abell et al., 2009; Furr, 2011). As 
previously noted, the development of a scale for psychological assessment is a stepwise, 
sequential process (Streiner & Norman, 2008). Consequently, a number of research methods 
were used in the construction and validation of a self-report rating scale for antenatal anxiety 
documented in this thesis. These included, in the initial phases of scale development and 
refinement, a systematic review, semi-structured qualitative interviews, a Delphi study with 
a group of experts in perinatal mental health and psychometric testing of a preliminary 
version of the scale on a sample of pregnant women. Subsequently, the final version of the 
scale was tested to examine its screening accuracy and other psychometric properties by 
carrying out a psychometric validation study. The research was thus designed to answer the 
research questions presented in 1.3, which are also included in Table 3 presented in 
conclusion to this section.  
For illustrative purposes, the present research can be subdivided into three main phases, as 















These three phases essentially correspond to the various steps in scale development and 
psychometric validation outlined in 3.2. A brief outline of the different phases of the research 
is presented below to provide a general overview of the research design and of the research 
methods that were used. A table (Table 3) is also included at the end of the section to 
illustrate how a combination of quantitative and qualitative research methods were used to 
address the research questions presented above. Detailed descriptions of each phase, with 
regard to the research method, recruitment, data collection and analysis are presented in the 
following chapters of this thesis.  
In Phase 1 of this research, Research Questions 1 and 2 were addressed by carrying out a 
systematic review of existing anxiety scales used with pregnant populations and conducting 
qualitative interviews with women with experience of problematic anxiety symptoms during 
pregnancy. Both the systematic review and the qualitative interviews were instrumental in 
informing the construct definition of antenatal anxiety and guiding the generation of an 
initial item pool to reflect the proposed construct. The systematic review was conducted 
specifically to examine the psychometric properties and content of anxiety measures used in 
pregnancy, in order to map a set of core anxiety symptoms and domains identified to be 
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psychometrically sound for the assessment of anxiety during pregnancy (Chapter 4). 
Evidence from the systematic review was subsequently combined with the findings of semi-
structured, qualitative interviews with women with experience of significant anxiety 
symptoms during pregnancy (Chapter 5). The interviews aimed to explore the experience of 
problematic anxiety symptoms in the antenatal period and, similarly to the systematic 
review, identify anxiety symptoms and domains which could be considered relevant 
indicators of antenatal anxiety. Based on the findings from these two studies, a formal 
construct definition of antenatal anxiety was articulated, and items were generated reflecting 
the relative importance of different content areas in the assessment of the construct of interest 
(Chapter 6). At the stage of item generation, the measurement format of the scale was also 
determined, and decisions were made on the scaling response, the type and number of 
response options and the timeframe assessed by the scale.   
During Phase 2, which addressed Research Question 3, key informants were consulted in 
order to refine the initial item pool and reduce the total number of items by discarding those 
which were considered not sufficiently relevant, clear, or acceptable to the population of 
potential respondents (Chapter 6). Key informants included both women with experience of 
mental health problems during the perinatal period, who reviewed all items in the initial item 
pool in relation to their wording, clarity and acceptability, and a group of health professionals 
with expertise in the area of perinatal mental health, who participated in a Delphi study and 
were asked to rate all items in relation to their importance as indicators of antenatal anxiety. 
As a result of this phase, only items reaching an adequate level of expert consensus regarding 
their relevance to the assessment of the construct of antenatal anxiety were selected to be 
included in a preliminary version of the scale. This preliminary version of the scale was 
subsequently completed by a sample of pregnant women in a cross-sectional survey to 
examine its psychometric properties and further reduce the total number of items in order to 
produce a brief and psychometrically robust final version of the scale, as detailed in Chapter 
7.  
In the third and final phase of the present research, a 10-item version of the scale was 
generated based on the findings from the previous phase. The final stage of the research 
consisted in a psychometric validation study, which aimed to address Research Question 4 
and 5. The final version of the scale, along with the GAD2/7 (Spitzer, Kroenke, Williams, 
& Löwe, 2006) and the Edinburgh Postnatal Depression Scale (EPDS: Cox et al., 1987), 
were completed in a second cross-sectional survey by a different sample of pregnant women. 
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The convergent and discriminant validity of the scale, both indexes of construct validity, 
were evaluated by examining the correlations between the new scale, the GAD-7 
(convergent validity) and the EPDS (discriminant validity). The factor structure of the new 
scale was examined by carrying out exploratory factor analysis. Internal consistency of the 
scale was also determined. Additionally, a subsample of women was also assessed via a 
structured diagnostic interview for anxiety disorders. The screening accuracy (i.e. criterion 
validity) of the new scale and the GAD-2/7 in discriminating between women who were or 
were not clinically anxious was subsequently determined by calculating a number of 
statistical parameters (i.e. sensitivity, specificity, positive and negative predictive values) for 
the new scale, the GAD-2 and the GAD-7. Analysis of Receiver Operating Characteristic 
(ROC) curves  were also conducted to determine the optimal cut-off score for the new scale 
and the GAD-2/7 The psychometric validation study is presented in Chapter 8.  
Table 3 illustrates the different phases of the research, the research methods used and the 
















TABLE 3 – Overview of research methods used and type of validity addressed in 
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RQ3: Which items are 
considered clear, 
relevant and acceptable 
by the target population 
and experts, and can 
thus be used to create a 
short and 
psychometrically robust 
self-report scale to 
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RQ4: What is the 
evidence in relation to 
the convergent and 
discriminant validity, 
internal consistency and 
factor structure of the 
final version of the 
scale? 
RQ5: How does the new 
scale perform when 
compared to the 
measure currently 
recommended by NICE 
(GAD-2/7), and to 
expert assessment using 
a structured diagnostic 
interview; and what are 
the optimised cut-off 
points for maximising 
sensitivity and 









































3.4 Ethical considerations  
In this research, study participants were recruited either to be interviewed about their 
experience of anxiety symptoms during pregnancy (qualitative interviews in Phase 1 or 
structured clinical interviews in Phase 3) or to complete one of the two versions of the scale 
in the cross-sectional surveys. As noted above, only in the final psychometric validation 
study all participants were also asked to complete the GAD-7 and the EPDS. Before any 
women were recruited, ethical and management approval was sought and obtained from the 
South East Scotland Research Ethics Committee 02 and the Research & Development 
service of the NHS Greater Glasgow & Clyde (GG&C) Health (see Appendices 1 and 2). 
Internal approval was also received from the School Research Ethics Committee (SREC) of 
the Faculty of Health Sciences and Sport at the University of Stirling. In the next pages, 
ethical issues related to recruiting and obtaining informed consent from women taking part 
in the research are discussed in 3.4.1. Potential risks and burdens for research participants 
were also carefully considered at all stages, and a number of procedures and measures were 
in place in order to keep participants’ discomfort and distress to a minimum, as explained in 
section 3.4.2. Finally, the issue of safeguarding the confidentiality of any sensitive 
information provided by study participants was also addressed (3.4.3). Further details on 















3.4.1 Recruitment and informed consent 
Individuals invited to take part in research studies as study subjects need to be able to make 
an informed decision about their participation (Department of Health [DoH], 2005). The 
general principles related to obtaining informed consent as detailed in the most recent 
version of the Declaration of Helsinki (World Medical Association, 2013) were followed 
when designing this study. Consequently, the information sheets that all potential 
participants were given (see Appendix 3 for an example) included information about the 
purpose of the study, what it involved, the potential risks and benefits of taking part, and the 
way in which information they provided was going to be managed and stored. It was also 
made clear that participation was entirely voluntary. No participants were approached 
directly by the researcher in the initial recruitment phase, thus preserving their right to be 
free of intrusion (De Vaus, 2014). With regard to the qualitative interviews in Phase 1, all 
potential recruits were approached either by the coordinator of the Maternal Mental Health 
Scotland Change Agents (a group of women with lived experience of perinatal mental health 
problems who contributed to the research at various stages, as further detailed in Chapters 5 
and 6) or by a Nurse Consultant in perinatal mental health who gauged the suitability and 
interest of potential participants to be interviewed. Women taking part in one of the two 
cross-sectional surveys were, in contrast, approached during routine antenatal clinics by 
midwives who were part of the participants’ direct healthcare team Further details about the 
recruitment process and how this was designed to enable potential participants to make an 
informed decision regarding their participation to the research are discussed in the relevant 










3.4.2 Minimising risks and burdens for study participants 
It was acknowledged that both the interviews on the experience of anxiety in pregnancy and 
the psychological scales that study participants were asked to complete contained questions 
potentially sensitive and distressing for women. In this cases, there is an ethical duty to 
inform study participants of this (Bowling, 2014).  In relation to the qualitative interviews, 
all potential recruits were informed verbally (i.e. by the Change Agents’ coordinator or the 
clinician) and in written form through the information sheet about the content of the 
interview before they decided whether to participate, and it was made clear that the interview 
looked into their experience of anxiety symptoms during pregnancy. In order to minimise 
any burdens and inconvenience for women who consented to be interviewed, who all lived 
in the Greater Glasgow & Clyde area, they were given the opportunity to choose a date and 
time that best suited them for the interview, and were offered a choice of location which 
included the interviewees’ home and local NHS and university sites (the Mother & Baby 
Unit within the Leverndale Hospital and Glasgow Caledonian University). The author 
conducted all the interviews and reminded participants before commencing that they could 
pause or withdraw from the interview at any time without giving a reason. Time was also 
spent at the end of each interview to reflect on how participants found the process and briefly 
go through the information sheet, which included information on what to do in case a 
participant felt distressed following the interview, as also detailed in Chapter 5. For the two 
cross-sectional surveys, women were asked to complete one (preliminary psychometric 
testing) or three (psychometric validation) scales asking about symptoms of anxiety and 
depression. Self-report scales to screen for perinatal mental health problems are commonly 
used in routine maternity care and the potential distress caused to participants by completing 
these scales can generally considered to be minimal (Meades & Ayers, 2011). However, it 
was appreciated that the potential distress caused to participants by answering questions 
which asked about sensitive topics partially overlapped with that discussed for the qualitative 
interviews above and for the structured clinical interviews. Consequently, the information 
sheets given to all women taking part in the research contained information and contact 
details for accessing support in case they felt distressed as a result of discussing their own 
experience of anxiety in pregnancy or completing the self-report scales. The information 
sheets also included advice in relation to health professionals that could be contacted (GP or 




3.4.3 Confidentiality and safeguarding of sensitive information  
While the recent EU General Data Protection Regulation (GDPR) was not in place yet when 
this research was conducted, previous legislative frameworks on data privacy regulation 
such as the Data Protection Act (1998), the NHS Research Governance Framework (DoH, 
2005) and the Caldicott principles (DoH, 1997) were consulted when planning each of the 
studies contained in this thesis. The procedures that were followed to safeguard the 
confidentiality of sensitive information gathered from study participants at all stages of the 
research are discussed respectively in Chapter 5 (qualitative interviews), Chapter 7 (pilot 
psychometric testing) and Chapter 8 (psychometric validation). 
 
The following chapters (4-8) document the three experimental phases of the research 
outlined earlier, commencing with the systematic review of the psychometric properties and 






Chapter 4   Systematic review of anxiety scales used in pregnancy 
 
4.1   Introduction and rationale for the review 
The systematic review presented in this chapter was the initial, instrumental step in the 
development of a self-report scale to screen for antenatal anxiety. As discussed in the 
previous chapter, in scale development a review of the existing literature related to the 
construct of interest is recommended by various authors (Spector, 1992; Kline, 2005; 
DeVellis, 2012) as an essential part of the process of scale construction. Such a review 
appeared to be particularly appropriate for a construct such as antenatal anxiety, which has 
been measured using a variety of different instruments for general anxiety, specific anxiety 
disorders and pregnancy-related anxiety (Meades & Ayers, 2011). As noted in 2.3.3, this 
heterogeneity of measures used would appear to reflect substantial differences in construct 
conceptualisation. Consequently, a review of these previous attempts to measure the 
construct of antenatal anxiety was considered important.  
The aim of this study was to systematically examine and synthesise both the psychometric 
properties and content of self-report scales used to assess anxiety in pregnancy in order to 
identify a core set of anxiety symptoms and domains with sound psychometric performance 
in pregnant populations. The study thus contributed to answer Research Questions 1 and 2: 
 What should a construct definition of antenatal anxiety include in order to cover the 
core domains of significant anxiety symptoms in pregnancy? 
 
 Which items are the most appropriate to operationalise the proposed construct of 
antenatal anxiety into a self-report rating scale? 
 
This was achieved by conducting a systematic review of studies reporting at least one 
psychometric property (i.e. one aspect of reliability or validity) of a self-report measure used 
to assess antenatal anxiety, and by appraising and summarising the best available evidence 
in the form of a narrative synthesis. In order to guarantee that the conclusions were only 
based on the strongest evidence available, only studies of good or excellent methodological 
quality were included in the best-evidence synthesis of this review.    
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4.2   Method 
The review was conducted based on guidance for undertaking reviews of clinical tests from 
the Centre of Reviews and Dissemination (CRD, 2009) and COSMIN (COnsensus-based 
Standards for the selection of health status Measurement INstruments) recommendations for 
systematic reviews of measurement properties (Terwee, 2011), and was reported according 
to the PRISMA statement (Moher et al., 2009).  
 
4.2.1  Search strategy and selection criteria  
Computerised searches were performed to query the following electronic bibliographic 
databases: MEDLINE, PsycINFO, and the Cumulative Index to Nursing and Allied Health 
Literature (CINAHL). The initial objective of the review was to locate primary research 
articles reporting psychometric properties of self-report rating scales used to assess anxiety 
symptoms in a pregnant population. The databases were searched from 1991 up to and 
including February 2017 and searches were restricted to articles published in peer-reviewed 
journals and available in English. A combination of four main themes was used in the search, 
as it was considered the most appropriate to retrieve relevant articles while keeping the scope 
of the search broad enough, thus reducing the risk of missing potentially relevant studies 
(CRD, 2009).  Specifically, the major concepts searched were “anxiety”, “pregnancy”, 
“measurement” and “psychometrics” and search terms included both free text and MeSH 
terms. Major concepts and related synonyms for the four main themes were searched in the 
title and abstract fields, with several key terms also searched as a major concept within each 
database (see Appendix 4 for the search strategy and all search terms). Reference lists and 
citation records of papers included in the review were also inspected for potential inclusion 
of additional studies. Reports, commentaries, conference proceedings and other grey 
literature were not searched. Methodological search filters were not applied as there is 
evidence that, because of the variety of designs used in studies of diagnostic or screening 
test accuracy, applying methodological filters is likely to result in the omission of a 
significant number of relevant studies (Leeflang, Scholten, Rutjes, Reitsma, & Bossuyt, 
2006; Whiting et al., 2011). A predefined list of inclusion and exclusion criteria was applied 
in relation to type of study, population, construct of interest and type of measurement. A 




Table 4 – Inclusion and exclusion criteria for the review 




- Primary research articles reporting at least 
one psychometric property of a self-report 
rating scale used to assess anxiety 
symptoms in pregnancy 
- Published in a peer-reviewed journal in 
English in or after 1991 
- Studies conducted in countries with 
substantial cultural differences with the UK 
(i.e. African and Asian countries) for which 
cultural equivalence cannot be assumed  
-  Qualitative studies on the experience of 
anxiety symptoms during pregnancy 
 
Population 
- Pregnant or perinatal sample (for perinatal 
samples, subgroup analyses of 
psychometric properties of the measure 
available for the subsample of pregnant 
women) 
- Sample composed exclusively of women 
with high-risk pregnancies, because of 
obstetric complications (e.g. pre-eclampsia, 




- A specific anxiety disorder, as determined 
by DSM-5 or ICD-10 diagnostic criteria 
- General “anxiety” or “worry”  
- Pregnancy-related anxiety (PrA), as 
defined by Huizink and colleagues (2004) 
- Fear of childbirth, as this is deemed to be 
a relevant component of PrA   
- Any other construct, as for example 
general mental health, mental disorders 
other than anxiety during pregnancy, stress 




- All studies with published psychometric 
data using self-report rating scales to assess 
anxiety symptoms in pregnancy and 
meeting the inclusion criteria for type of 
study, population, and construct of interest 
detailed above were eligible for inclusion in 
the review 
- Anxiety symptoms assessed exclusively 
with methods other than a self-report rating 
scale (e.g. open questions by a health 
professional, physiological measures of 
anxiety) 
- Scale designed to be completed by a health 
professional after observation (i.e. not self-
report) 
- Scale not developed to generate a total 









4.2.2  Study selection and data extraction 
All articles resulting from the electronic bibliographic database searches were imported into 
RefWorks and duplicates were removed. Titles and abstracts of articles resulting from the 
initial search were reviewed to identify potentially relevant studies. When there was an 
indication that an article may have met the inclusion criteria for the review, the full-text 
publication was obtained and reviewed. I screened titles and abstracts of all retrieved articles 
to determine their appropriateness for inclusion in the review. My first supervisor (HC) 
independently screened a sample (10%) of all retrieved articles to establish an index of inter-
rater agreement determined as percent agreement (McHugh, 2012), which was 98% for titles 
and abstracts screened by both reviewers. Discrepancies were discussed and resolved by 
applying the relevant study eligibility criteria to reach consensus. The PRISMA flow 
diagram (Moher et al., 2009) was used to document the different stages of the study selection 
process. In relation to data extraction, the full-text article of all studies included in the review 
was inspected and the full version of the rating scale used was obtained in order to extract 
information relevant to the review. Data extraction forms and summary tables were 
developed and piloted on a small number of studies (n = 6) identified as eligible for inclusion 
at an early stage of the review. For each included study the following information was 
extracted: (a) author/s (b) year of publication (c) country (d) name of index test (e) sample 
size (f) timing of assessment (expressed as trimester or mean gestational week) (g) construct 
of interest.  For each of the rating scales, I extracted: (a) number of items (b) type and number 
of response options (e.g. Likert scale, dichotomous) (c) timeframe assessed (e.g. past week, 
past month) (d) score range (e) total possible score (f) cut-off score (if available).  In order 
to determine which psychometric properties were evaluated in each study, the COSMIN 
taxonomy and definitions of measurement properties were used (Mokkink et al., 2010a). The 
following psychometric properties were extracted: internal consistency reliability, 
convergent and discriminant validity, structural (i.e. factorial) validity, content validity 
(which was narratively summarised when reported) and criterion validity.  
 
4.2.3 Quality assessment  
An assessment of the methodological quality of each study included in the review was 
conducted using the COSMIN checklist, specifically developed to evaluate the study quality 
and risk of bias in systematic reviews of studies on the measurement properties of health 
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measurement instruments (Mokkink et al., 2010b). In this review, five of the nine possible 
boxes in the checklist were employed as they were considered to be relevant to evaluate the 
methodological quality of studies assessing the construct of anxiety in pregnancy. 
Specifically, these were box A (internal reliability), D (content validity), E (structural 
validity), F (hypotheses testing) and H (criterion validity). Each measurement property is 
scored on a four-point rating scale as “poor”, “fair”, “good” or “excellent”. An overall score 
for the methodological quality of a study is determined by using a “worse score counts” 
system (Terwee et al., 2012). I performed the quality assessment for all studies included in 
the review, with my first supervisor (HC) assessing a random sample of studies (n=5) to 
confirm the accuracy of the scoring system. It was decided that only studies which achieved 
an overall rating of good or excellent were considered in the best-evidence synthesis in order 
to guarantee the quality of the conclusions reached by the review. The rationale for this 
decision was informed by the developers of the COSMIN checklist, who argue that low 
quality studies present a high risk of bias, which in a systematic review of measurement 
properties can lead to incorrect conclusions (Mokkink et al., 2010b) 
  
4.2.4  Best evidence synthesis 
The main aim of this review was to examine the psychometric properties and content of 
anxiety scales used in pregnancy, both at the scale and at the item level, in order to identify 
specific items (i.e. questions) or anxiety domains with established psychometric properties 
in this population. A synthesis of the best available evidence is presented for each scale in a 
narrative form. At the scale level, the psychometric properties discussed above were 
examined and synthesised. The number of studies, their methodological quality and the 
consistency of findings were taken into account. Specifically, the following criteria were 
used to classify the strength of evidence from one or more studies, based on COSMIN 
recommendations for quality criteria (Terwee et al., 2007): (a) strong evidence: consistent 
findings in multiple studies of good or excellent methodological quality or in one study of 
excellent quality (b) moderate evidence: consistent findings in multiple studies of good or 
excellent quality, except for one study with contrasting findings (c) limited evidence: one 
study of good methodological quality (d) unclear or conflicting evidence: contrasting results 
in multiple studies of good quality. Only items and anxiety domains with moderate or strong 
psychometric evidence of being accurate indicators of anxiety symptoms in pregnancy were 
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considered sufficiently robust, and contributed to inform the generation of items for the scale 
developed in this research, as discussed in Chapter 3 and detailed in conclusion of this 
chapter.   
At the item level, the analysis was primarily based on factor analysis, and specifically on the 
examination and comparison of coefficients of item loadings on specific anxiety factors for 
each scale. In psychometrics, the examination of item loadings is recommended in order to 
determine which items within a scale possess the strongest psychometric performance in 
terms of their discriminative power (Streiner & Norman, 2008), and can be therefore 
considered to detect an important aspect of the construct assessed (DeVellis, 2012). Factor 
analysis in the psychometric testing of scales is used to reduce variables (i.e. single items) 
that share common variance into set of clusters (i.e. factors) (Bartholomew et al., 2011). In 
this review, the criteria proposed by Tabachnick and Fidell (2007) and listed as follows were 
adopted to evaluate the strength of item loading coefficients: (a) 0 – 0.44 = poor; (b) 0.45 – 
0.54 = fair; (c) 0.55 – 0.62 = good; (d) 0.63 – 0.70 = very good; (e) > 0.70 = excellent. Only 
items which showed very good or excellent loadings (i.e. 0.63 or above), and for which the 
strength of evidence from one or multiple studies was moderate or strong according to the 
criteria discussed above, were considered to be psychometrically sound in measuring anxiety 
symptoms in pregnant women. When items forming a factor were found to be particularly 
homogeneous in relation to their content, the entire dimension or domain that the factor 
represented rather than individual items was selected as a domain identified as 
psychometrically sound. Secondary indexes that were examined at the item level when factor 
analysis was not conducted were the correlations between individual items and the remainder 
of items within a scale (corrected item-total correlations) and item discrimination parameters 









4.3   Results 
The initial search yielded 2879 citations, which were reduced to 1756 following 
deduplication in RefWorks. The titles and abstracts of remaining articles were screened for 
potentially eligible studies, resulting in 74 publications for which the full text article was 
retrieved. At this stage 47 studies were excluded and two publications were added from hand 
searches of reference lists of included studies. This resulted in a final sample of 29 studies 
included in the review. The main reasons for excluding studies after retrieving the full text 
were: (i) no psychometric data available (ii) construct of interest different from inclusion 
criteria (e.g. antenatal stress, general mental health) (iii) study participants recruited 
exclusively from high-risk samples. The study selection process is summarised in the 
PRISMA flowchart shown in Appendix 5.  
The 29 included studies used 9 different scales as index tests to measure antenatal anxiety. 
The most commonly reported psychometric properties were internal consistency reliability 
(n = 27; 93% of studies), concurrent validity (n = 21; 72%) and structural validity (n = 16; 
55%). Included studies showed a considerable degree of heterogeneity in relation to the 
construct assessed (i.e. general anxiety or an anxiety disorder or pregnancy-related anxiety), 
gestational age of participants, sample size and type of psychometric properties reported. As 
discussed in the method section, a quality assessment of all included studies was performed 
and only studies achieving a rating of good or excellent in relation to their methodological 
quality and risk of bias were included in the best evidence synthesis. Seven studies were 
given a rating of poor (Öhman, Grunewald, & Waldenström, 2003; Tendais, Costa, Conde, 
& Figueiredo, 2014; Haines et al., 2015) or fair (Levin, 1991; Jomeen & Martin, 2005b;   
Garthus-Niegel, Størksen, Torgersen, Von Soest, & Eberhard-Gran, 2011; Simpson, Glazer, 
Michalski, Steiner, & Frey, 2014) for their methodological quality and were thus not 
considered in the synthesis. The quality assessment of all 29 studies included in the review 








Table 5 – General characteristics of studies included in the review 
 
























































2012 285 Mean 14.1 
weeks 
Spain CWS Present time Worry during 
pregnancy 
 
Coates 2016 5551 18 and 32 
weeks 


















































































Green 2003 1207 1st/2nd/3rd 
Trimester 
 
























2004 172 1st/2nd/3rd 
trimester 




Huizink 2016 1144 24 and 34 
weeks 
 
























2004 101 Mean 
13.57 weeks 







2005b 129 Mean 
13.86 weeks 






2005a 101 Mean 
13.57 weeks 
















































Ohman 2003 200 8-42 weeks Sweden CWS Present time Worry during 
pregnancy 
 
Petersen 2009 344 Mean 31.4 
weeks 
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Westerneng 
 
2015 6004 Mean 19.8 
weeks 
 





















Zhong 2015 946 Mean 9.6 
weeks 







Note: BMWS = Brief Measure of Worry Severity; CWS = Cambridge Worry Scale; EPDS-A = 
Edinburgh Postnatal Depression Scale – Anxiety subscale; GAD-7 = Generalised Anxiety Disorder 
– 7; HADS-A = Hospital Anxiety and Depression Scale – Anxiety subscale; PAS = Pregnancy 
Anxiety Scale; PRAQ-R and PRAQ-R2 = Pregnancy-Related Anxiety Questionnaire- Revised; STAI 









4.4. Best evidence synthesis  
Following an assessment of the methodological quality of all studies, 22 were included in 
the best evidence synthesis phase of the review. This section discusses the findings from 
these studies, through an examination of the psychometric properties of each scale and a 
critical analysis of the content of their items and anxiety domains found to be 
psychometrically sound for the assessment of antenatal anxiety. The analysis was carried out 
accordingly to the criteria discussed in detail in the Method section of this paper.  For clarity 
of exposition, a synthesis is presented here separately for each scale, while the final section 
summarises the key findings of the review.  
 
4.4.1  Edinburgh Postnatal Depression Scale – Anxiety subscale 
The Edinburgh Postnatal Depression Scale (EPDS: Cox et al., 1987) is a 10-item self-report 
scale originally developed to screen for Postpartum Depression. Because of the lack of items 
specific to the postpartum period, the EPDS has also been validated for use with pregnant 
women (Murray & Cox, 1990; Green & Murray, 1994). Although the EPDS was developed 
as a unidimensional measure of depression, it was included in this review due to growing 
evidence that it contains a separate subscale measuring anxiety rather than depressive 
symptoms, in both antenatal and postnatal populations (Pop et al., 1992; Ross, Evans, 
Sellers, & Romach, 2003; Matthey et al., 2013a). Six studies included in this review 
examined the psychometric properties of the EPDS anxiety subscale in a sample of pregnant 
women. All studies except one (Simpson et al., 2014) achieved an overall methodological 
quality rating of good (Brouwers, van Baar, & Pop, 2001; Matthey, Valenti, Souter, & Ross-
Hamid, 2013; Swalm, Brooks, Doherty, Nathan, & Jacques, 2010) or excellent (Jomeen & 
Martin, 2005a; Coates, Ayers, & Visser, 2016)  and were thus included in the best evidence 
synthesis. Four of the five studies examined the factor structure of the EPDS to investigate 
whether the existence of an anxiety subscale could be confirmed. Brouwers and colleagues 
(Brouwers et al., 2001) performed exploratory factor analysis (EFA) of EPDS scores in 
women in their second trimester of pregnancy. The EFA revealed three components within 
the EPDS, namely two separate depressive (items 1, 2, 8) and anxiety (items 3, 4, 5) 
symptoms subscales and a third component consisting only of item 10 (“The thought of 
harming myself has occurred to me”). However, this third factor was not included in the 
final factor solution as the authors argued that a single-item loading could not plausibly 
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identify a distinct latent factor (Brouwers et al., 2001). A two-factor solution, comprising of 
separate depression and anxiety subscales, was therefore proposed. The three items of the 
anxiety subscale (item 3 “I have blamed myself unnecessarily when things went wrong”, item 
4 “I have been anxious or worried for no good reason”, item 5 “I have felt scared or panicky 
for no very good reason”) were the only ones, among the ten EPDS items, with item loadings 
on a single factor above the pre-defined cut-off of 0.63, ranging from 0.68 (item 3) to 0.73 
(item 4). An examination of their content appears to indicate that these questions, all loading 
highly on a single factor, tap important affective and cognitive components of anxiety (e.g. 
feeling panicky or worried), although it could be argued that item 3 is more related to 
depressive symptomatology. Similar findings were reported by Jomeen and Martin (2005a) 
in a sample of women in their first trimester of pregnancy. EFA resulted in a three-factor 
solution which included depression and anxiety dimensions, and the same third factor 
identified by Brouwers and colleagues (2001). The items loading significantly (>0.63, range 
0.73-0.85) onto the anxiety subscale were entirely consistent (items 3, 4, 5) with those 
identified in the previous study (Brouwers et al., 2001). The authors then conducted 
confirmatory factory analysis (CFA), a more refined data reduction technique than EFA 
allowing to test predefined factor solutions (Child, 2006), and tested various factor models 
including the original unidimensional depression model (Cox et al., 1987) as well as both a 
two- and a three-factor solution identified by Brouwers and colleagues (Brouwers et al., 
2001). Results from the CFA revealed once again a clear superiority of the two-factor 
solution, thus confirming the previous finding that the EPDS both in early and in mid-
pregnancy consistently measures two distinct dimensions of depression and anxiety. A 
further study included in this review (Matthey et al., 2013b) used the three-item EPDS 
anxiety subscale (EDS-3A) identified in previous studies to examine its criterion and 
convergent validity in pregnancy when compared to other anxiety measures. The EDS-3A 
performed better than both the anxiety subscale of the Hospital Anxiety and Depression 
Scale (HADS-A82) and the Pregnancy Related Anxiety Questionnaire-Revised (PRAQ-R: 
Huizink et al., 2004) in detecting women with an anxiety disorder as determined by DSM 
diagnostic criteria. Furthermore, the EDS-3A showed a moderately high correlation with the 
HADS-A (r = 0.68) and a low to moderate correlation with the PRAQ-R (r = 0.23), which 
may be interpreted as an indication that the three measures tap into different aspects of 
antenatal anxiety. While a potential limitation of the three studies reported above is their 
relatively small sample size (n < 200), the existence of an anxiety subscale within the EPDS 
was further confirmed in two subsequent studies with much larger sample sizes (n > 4000). 
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Swalm and colleagues (2010) examined the EPDS factor structure in an Australian sample 
across the three trimesters of pregnancy. A two-factor solution consisting of anxiety and 
depression components was found once more to be optimal, accounting for 55% of the score 
variance (anxiety subscale =29.4%; depression subscale =25.4% of the total variance). 
Moreover, an analysis of individual item loadings confirmed that items 3, 4 and 5 were the 
only ones with loadings higher than 0.63 on the anxiety subscale (range 0.75-0.78). A recent 
study (Coates et al., 2017) conducted both EFA and CFA on a large UK population-based 
sample at two time points (18 and 32 weeks gestation). Although both EFA and CFA 
indicated a three-factor model as the best factor solution, this was primarily due to the 
“depression” factor which was split into an anhedonia (items 1 and 2) and a depression (items 
7-10) factor. Importantly, this was the only study in which item 3 “I have blamed myself 
unnecessarily when things went wrong” (0.56) did not reach the predefined item loading 
coefficient of 0.63. In summary, according to the criteria previously discussed to evaluate 
the strength of evidence in relation to the psychometric properties of reviewed scales, item 
3 of the EPDS showed moderate evidence of its psychometric value, while items 4 and 5 
demonstrated strong evidence of being psychometrically sound in assessing antenatal 
anxiety, as their item loadings on the anxiety subscale consistently exceeded the 0.63 cut-
off in all reviewed studies.  
 
4.4.2 Hospital Anxiety and Depression Scale – Anxiety subscale 
The Hospital Anxiety and Depression Scale (HADS: Zigmond & Snaith, 1983) is a widely 
popular screening tool (Cosco, Doyle, Ward, & McGee, 2012), originally developed to 
assess anxiety and depression in non-psychiatric patients. This 14-item measure consists of 
two subscales (anxiety: HADS-A; depression: HADS-D), both comprising seven items and 
enquiring about feelings over the past week with four response options (Zigmond & Snaith, 
1983). It is particularly important to establish the psychometric properties of the HADS 
when used in the antenatal period, as a considerable number of studies have used this 
screening tool to assess anxiety and depression levels in pregnant samples (Rubertsson et 
al., 2014; Owen et al., 2017). Three studies included in this review examined psychometric 
aspects of the HADS in a pregnant population (Karimova & Martin, 2003; Jomeen & Martin, 
2004; Matthey et al., 2013b). They all achieved a rating of good in relation to their 
methodological quality. Karimova and Martin (2003) investigated the factor structure of the 
87 
 
HADS in the third trimester of pregnancy by conducting EFA of HADS scores in a sample 
of nulliparous women, and a post-hoc factor analysis revealed a two-factor solution. 
Specifically, six of the seven HADS-D items loaded higher on one factor and an equal 
number of HADS-A items loaded higher on a second factor. However, there was significant 
overlapping of item loadings on the two subscales, with only four HADS-A items (item 3 “I 
get a sort of frightened feeling as if something awful is going to happen”; item 5 “Worrying 
thoughts go through my mind”; item 9 “I get a sort of frightened feeling like “butterflies” in 
the stomach” and item 13 “I get sudden feelings of panic”) loading above 0.63 on the anxiety 
factor. The authors therefore concluded that the 7-item HADS-A and HADS-D subscales do 
not reliably distinguish between anxiety and depressive symptoms in pregnancy. A further 
study was conducted by Jomeen and Martin (2004) on a sample of women in early 
pregnancy. Both EFA and CFA revealed a three-factor solution which confirmed that the 
HADS in pregnancy is not a bi-dimensional measure of anxiety and depression. However, a 
comparison of individual item loadings of the HADS anxiety subscale in the two studies was 
carried out in this review to examine psychometric information for each individual item 















Table 6 – Item loading coefficients of the HADS-A subscale in Karimova & Martin 




Martin  (2003) 
 
Anxiety factor 




Anxiety factor  
(factor 2) 
   
1   I feel tense or wound up  0.18 0.31 
3   I get a sort of frightened feeling as if 
   something awful is going to happen 
0.67 0.74 
5   Worrying thoughts go through my mind  0.78   0.69 
7   I can sit at ease and feel relaxed 0.33 0.07 
9   I get a sort of frightened feeling like 
   “butterflies” in the stomach 
0.65 0.57 
   
11 I feel restless as if I have to be on the move 0.57 0.36 
13  I get sudden feelings of panic 0.67 0.75 
 
Note: Item loadings in bold indicate loadings of 0.63 or above. 
 
The observation that three items of the HADS-A (items 3, 5, 13) are the only ones to reach 
an item loading above 0.63 on the anxiety factor in both studies is of particular importance. 
Although the two studies reached the conclusion that the seven-item HADS-A as a whole is 
not a psychometrically sound measure of anxiety in pregnancy, the three HADS-A items 
identified here showed a consistent pattern across the two studies, with significantly similar 
loadings on the anxiety factor. These items would therefore appear to have good 
psychometric value in assessing specific anxiety symptoms in pregnancy. A subsequent 
study (Matthey et al., 2013b) compared the screening performance of the HADS-A with 
diagnosis of an anxiety disorder according to DSM criteria. The authors found that high 
anxiety scores on the HADS-A, defined as the top 15% of scores, had poor concordance 
(34%) with formal diagnosis of an anxiety disorder. The poor concordance with DSM 
diagnoses seems to confirm the previous findings indicating that the 7-item HADS anxiety 
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subscale as a whole is not a reliable screening tool to assess anxiety in pregnancy. However, 
based on the evidence provided by the two studies discussed above on the factor structure of 
the HADS, it was concluded that the three identified items represent a shortened version of 
the HADS-A which, unlike the entire HADS-A, has good evidence of its psychometric 
properties to measure antenatal anxiety.  
 
4.4.3  State-Trait Anxiety Inventory   
The STAI comprises two subscales, each composed of 20 items. It is based on a model of 
anxiety which distinguishes between state and trait anxiety (Spielberger et al., 1983). State 
anxiety refers to the situation-specific, transient component of anxiety. Conversely, trait 
anxiety reflects a relatively stable personality trait, a dispositional anxiety proneness (Green, 
Kafetsios, Statham & Snowdon, 2003). Response options range from 1 (not at all) to 4 (very 
much so) for both the state and trait form, and each scale includes 10 anxiety-present (e.g. “I 
am worried”) and 10 anxiety-absent (e.g. “I feel secure”) items. The STAI has been widely 
validated in the general population (Austin et al. 2007) and is one of the most common 
measures used in research to assess anxiety in perinatal women (Meades & Ayers, 2011). 
This review located four studies reporting psychometric properties of the STAI in pregnant 
populations, one of which (Tendais et al., 2014) scored poor in relation to its methodological 
quality. Both the state and trait form of the STAI were used in an Australian study by Grant 
and colleagues (2008) on women in the third trimester of pregnancy. Internal consistency 
was found to be high for the full version of the scale, with a Cronbach’s Alpha (α) of 0.95. 
A structured diagnostic interview was also used (Mini International Neuropsychiatric 
Interview [MINI]: Sheehan et al., 1998) to identify women meeting DSM-IV diagnostic 
criteria for an anxiety disorder. The authors found a cut-off score of 40 to yield the highest 
accuracy in identifying women with a diagnosed anxiety disorder, with a sensitivity of 81% 
and a specificity of 80%. However, they also acknowledged the limited generalisability of 
the findings due to the relatively small sample. The study did not provide any psychometric 
data at the item level and it was thus not possible to reach conclusions on the psychometric 
qualities of individual items measuring specific symptoms. A further study (Marteau & 
Bekker, 1992) tested various shortened versions of the STAI-S form to determine the 
smallest subset of items that preserved high correlations (r >0.90) with the original, 20-item 
STAI-S. They found that a six-item version produced scores comparable to the full version 
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(r >0.94) while retaining a good level of internal consistency (α = 0.82). The six items 
selected were the ones with the highest correlations with the remaining 19 items of the STAI-
S (i.e. corrected item-total correlations). Specifically, the authors identified three anxiety-
present and three anxiety-absent items, corresponding to the following emotional states: 
calm, tense, upset, relaxed, content and worried. This is a significant finding, as it identifies 
a number of symptoms (i.e. feeling tense, upset or worried) that correlate highly with the 20-
item STAI-S total score, providing an initial indication that these anxiety-present symptoms 
may be considered relatively accurate indicators of problematic anxiety in pregnancy. This 
was confirmed in a further study by Bayrampour and colleagues (2014) which examined the 
psychometric properties of three six-item shortened versions of the STAI-S when compared 
to the full state form. The three short versions are the one discussed above (Marteau & 
Bekker, 1992) and two other versions developed in non-perinatal populations. The six-item 
version by Marteau and Bekker (1992) had the highest correlation with the sum score of the 
full form (r =0.94). Furthermore, confirmatory factory analysis was conducted and the 
version by Marteau and Bekker (1992) was found once more to consistently have the best 
values for all fit indexes considered, with the three anxiety-present items (i.e. feeling 
tense/upset/worried) all found to have coefficient item loadings above 0.63, a further 
indication of their psychometric soundness. In sum, the three items from the STAI-S short 
form discussed above were identified in two studies of good methodological quality 
(Marteau & Bekker, 1992; Bayrampour et al., 2014) as potentially reliable indicators of 
anxiety symptoms during pregnancy.  
 
4.4.4  GAD-7 
The GAD-7 (Spitzer et al., 2006) was developed in 2006 as a brief screening measure for 
Generalised Anxiety Disorder (GAD). Its original psychometric validation study in a large 
sample of primary care patients indicated very good screening accuracy in identifying people 
with a diagnosis of GAD (Spitzer et al., 2006). The scale consists of seven items asking 
respondents about some of the core GAD symptoms (e.g. excessive or persistent worry, 
trouble relaxing) experienced in the previous two weeks. As previously discussed, the first 
two questions of the GAD-7 (GAD-2) have been recently recommended by NICE (2014) as 
a brief screening measure for anxiety in perinatal women. Only two studies examining the 
measurement properties of the GAD-7 in a pregnant population were identified by this 
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review (Simpson et al., 2014; Zhong et al., 2015), and only one (Zhong et al., 2015) achieved 
a satisfactory rating for its methodological quality. Importantly, this was one of the few 
included studies which performed assessment of a scale against a gold standard diagnostic 
interview, the Composite International Diagnostic Interview (CIDI: Kessler & Üstün, 2004), 
to determine the criterion validity of the scale.  In this antenatal sample at a cut-off score of 
7 or above, different from the cut-off of 8 identified in the general population, the measure 
yielded moderately good sensitivity (73%) and specificity (67%) (Zhong et al., 2015). 
Internal consistency was close to excellent (α= 0.89). Both EFA and CFA were conducted 
and confirmed the unidimensional structure (e.g. a single factor) of the GAD-7 previously 
found in the general population (Spitzer et al., 2006). The results of the factor analysis 
indicated that the seven items loaded on a single factor with item loadings all exceeding 
0.63. In order to identify which items provided the most accurate screening performance, I 
examined the item discrimination parameters, which are based on item response theory and 
indicate how well individual items differentiate between different levels of the target 
condition among respondents (Li & Baser, 2012). Two items showed considerably higher 
discrimination parameter estimates than the remaining ones. These were item 3 “Worrying 
too much about different things” (2.05) and item 2 “Not being able to stop or control 
worrying” (2.04), which clearly tap into the experience of pervasive or persistent worry 
typical of GAD. All other items exhibited substantially lower discrimination parameter 
estimates. Considering that this study was of excellent methodological quality, the two 
identified items have consequently strong evidence of their psychometric value in the 
antenatal period.  
 
4.4.5  Brief Measure of Worry Severity  
A single study (Austin et al., 2007) was located reporting psychometric data of the Brief 
Measure of Worry Severity (BMWS: Gladstone et al., 2005) in a pregnant sample. Self-
report scales assessing the construct of ‘worry’ were included in this review (see Table 4) as 
worry is a core clinical feature of Generalised Anxiety Disorder (APA, 2013). A number of 
studies indicate that GAD is the most common anxiety disorder in pregnancy (for a review 
see Dennis et al., 2017) and for this reason worry can be hypothesised to be an important 
dimension of the construct of antenatal anxiety. The BMWS was developed as a 
unidimensional measure of the functional impact and severity of worry (Gladstone et al., 
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2005). It includes 8 items assessing different aspects of worry with four verbally-anchored 
response options (not true at all – definitely true). Internal consistency was very good (α = 
0.89) in this antenatal sample, and the BMWS also showed good convergent validity with 
the STAI Trait (r = 0.71). While psychometric properties of the scale at the item level were 
not reported, there was evidence that the construct of worry as measured by BMWS is a 
reliable indicator of antenatal anxiety. First, the BMWS was found to have good construct 
validity in this sample of pregnant women, as it showed significant correlations with a 
number of other variables linked to a current episode of anxiety and depression (Austin et 
al., 2007). Moreover, it was a better predictor of postnatal depression than the STAI-S after 
controlling for possible confounding factors. As the literature indicates that antenatal anxiety 
is a strong predictor of PND (Milgrom et al., 2008; Grant et al., 2008), it would appear than 
the BMWS taps into a core component of antenatal anxiety considering its good predictive 
validity. Consequently the construct of worry has strong evidence of being psychometrically 
robust according to the criteria used in this review (i.e. consistent findings in multiple studies 
of good or excellent methodological quality), as it was also identified as psychometrically 
sound in other studies in this synthesis as detailed earlier.  
 
4.4.6  Cambridge Worry Scale  
The Cambridge Worry Scale (CWS) is a 16-item measure assessing the extent and content 
of women’s worries during pregnancy (Green et al., 2003). The 16 items in the CWS enquire 
both about worries specific to pregnancy, such as “The possibility of miscarriage”, “The 
possibility of something being wrong with the baby” or “Giving birth”, and more general 
concerns including “Money problems” and “Your relationship with your family and 
friends”. Items are scored on a 6-point Likert-type scale with verbally described anchors 
ranging from 0 (Not a worry) to 5 (Major worry). Six studies examining psychometric 
aspects of the CWS in a pregnant population were included in this review, four of which are 
considered here. The other two studies were rated as poor (Öhman et al., 2003) or fair 
(Jomeen & Martin, 2005b) for their methodological quality. Green and colleagues (Green et 
al., 2003) were the first to investigate the structural validity (i.e. the factor structure) of the 
CWS.  A longitudinal design was used in a large sample (n = 1207) of women completing 
the CWS at gestational weeks 16, 22 and 35. The authors analysed scores at these three time 
points by means of principal component analysis (PCA), a form of exploratory factor 
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analysis. The PCA revealed a four-factor structure, consisting of the following factors:  1) 
Socio-medical aspects of having a baby 2) Socio-economic issues 3) Health of mother and 
baby 4) Relationships with partner, family and friends.  This four-factor solution was 
subsequently replicated in all the other studies examined in this synthesis (Petersen, 
Paulitsch, Guethlin, Gensichen, & Jahn, 2009; Carmona Monge, Peñacoba-Puente, Marín 
Morales, & Carretero Abellán, 2012; Gourounti, Lykeridou, Taskou, Kafetsios, & Sandall, 
2012). This can be considered robust evidence of factorial invariance of the CWS in different 
samples and stages of pregnancy. The convergent validity of the CWS was examined by 
comparing it with STAI state and trait scores (Green et al. 2003; Petersen et al., 2009; 
Gourounti et al., 2012) and with the anxiety subscale of the Symptom Checklist 90 (CL-90-
R: Derogatis, 1977) by Carmona Monge and colleagues (2012). Two of the four CWS 
subscales were found to have the highest correlations with state anxiety (STAI-S) scores 
across studies. These were the “socio-medical” and the “health of mother and baby” factors. 
For the purpose of this review, the focus is specifically on these two factors, both because 
of their higher correlations with state anxiety and because the content of items in these 
subscales appears to reflect worries more closely related to pregnancy. Thus, an examination 
of individual item loadings for these two factors was carried out. In relation to the “socio-
medical” subscale, one item (“Giving birth”) was found to load above the predefined 
criterion of 0.63 in all four studies, thus demonstrating strong evidence of its psychometric 
properties in assessing a major worry in pregnancy. Another three items showed moderate 
strength of evidence as they loaded above 0.63 on the “socio-medical” subscale in all studies 
apart from one. Specifically, “Internal examinations” had an item loading coefficient of 
0.61 in Gourounti and colleagues (2012), but item loadings above 0.63 in all the other 
studies; “Going to hospital” (0.68-0.79), apart from Gourounti and colleagues (2012) (0.47); 
and “Coping with the new baby” (0.65-0.68), except for the study by Petersen and colleagues 
(2009), in which its loading was 0.58. An inspection of the second factor examined, “Health 
of mother and baby”, indicated two further items with loadings >0.63 in all the studies, 
namely “The possibility of miscarriage”, which ranged between 0.75 (Green et al., 2003) 
and 0.85 (Carmona Monge et al., 2012), and “The possibility of something being wrong with 
the baby” (range 0.65-0.83). The other two items included in this subscale, “Own health” 
and “Health of someone else close”, consistently loaded below the pre-defined cut-off. In 
summary, three items of the CWS (“Giving birth”, “The possibility of miscarriage”, “The 
possibility of something being wrong with the baby”) demonstrated strong evidence of their 
psychometric value. Three further items (“Internal examinations”, “Going to hospital” 
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“Coping with the new baby”) showed a moderate strength of evidence of their psychometric 
performance in pregnancy.  
 
4.4.7  Wijma Delivery Expectancy/Experience Questionnaire 
The Wijma Delivery Expectancy/Experience Questionnaire (W-DEQ; Wijma et al., 1998) 
was developed in the late nineties to assess the construct of fear of childbirth. As observed 
in Chapter 2, within the research literature on pregnancy-related anxiety, fear of childbirth 
(FoC) or tokophobia has emerged as a central dimension of PrA (Heimstad et al, 2006; 
Blackmore et al., 2016). The W-DEQ -Version A (Wijma et al., 1998) includes 33 items 
enquiring about thoughts and feelings relating to the approaching childbirth, with six 
response options ranging from “Not at all” to “Extremely”. Five studies included in the 
present review reported psychometric information on the W-DEQ in an antenatal population, 
and three studies achieved a good or excellent methodological quality rating (Wijma et al., 
1998; Johnson & Slade, 2002; Fenaroli & Saita, 2013). In the original development study of 
the W-DEQ (Wijma et al., 1998), the authors provided good evidence of the face and 
construct validity of the W-DEQ, with all items formulated based on the clinical experience 
of the first two authors and incorporating women’s input in the wording of items. The W-
DEQ showed higher correlations with other anxiety measures than with extraversion or 
depression measures. However, these correlations were only moderate (STAI-T: r = 0.54; 
S-R Inventory of anxiousness: r = 0.52), thus showing a degree of conceptual overlap but 
also a sufficient level of variance left to indicate that the W-DEQ measures other than anxiety 
as a dispositional trait (Wijma et al., 1998). At the item level, item-total correlations were 
ranked and the authors examined the ten items with the highest ranking. Two domains of 
FoC, “Negative feelings towards childbirth” and “Fear of labour and delivery”, were 
identified among the items more strongly correlated with the sum score, thus suggesting a 
stronger relation with the overall construct of FoC. As single items composing the W-DEQ 
are very specific to a given feeling or cognitive appraisal, it was considered appropriate for 
this review to focus on domains of FoC rather than individual items. Two other studies 
included in this synthesis conducted factor analysis of W-DEQ scores and found four distinct 
dimensions of the construct of FoC as measured by the scale. Johnson and Slade (2002) 
named the four identified domains Fear, Lack of positive anticipation, Isolation and 
Riskiness. The latter two refer to feelings of isolation related to childbirth and to the extent 
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to which women anticipate risks for the child during delivery. Fenaroli and colleagues (2013) 
also found a four-factor structure of the W-DEQ, and although the four domains were named 
with slightly different labels than those used by Johnson and Slade (2002), the four factors 
were considerably similar and had a high degree of conceptual overlap. In this best evidence 
synthesis two dimensions of pregnancy-specific anxiety, namely Fear of labour and delivery 
and Negative feelings towards childbirth (corresponding to Lack of positive anticipation in 
Fenaroli and colleagues, 2013), were thus found to exhibit strong evidence of being 
psychometrically sound in assessing this specific aspect of antenatal anxiety. A third 
dimension (Fear for baby’s health) showed moderate strength of evidence as, although it 
was identified in two studies, contrasting results were found in another study (Wijma et al., 
1998).  
 
4.4.8  Pregnancy Related Anxiety Questionnaire - Revised  
This PrA measure is composed of 10 items assessing various manifestations of anxiety 
related to a current pregnancy. Each item has 5 response options ranging from “never” to 
“very often”. Its original version (PRAQ: Van den Bergh, 1991) consisted of 58 items and 
was developed based on previous anxiety measures. The first study testing the psychometric 
properties of the PRAQ was carried out by Huizink and colleagues (2004) who initially 
tested a revised, 34-item version (PRAQ-R: Huizink et al., 2004) of the original PRAQ on 
230 nulliparous women. The authors’ aim was to examine the factorial structure of the 
PRAQ-R and test the hypothesis that PrA could be differentiated from general anxiety by 
comparing STAI and PRAQ-R scores. They found that only between 8 and 27% of the 
PRAQ-R variance was accounted for by the index of general anxiety at different time-points 
during pregnancy, with no linear association found between the two measures. This was 
interpreted as evidence of the distinctiveness of the PrA construct (Huizink et al., 2004) and 
highlighted once more that measures of general anxiety cannot be accurately used to identify 
women experiencing fears and worries specific to pregnancy. The authors initially conducted 
EFA and removed a number of items because of high error variance, resulting in a final 
version comprising 10 items (PRAQ-R). A subsequent CFA revealed that a solution with 
three factors provided the best fit to the data, with the three identified factors labelled by the 
researchers “Fear of giving birth” (three items), “Fear of bearing a physically or mentally 
handicapped child” (four items) and “Concern about one’s appearance” (three items). All 
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individual items loaded on one of the factors above the cut-off of 0.63, except for two items, 
“I am worried about not being able to control myself during labour and fear that I will 
scream” and an item related to concerns about one’s appearance. Similarly to the approach 
used for the W-DEQ and discussed above, the whole factors were considered as anxiety 
domains rather than individual items. Two further studies (Westerneng et al., 2015, Huizink 
et al., 2016) included here tested the measurement properties of the PRAQ-R, and both 
replicated the previous finding of a three-factor structure of the PRAQ-R by means of CFA. 
As the original sample of the 10-item PRAQ-R was exclusively composed of nulliparous 
women, Westerneng and colleagues (2015) aimed to test the factorial stability of the three-
factor solution of the PRAQ-R (Huizink et al., 2004) on a large (n>6000) dataset of both 
nulliparous and parous women. This involved the deletion of item 8 “I am anxious about the 
delivery because I have never experienced one before”, obviously not suitable for use with 
women who had already experienced childbirth. CFA confirmed the same three-factor 
structure of the original 10-item PRAQ-R with good indexes of fit to the data for both 
nulliparous and parous women. Three factors were also found in a recent study (Huizink et 
al., 2016) which replaced item 8 of the original PRAQ-R with the more generic “I am 
anxious about the delivery”, in order to preserve a 10-item scale while making it appropriate 
for all pregnant women irrespective of parity (PRAQ-R2: Huizink et al., 2016). All item 
loadings were once more above 0.63 (range: 0.70 - 0.93) except for two items, “I am worried 
about not being able to control myself during labour and fear that I will scream”, similarly 
to Huizink and colleagues (2004), and “I sometimes think that our child will be in poor 
health or will be prone to illnesses”. In summary, across the three studies examined above, 
eight items from the PRAQ-R were found to consistently have high loadings on one of three 
factors (i.e. PrA domains). These three PrA domains, namely “Fear of giving birth”, “Fear 
of bearing a physically or mentally handicapped child” and “Concern about one’s 
appearance”, were all identified in studies of good or excellent methodological quality, thus 







4.5   Summary of key findings  
This review has identified a number of anxiety items and domains from existing self-report 
scales with demonstrated psychometric value when used to assess symptoms of anxiety in 
pregnant women. Eight self-report scales were considered in the synthesis of the best 
available evidence presented above. One further scale located by this review (Pregnancy 
Anxiety Scale (PAS: Levin, 1991) was not examined at the best evidence stage as the single 
study reporting its psychometric properties was rated poor for its methodological quality 
(Levin, 1991). The key findings regarding anxiety items and domains identified as accurate 
indicators of antenatal anxiety are briefly summarised here. As discussed earlier, they were 
subsequently used (Chapter 6) to inform the generation of a proportion of candidate items 
for the assessment of antenatal anxiety. A complete list of all the identified anxiety items 
and domains is also presented in Appendix 7.  
Items assessing excessive, generalised worry were found to be psychometrically sound in 
the antenatal period in the EPDS, HADS-A, BMWS, GAD-7 and STAI-S. Overall, there 
was strong evidence of the psychometric robustness of items measuring the domain of worry, 
with consistent findings in multiple studies of good or excellent quality. Since excessive 
worry is essentially a cognitive symptom, it could be argued that it is less susceptible to the 
physical and physiological changes of pregnancy, and it remains thus a good indicator of 
problematic anxiety in pregnancy as it is in the general population. A second anxiety domain 
that showed good evidence of its psychometric soundness in pregnant populations concerned 
items tapping into symptoms of fear or panic. Feelings of fear are another important 
component of different anxiety disorders, including Panic Disorder, Agoraphobia, Social 
Anxiety Disorder and Specific Phobia (Craske et al., 2009; APA, 2013). In this review, items 
assessing the Fear/Panic domain were identified as psychometrically sound for use in 
pregnancy in various scales, including the HADS-A, the EPDS and several PrA scales. Other 
specific symptoms identified by this review showed moderate evidence of their screening 
ability in the assessment of antenatal anxiety. These included being excessively self-critical 
(EPDS, item 3), feeling upset (STAI-S, item 6) and the experience of nervous or motor 
tension (STAI-S, item 3). While these symptoms may not appear to be specific of anxiety 
disorders, these findings are in line with the well-established tripartite model of anxiety and 
depression proposed by Clark and Watson (1991). This model postulates that depressive and 
anxiety disorders share a common component of general emotional distress, and the 
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symptoms above can be categorised as manifestations of general distress, which can be 
present in both depressive and anxiety symptomatology (Clark & Watson, 1991). 
In relation to anxiety symptoms specifically related to pregnancy, fear of childbirth was 
shown to be a good indicator of antenatal anxiety. Specifically, PrA symptoms of fear related 
to giving birth exhibited strong evidence of their psychometric value in the W-DEQ (several 
items) and the PRAQ-R (two items related to fear of childbirth). Items assessing persistent 
worries specifically related to pregnancy also showed good psychometric properties in the 
CWS, the W-DEQ and the PRAQ-R. The worries with the strongest evidence to support 
their screening accuracy related to concerns regarding the health or safety of the baby and 
the possibility of miscarriage. Other worries, including being in hospital and worrying about 
future parenting showed only moderate evidence of their screening value (see Appendix 7). 
It may be argued that most women are likely to experience some degree of concern regarding 
these aspects of pregnancy, but that in women experiencing clinical levels of anxiety these 
worries may be more intense or persistent (i.e. higher severity or frequency).  
In conclusion, the systematic review presented here was conducted with the aim to examine 
the psychometric properties and content of anxiety scales used in pregnancy and map a set 
of core anxiety symptoms and domains identified to be psychometrically sound for the 
assessment of anxiety during pregnancy. Both this systematic review and the qualitative 
interviews with women with experience of problematic anxiety during pregnancy presented 
in the following chapter contributed to the initial phase of scale development, as detailed in 
Chapter 3. Evidence from these two studies was subsequently considered in combination to 
inform the construct definition of antenatal anxiety and guide the generation of an initial 




Chapter 5   Women’s perspective: qualitative interviews on the 
experience of anxiety symptoms in pregnancy  
 
5.1 Introduction  
The aim of the study presented in this chapter was to explore the experience of problematic 
anxiety symptoms in pregnant women in order to determine which anxiety symptoms can be 
used for the accurate identification of antenatal anxiety. This was achieved by conducting 
semi-structured, qualitative interviews with women with a current or past experience of 
clinically significant anxiety during pregnancy, who were selected based on predetermined 
criteria.  
Similarly to the systematic review presented in Chapter 4, this study thus contributed to 
answer Research Questions 1 and 2:  
 What should a construct definition of antenatal anxiety include in order to cover the 
core domains of significant anxiety symptoms in pregnancy? 
 
 Which items are the most appropriate to operationalise the proposed construct of 
antenatal anxiety into a self-report rating scale? 
 
While planning the design of this study, I carried out a scoping search of the literature to 
examine which qualitative studies had previously been conducted to investigate the 
experience of anxiety during pregnancy. A meta-synthesis of the qualitative research 
literature on maternal antenatal psychological distress was recently carried out by Staneva 
and Bogossian (2015). The authors located eight studies, with the majority investigating the 
experience of antenatal depression. Only two studies were found which focused on antenatal 
anxiety, and neither examined the full range of anxiety symptoms that can be experienced 
during pregnancy. Firstly, a Swedish study conducted in 2006 specifically explored the 
psychological experience of fear of childbirth, using a grounded theory approach to 
investigate how intense fear related to birth was experienced, as well as women’s coping 
mechanisms and communication strategies (Eriksson, Jansson, & Hamberg, 2006). The 
second study, which also adopted a grounded theory approach, was carried out in rural 
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Cambodia (MacLellan, 2010) and aimed to examine the co-occurrence of depressive and 
anxiety symptoms in the antenatal period, as well as the barriers in accessing midwifery care 
in this population. While these investigations provided some level of insight into the 
experience of emotional and psychological distress that may occur during pregnancy, the 
study presented here specifically aimed to conduct a focused exploration and analysis of the 
range and relative importance (used with the meaning of impact, significance) of problematic 




















5.2 Method  
When considering the most appropriate research method to investigate clinically significant 
anxiety symptoms experienced by pregnant women, it was clear since the early phases of 
study design that a qualitative method of inquiry was most suitable. Despite the diverse set 
of approaches that exist in qualitative research, they all tend to be characterised by an 
emphasis on the exploration of individual experiences or views in relation to one or more 
specific topics, and typically provide rich and nuanced accounts of the phenomenon under 
investigation (Silverman, 2001; Bowling, 2014). Within the realm of qualitative research 
methods, each with its own epistemological assumptions and methodological techniques, 
different approaches are used to answer different research questions (Mason, 2009). Given 
the primary aim of the research documented in this thesis (i.e. the formulation of items for 
the accurate assessment of antenatal anxiety), the focus of this study was less on the 
meanings that women attributed to their anxiety symptoms and how these were constructed, 
and more on the explicit description of these symptoms as experienced and reported by study 
participants. This was an initial indication that more interpretative approaches such as 
grounded theory or interpretative phenomenology were likely to be less suited to address the 
specific research questions of this study (Russell & Gery, 2010). It was considered that 
individual interviews or focus groups represented the two best candidates for data collection 
method, since they can both provide information-rich, detailed accounts of a specific object 
of inquiry by consulting a relatively small number of key informants. Individual, semi-
structured interviews, which were analysed using inductive thematic analysis, were 
eventually favoured over focus groups for several reasons, briefly discussed here. First, it 
was considered that individual interviews provided a ‘safer’ environment for the discussion 
of a personal and potentially sensitive topic (Flick, 2002). Although it has been suggested 
that focus groups, because of the interactive nature of the technique, may also encourage and 
facilitate discussion on sensitive or delicate topics (Mason, 2009), other scholars have noted 
that in focus groups the conversation may be dominated by a small number of individuals, 
with the risk of loss of information, particularly if sensitive topics are discussed (Patton, 
2002). It may also be argued that focus groups are a more efficient way of collecting data 
from a given number of individuals within a relatively short amount of time. However, in a 
focus group setting the detailed and nuanced accounts of individual experiences that can be 
obtained through individual interviews are arguably less likely to emerge. Individual 
interviews also typically have the benefit of providing more flexibility and choice for study 
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participants with regard to practical aspects such as the location or date and time of the day, 
which might in turn facilitate participation in the research (Bowling, 2014).  
The following sections discuss a number of methodological considerations and decisions 
taken in relation to the recruitment of study participants, sampling and sample size, study 
eligibility criteria, as well as data collection and analysis. The remainder of the chapter 
presents the findings of this study in relation to the anxiety symptoms and domains that were 
most commonly reported by women with experience of problematic antenatal anxiety.  
 
5.2.1 Recruitment of study participants 
Study participants were recruited through two main routes, specifically the Maternal Mental 
Health Scotland Change Agents and the Perinatal Mental Health Service in NHS Greater 
Glasgow & Clyde (NHS GG&C). Maternal Mental Health Scotland (MMHS) is a forum of 
health professionals and women with experience of perinatal mental illness who work to 
champion the cause of maternal mental health and support research in this area. The MMHS 
Change Agents are a group of mothers with lived experience of perinatal mental health 
problems, who campaign for better services in Scotland and actively challenge the stigma 
associated with poor mental health during the perinatal period. They had been informed of 
this study in its early phases and communicated their interest in contributing to the research. 
The MMHS Change Agents coordinator agreed to facilitate recruitment among the Change 
Agents according to the recruitment procedure and study eligibility criteria discussed below. 
The remaining proportion of women who were interviewed were recruited through the 
Perinatal Mental Health Service in NHS GG&C. In this instance, recruitment was facilitated 
by a Nurse Consultant in Perinatal Mental Health for NHS GG&C, who is also a member of 
the Scottish National Managed Clinical Network on perinatal mental health. She coordinated 
recruitment of pregnant women currently or previously in treatment with the NHS GG&C 
Perinatal Mental Health Service who had a diagnosed anxiety disorder in the antenatal 
period.  
All potential participants were initially approached either by the MMHS Change Agents 
coordinator or by the Nurse Consultant, who gauged the interest and suitability of women to 
be interviewed. This indirect approach to recruitment had the additional benefit of reducing 
the possibility of a woman feeling obliged to take part in the study (Wilson, Draper. & Ives, 
2008). A meeting took place between me and the two recruiters prior to any potential 
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participants being approached, and study packs for the initial recruitment phase were 
distributed to them. During the initial approach, all women were given a brief, verbal 
explanation of the study and what it involved. If a woman expressed interest in taking part 
in the study, she was given a study pack containing a letter of invitation, the study 
information sheet, a consent form and a reply slip (see Appendices 8 and 9 for examples), 
and was asked to read the information provided in her own time. The invitation letter asked 
women who decided to take part in the study to return the reply slip to the study office 
(NMHAP Research Unit, University of Stirling) in a pre-paid, addressed envelope. Return 
of the reply slip allowed me to contact potential participants through their preferred contact 
method (i.e. phone or email, as indicated in the reply slip). At this stage, women interested 
in taking part were given the opportunity to ask questions about the study and what it 
involved and, if they agreed in principle to participate, a suitable date and location for the 
interview was agreed (further details in 5.2.3). Women could decide to be interviewed in 
their homes, or at a local NHS or university site (the Mother & Baby Unit within the 
Leverndale Hospital in Glasgow and Glasgow Caledonian University), where I had access 
to an interview room. The option of a video interview (via Skype) was also available. 
Consent to be interviewed was taken on the day of the interview when participants signed 
the consent form prior to the interview starting.  
 
5.2.2 Study inclusion and exclusion criteria  
The target sample consisted of women with a current or past experience of problematic 
anxiety symptoms in pregnancy. Specifically, the following inclusion and exclusion criteria 
were applied to determine study eligibility:  
Inclusion criteria 
- A current or past diagnosis of at least one anxiety disorder during pregnancy, as per ICD-
10 criteria1 (WHO, 1992).  
                                                          
1 These diagnoses were made by consultant psychiatrists or clinical psychologists working for the NHS GG&C 
Perinatal Mental Health Service, where a proportion of study participants were recruited, as discussed earlier. 
Women experiencing any of the following anxiety disorders were eligible for inclusion:  Agoraphobia, Panic 
disorder, Social phobias, Specific phobias, Generalised anxiety disorder, Obsessive-compulsive disorder, 
Posttraumatic stress disorder and Unspecified anxiety disorder.  
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- A further inclusion criterion was ‘self-identified antenatal anxiety’. This criterion was 
applied independently and not in addition to a formal diagnosis, in order to benefit from the 
contributions of the lived experiences of MMHS Change Agents, some of whom had 
experienced significant anxiety during pregnancy but may have not been formally 
diagnosed. Similarly to well-established diagnostic criteria for anxiety disorders (WHO, 
1992; APA, 2013), for the purpose of this study ‘self-identified antenatal anxiety’ was 
defined as anxiety symptoms experienced during pregnancy that a woman recognises as 
problematic and that interfere significantly with her normal routine, occupational 
functioning or social activities.  
Exclusion criteria 
- Women who were diagnosed with a severe mental health disorder other than anxiety during 
pregnancy (e.g. bipolar disorder, psychotic disorder).  
- Women with a level of spoken English gauged as not adequate to provide sufficient details 
about their experience of anxiety in pregnancy.  
- Women with no experience of an anxiety disorder or ‘self-identified antenatal anxiety’ 
during pregnancy.  
In order to determine whether the inclusion criterion of ‘self-identified antenatal anxiety’ 
was met by women who did not have a diagnosis of an anxiety disorder during pregnancy, I 
asked all potential recruits (by phone or email) to rate on a scale from 1 (not at all) to 10 
(very much) how much the definition of ‘self-identified antenatal anxiety’ presented above 
reflected their experience of anxiety symptoms during pregnancy, explaining that this was 
part of the inclusion criteria for the study. The question was slightly adapted depending on 
whether a woman had a present or past experience of problematic anxiety during pregnancy. 
In consultation with my supervisory team, it was agreed that only women who reported a 
self-identified antenatal anxiety score of 7 or above were eligible to be interviewed about 
their experience.   
 
5.2.3 Sampling and sample size 
Due to the nature and the target sample of this qualitative study, a convenience sampling 
technique was employed. Only participants who were likely to have experienced a past or 
105 
 
current episode of clinically significant anxiety in pregnancy were approached in the initial 
recruitment phase.  
In relation to sample size, the qualitative research literature often cites data saturation as a 
guiding principle (Glaser & Strauss, 1967; Mason, 2009). Data saturation is considered to 
occur when no new concepts or themes appear to emerge from the data, and further data 
collection is thus considered unlikely to provide additional significant insights into the object 
of inquiry (Francis et al., 2009). It follows that a precise sample size in qualitative research 
is commonly not determined a priori. An estimated sample size was nonetheless required by 
the local Research Ethics Committee and the Research & Development service of NHS 
GG&C (Appendices 1 and 2). It was thus estimated that between 10 and 15 women, 
depending on data saturation, were going to be interviewed. The choice for this expected 
sample size was based on a combination of methodological and ethical considerations. First, 
considering the relatively homogeneous sample (i.e. women with experience of problematic 
anxiety during pregnancy) and the specific area that was going to be explored (symptoms of 
anxiety), it was considered that increasing the sample size to more than 15 interviewees was 
unlikely to result in further key insights into the experience of anxiety in pregnancy (Guest, 
Bunce, & Johnson., 2006). Furthermore, as previously noted, it had to be acknowledged that 
the content of these interviews was potentially distressing for participants. Thus, from both 
an ethical and a methodological perspective, it was considered important to keep to a 
minimum the number of women interviewed in relation to this sensitive topic while 
recruiting a sufficient number of participants to obtain an adequately rich and varied data 
set. The principle of data saturation was nonetheless applied by monitoring the percentage 
of new themes which were identified at regular intervals during the data collection phase. 
This process is further detailed in 5.3.  
 
5.2.4 Data collection 
Individual, semi-structured interviews were chosen as the data collection method to gather 
information on women's experiences of antenatal anxiety. The semi-structured format in 
qualitative interviewing is, by definition, flexible in nature (Bowling, 2014). The interviewer 
typically makes use of an interview or topic guide, which contains a relatively small number 
of open-ended questions related to key topic areas that the researcher intends to explore. The 
guide is, however, used flexibly, for example by altering the order of questions or by 
following up content areas that were not initially included in the interview guide. It thus 
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allows the investigation of pre-defined topics as well as the exploration of unanticipated 
themes (Edwards & Holland, 2013). As can be seen in Appendix 10, the main section of the 
interview guide consisted of open-ended questions aimed to explore a range of affective, 
cognitive, behavioural and somatic symptoms experienced during pregnancy by the 
interviewees. During the interviews, I also used various probes and follow-up questions (e.g. 
“Can you tell me a bit more about that?”) to further explore specific areas of content, as 
well as empathy statements (e.g. “That must have been really hard for you”) when I felt that 
it was not appropriate to simply move on to the following question.  
As previously noted (5.2.1), a choice of location was offered to women who agreed to 
participate in the study. The majority of interviews were conducted at participants’ homes, 
as further detailed in section 5.3. Before starting the interview, women had a further 
opportunity to ask questions and agree or decline to be interviewed. Women who confirmed 
their willingness to participate were asked to complete and sign the consent form on the day 
of the interview. I aimed to keep the duration of interviews to a maximum of 40-45 minutes. 
An audio-recording device (Olympus WS-853 recorder) was used to record all the 
interviews. Once each interview was completed, the recording was securely sent to an 
approved transcriber, which performed ad verbatim transcriptions of all interviews. 
Confidentiality agreements between the transcriber and the University of Stirling were 
already in place. Basic socio-demographic and obstetric information was also gathered from 
all study participants at the end of the interview, and is also presented in section 5.3. While 
the ‘self-identified antenatal anxiety’ score was used to determine study eligibility, at the 
end of each interview I also asked women to rate their ‘self-identified antenatal depression’ 
during the pregnancy discussed, using the same 1-10 scale discussed earlier. The rationale 
for this was to gauge whether self-rated levels of depression indicated a possible comorbidity 
(i.e. score of 7 or above for both antenatal anxiety and depression) or if participants ascribed 
their psychological symptoms mainly or entirely to anxiety (i.e. score below 7 for antenatal 
depression). All interview transcripts were imported into NVivo (version 11), a computer 
assisted qualitative data analysis software package which was used to support the process of 
data analysis. Ethical considerations related to interviewing pregnant women, some of whom 
may have still been experiencing poor mental health at the time of the interview, were 




A note on reflexivity  
In preparation for this qualitative study, I attended two one-day training courses provided by 
the Social Research Association, specifically ‘Designing a qualitative study’ and 
‘Qualitative interviewing’. These courses, which proved particularly useful in practising my 
interviewing skills before the data collection phase, also made me aware of the important 
role played by reflexivity in qualitative research. Reflexivity can be defined as the act of 
critically considering how knowledge in research is generated taking into account the role 
of the investigator, including her or his biases, beliefs and personal characteristics 
(Guillemin & Gillam, 2004). Reflexivity contributes to increase the credibility of study 
findings, through a monitoring process of how the factors listed above can affect the research 
process, in particular in relation to the data collection and analysis phases (Berger, 2015). 
With regard to the phenomenon under investigation in this qualitative study, I was aware 
that I approached the study with some previous knowledge of antenatal anxiety, which I 
developed while reviewing the literature of interest in the early phases of the PhD. In part I 
used this knowledge to design the interview guide, by including a list of anxiety domains 
that I intended to discuss with study participants. At the same time, while conducting the 
interviews I paid particular attention to any new or unexpected content areas reported by 
women and tried to ensure that my pre-conceived ideas and assumptions about antenatal 
anxiety, and pregnancy more generally, did not constitute a barrier to the exploration of 
unanticipated themes. I was also aware that, as a male interviewer exploring the experience 
of anxiety symptoms in pregnant women, some interviewees may have felt uncomfortable 
regarding this aspect. I thus made sure that I informed all potential participants at the initial 
contact via phone or email of this, so that they could make an informed decision about 
whether to participate in the study taking also this element into account.  Additionally, as 
the interviews involved the exploration of physical, cognitive, affective and behavioural 
symptoms occurring during pregnancy, I considered important to become familiar with the 
natural physiological and emotional changes which typically occur during pregnancy, in 
order to ask relevant questions and correctly interpret women’s accounts. Consequently, I 
familiarised myself with the topic of interest by consulting specific textbooks and pregnancy 
websites. Reflexivity was also considered during the phase of data analysis, as detailed 




5.2.5 Data analysis 
Inductive thematic analysis was used to examine and analyse the data, following the well-
established and widely used approach for the analysis of qualitative data in psychology 
proposed by Braun and Clarke (2006). In the initial phase of study design the options of 
thematic, content and framework analysis were all considered. These approaches to data 
analysis arguably share more similarities than differences, including their focus on the 
examination of recurrent themes (or segments of text) and their iterative nature throughout 
the analytic process (Guest et al., 2012). The six-step approach to thematic analysis proposed 
by Braun and Clarke (2006), discussed further below, provided a clear but flexible 
framework to guide the different phases of the analysis and was considered suitable for the 
specific aim of this study. It could be argued, however, that framework or content analysis 
would have produced relatively comparable findings.  
The process of data analysis partially overlapped with the data collection phase, which is not 
uncommon in qualitative research and is deemed to inform and enhance the research process 
(Silverman, 2001). In this study, ongoing analysis during the data collection phase served 
two main purposes. First, I reviewed the field notes that I took following the conclusion of 
each interview, as well as the corresponding transcript as soon as available (generally three 
to five days after each interview), and noted any content areas that were reported and that I 
had not initially considered to explore. This enabled me to incorporate in subsequent 
interviews questions around these specific content areas, so that they could be investigated 
further. Secondly, the cyclical process of data collection and analysis was important to 
establish if and when data saturation was reached. A brief overview of the six phases of data 










Table 7 – The six phases of thematic analysis, adapted from Braun and Clarke (2006)  
Phase Key tasks 
Familiarisation with the data Data transcription, reading transcripts several times, writing 
down initial ideas 
Generation of initial codes Assigning codes to all relevant segments of the data set, clustering 
of similar data around specific codes   
Identification of themes Merging codes into potential themes, collating all data relevant 
to each individual theme 
Revision of themes Reviewing themes for consistency and conceptual meaning. In 
this phase themes can be merged or subdivided into sub-themes 
Defining themes Labelling of themes and formulation of a brief definition; further 
refinement of themes and sub-themes  
Reporting the findings Selection of relevant, meaningful excerpts to represent most 
relevant themes; final discussion of key themes in relation to the 
research question 
 
Here, it is important to briefly discuss a number of key methodological decisions that were 
made while planning data analysis or in its initial phases. As researchers’ judgement in 
relation to specific methodological choices (e.g. inductive versus deductive approach; when 
does data saturation occur, etc.) necessarily affects the process of data analysis in qualitative 
research, these decisions should always be made explicit in order to guarantee the rigour of 
the analytical process and the credibility of study findings (Mason, 2009)  
Inductive vs deductive approach: The analysis was largely inductive, as conceptual 
categories (i.e. themes) were developed based on the data set rather than established a priori 
based on a theoretical model and subsequently applied to the text (Flick, 2002). While a 
predefined coding frame was not used, it is important to note that even more inductive, 
exploratory approaches to data analysis are not entirely a-theoretical (Patton, 2002), as 
researchers almost invariably approach the data with some previous knowledge or belief 
about the topic of interest (see also note on reflexivity).  
The coding process: Coding essentially refers to the assignment of category labels (i.e. 
descriptive units of meaning typically consisting of one or a few words) to all segments of 
texts within the raw data that contain information potentially relevant to the research 
question (Flick, 2002). In thematic analysis, coding supports the analytical process by 
systematically reducing the complexity of the entire data set through the creation of a number 
of conceptual categories (i.e. themes). In this study, consistent with Braun and Clarke’s 
approach to thematic analysis (2006), preliminary codes were initially assigned to all 
relevant segments of text in the data set. Once the entire data set was subjected to this process 
110 
 
of initial coding, and all selected extracts collated into a number of distinct codes, the 
resulting lists of codes were re-examined. At this stage, some extracts were reassigned to a 
different code, while several of the codes were merged and other collapsed into multiple 
codes. This process of refinement and further development of conceptual categories occurred 
throughout the data analysis phase, and resulted in a number of higher-level anxiety domains 
and more specific themes (i.e. respectively broader and narrower conceptual categories) as 
detailed in the Findings section.  
Data saturation: As noted earlier, the study obtained ethical approval to recruit up to 15 
women to be interviewed. The criterion used to determine if data saturation was reached 
before completing 15 interviews was to stop after three consecutive interviews in which no 
more than 10% of new codes (i.e. codes not previously emerged) were identified from the 
data analysis.  
Before presenting the findings from this qualitative study, it is also important to briefly 
describe how the data analysis phase was carried out in practice, based on the approach to 
thematic analysis recommended by Braun & Clarke (2006). As noted above, data analysis 
commenced soon after I started collecting data, when I read each transcript several times and 
started assigning preliminary codes to the data. Anonymised Word versions of the first three 
transcripts were also read by two of my supervisors (HC and MM), who also assigned 
preliminary codes to all relevant segments of text. A discussion took place between me and 
my supervisors following the independent coding of these first three interviews, and a good 
concordance was found in relation to the extracts identified as relevant for the analysis. 
However, we considered important to agree on what should constitute a relevant or 
meaningful segment of text (i.e. a unit of analysis) for the remaining part of the analytical 
process. Following a discussion based on the preliminary codes we identified, we agreed to 
focus the data analysis, which I conducted on the remaining nine interview transcripts, on 
any segment of text describing or appearing to refer to a psychological symptom. This 
macro-category was labelled “any signs or symptoms that something is wrong” as reported 
by study participants, and allowed a more focused approach to coding for the remaining nine 
transcripts. At the same time, there was also a recognition that a subset of these symptoms, 
which we named “contested symptoms”, might have been due to the normal physiological 
and physical changes occurring during pregnancy or to a temporary reaction to a particular 
triggering event (e.g. a scan with uncertain results).  
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During the initial phases of data analysis, I also discussed with my supervisors the best 
possible approach for determining the strength of evidence for each of the anxiety symptoms 
identified through the analysis (i.e. each theme) to be a good indicator of antenatal anxiety. 
One of the ‘counting’ techniques indicated by Braun and Clarke to determine the “keyness” 
of themes (2006, p.82) was used. This approach consisted in calculating the number of 
interviews that contained at least one instance of a given symptom. Consequently, the 
relative importance of each single theme was determined by the prevalence of the theme at 
the data item level (i.e. whether a theme appeared anywhere in each individual interview). 
Specifically, we agreed to rate the strength of evidence in representing a relevant symptom 
of antenatal anxiety according to the following criteria: 
 Strong evidence: At least one instance of a given symptom is reported by more than 
half the sample (>50%, n > 6)  
 Moderate evidence: At least one instance of a given symptom is reported by more 
than 25% and up to 50% of the sample (n = 4 - 6).  
 Limited evidence: At least one instance of a given symptom is reported by more than 
10% and up to 25% of the sample (n = 2 – 3).  
Only symptoms with moderate or strong evidence were considered as potentially important 
indicators of antenatal anxiety, and consequently used to generate a proportion of items for 
potential inclusion in the antenatal anxiety screening scale.  While it can be argued that these 
numerical criteria are somewhat arbitrary, particularly in view of the relatively small sample, 
it was considered that they provided a rational and pragmatic way of categorising a relatively 
large data set and reaching conclusions (i.e. identifying relevant anxiety symptoms) based 
on a systematic principle of evaluation. Moreover, the ‘counting’ approach used here was 
not based on counting all the instances of a given theme wherever they appeared in all the 
interview transcripts, as more instances of a specific theme in the entire data set do not 
necessarily indicate that such theme is more important (Patton, 2002; Braun & Clarke, 2006). 
This system of evaluation was instead based on determining the number of study participants 
within the entire sample who had experienced a specific symptom. This was considered to 
provide a reliable indication of the relevance and significance of a given symptom in women 






5.3.1 Socio-demographic and obstetric characteristics of study participants 
All study data were collected between October 2016 and February 2017. Twelve women 
were interviewed, with the majority of interviews taking place at participants’ homes (66%; 
n = 8). The remaining interviews were carried out at a local NHS facility (25%; n = 3) and 
via Skype (n = 1). All women who returned a reply slip had a score of 7 or above in relation 
to ‘self-identified antenatal anxiety’ and were thus eligible to take part in the study. This is 
arguably a consequence of the sampling technique that was used to recruit potential 
interviewees. A summary of the socio-demographic and obstetric characteristics of study 
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The average age of participants at the time of the interview was 35. However, the average 
age at the time of the pregnancy discussed in the interview was 33.5 (age range 26-43). Four 
interviews were conducted with women who were experiencing antenatal anxiety at the time 
of the study, while the remaining eight interviewees had a past experience of anxiety in 
pregnancy. In case of multiple pregnancies, at the beginning of each interview I asked study 
participants to focus on the pregnancy in which they experienced the most problematic 
anxiety symptoms. The column ‘Pregnancy discussed’ indicates which pregnancy was 
discussed in the interview, and the total number of pregnancies for each woman. Notably, 
half of the sample (n = 6) had a history of obstetric complications or miscarriage in previous 
pregnancies. Two participants had a ‘self-identified antenatal depression score’ of 7 or 
above, indicating elevated levels of both anxiety and depressive symptoms during 
pregnancy. The average duration of an interview was 38 minutes (27m – 56m).  
 
 
5.3.2 Data saturation and the analytical process 
Data saturation was reached after twelve interviews according to the criterion specified 
earlier. Interviews were divided into groups of three and the percentage of new codes (i.e. 
codes not assigned in previous interviews) was calculated at the end of every three 
interviews. As shown in table 9, only approximately 6% of new codes were identified in the 
last three interviews.  
 
Table 9 – Proportion of themes identified every three interviews on the total number 

















Percentage of codes assigned to 
relevant segments of text 1 
 








Percentage of new codes assigned 
to relevant segments of text 
 








1 Percentages in this row were calculated once the twelve interviews were completed. 
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The analysis was carried out as previously detailed in the Data analysis section. The process 
of comparison and refinement of codes (i.e. themes) continued until the final stages of the 
analytical process, when thirty themes were ultimately identified. In the conclusive stages of 
the analytic process, the analysis moved towards broader conceptual categories, and all the 
identified themes (i.e. specific anxiety symptoms) were organised into five higher-order 
anxiety domains, broad conceptual categories which were used to capture the essence of 
different themes considered to share similar features (Silverman, 2001). The identified 
anxiety domains were: 1) Worry and anxious apprehension 2) Fear 3) Pregnancy-related 
anxiety 4) General distress and 5) Anxiety-driven behaviours. Table 10 illustrates all the 
identified themes and corresponding anxiety domains identified through the study.  
 











No of participants 
reporting the theme 
Strength of evidence: 
Strong n > 6 participants; 
Moderate = 4-6 









 Excessive worry  
 Catastrophic thinking 
 Generalised worry 
 Feeling tense or on edge 
 Repetitive thoughts and rumination 
 Racing thoughts 















 Feeling frightened or fearful 
 Physical symptoms of hyperarousal 
and somatic activation 
 Severe or uncontrollable anxiety 
 Feeling of impending doom 













 Worried about the baby’s health or 
safety 
 Fear of childbirth 
 Worries about future parenting 
 Worries about possibility of 
miscarriage 














General distress  
 
 Feeling upset or distressed 
 Feeling overwhelmed 
 Feeling uneasy 
 Feeling unable to cope 
 Feeling irritable  
 Feeling guilty 
 Being self-critical 
 Loss of control 

















 Avoiding specific places or 
situations 
 Reassurance seeking 
 Withdrawing from people 









The following section presents all the themes which were reported by more than half the 
sample (n = 7 or above), thus indicating strong evidence of their relevance as symptoms of 
antenatal anxiety. The number of women who reported a specific symptom is indicated in 
parentheses next to each theme. For reasons of brevity, extracts of themes with moderate or 
limited strength of evidence are not reported here. Both themes with moderate and strong 
evidence were subsequently used in the generation of an initial item pool, as detailed in 
Chapter 6. The discussion below is structured by presenting separately the five higher-level 
anxiety domains developed in the conclusive phases of the analytical process. Within each 
domain, the corresponding key themes are illustrated through selected exemplary quotes for 












5.3.3 Anxiety domains and key themes   
 
ANXIETY DOMAIN 1: WORRY AND ANXIOUS APPREHENSION 
This anxiety domain included themes such as excessive worry, catastrophic thinking, 
nervous tension, repetitive thoughts and generalised worry that something bad will happen. 
These symptoms were all reported by the majority of women interviewed and were often 
characterised by anxious apprehension regarding a variety of topics, as well as excessive or 
pervasive worry which was generally recognised as disproportionate. While it could be 
argued that a certain degree of worry during pregnancy can be expected and is presumably 
a relatively common occurrence, what often characterised the accounts of women with 
experience of antenatal anxiety was the excessive level or persistence of worrying and 
apprehension, at times with a considerable negative impact on their quality of life. This is 
illustrated in the quotes from the key themes related to the anxiety domain of ‘Worry and 
anxious apprehension’ presented below.  
 
Excessive worry (n = 11)  
One of the most common symptoms reported by study participants was excessive worry. 
Women recognised that the level of worry was often disproportionate and caused significant 
distress. The continuous worrying in certain instances significantly impacted on areas of 
functioning and well-being, as illustrated in these extracts:  
P5: “There wasn’t really room for any, you know, for very much happiness to sneak in 
there because I was just worried all the time” 
P7: “Things would build up and then all of a sudden I couldn’t, I would just break down 
and I couldn’t think, I couldn’t do anything and I would just, you know, I couldn’t problem 
solve so even the simplest things were just too much to cope with and that made me even 
more anxious and worried” 
The pervasive nature of worry is also evident in this account:  
P11: “And then eventually I would get a new worry so the old worry would kind of go to 
the back burner and the new worry would go for a while and then it would just kind of 
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move on, so…. yeah, it was like a progression of things that could be worse than the next 
one” 
 
Catastrophic thinking (n =10)   
In numerous instances, continuous and excessive worry resulted in catastrophic thinking 
(Cox, 1996; Gellatly & Beck, 2016). Of note, both excessive worry and catastrophic thinking 
are key features of Generalised Anxiety Disorder, which is the most prevalent anxiety 
disorder during pregnancy (Dennis et al., 2017). Women reported thinking about worst-case 
scenarios and potentially disastrous consequences that could potentially result from their 
own actions (or inaction), as in these cases: 
P9: “So just really insignificant problems that I wouldn't normally have focused on at all, I 
would really start to think about them, sort of, blow them all out of proportion and imagine 
that from one tiny little thing that it was going to get bigger and bigger and something bad 
was going to happen and it would be all my fault.….  the things that you knew were never 
going to happen but you just thought 'oh well, you know, I'll be the person that this bad 
thing will happen to” 
P11: “So if I changed the cat's litter and I didn't wash my hands thoroughly enough then 
I'm definitely going to get toxoplasmosis and my baby's going to be born deaf and blind” 
At times this catastrophic type of thinking resulted in women being “convinced” that 
something terrible would happen to them.  
P6 “I had back pain when I was pregnant and I was convinced it was a tumour, you know 
that way I'd totally convinced myself” 
 
Generalised worry (n = 10) 
This theme included feelings of generalised worry, distinct from the previous theme for the 
absence of specific worst-case scenarios. Here, worry was described as more pervasive and 
not restricted to any particular topic or situation.  
P1: “I just think I felt worried a lot of the time and I just constantly had this feeling that 
something was going to go wrong” 
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Notably, women generally recognised that an overwhelming sense of worry was different 
from what other pregnant women experienced:  
P7: “I would say with worry it's an overbearing sense of worry maybe, so I think my worry 
seemed that, it just seemed to take over and it was not necessarily…I would describe that 
as something that I think differed from me to my other, my friends that appeared to have 
normal pregnancies, or … have seemed to be able to kind of yes they're worried but they 
can get on with their life” 
While conducting the analysis, I considered merging the three themes presented above 
(Excessive worry; Catastrophic thinking; Generalised worry) into a single ‘Worry’ theme. 
However, as symptoms related to worry and anxious apprehension were among the most 
commonly reported, an indication of their potential significance as indicators of antenatal 
anxiety, it was deemed important to preserve distinct features of this component of anxiety 
by categorising different aspects of worrying into separate themes.  
 
Feeling tense or on edge (n=9) 
A considerable proportion of women reported feeling on edge, as shown in these instances:  
P2: “Yeah, you feel very much on that sort of edge, so the stress levels or whatever you 
feel, like, you're more on that level so you can be tipped much quicker, haven't got the 
same patience” 
P5 “Yeah, I mean, being on edge, being very snappy with people because I would... I was 
very edgy, you know, a loud noise or something I would panic and it would be out of all 
proportion reaction” 
These feelings of apprehensive anticipation were often accompanied by physical symptoms 
of nervous or muscular tension, as illustrated here:  
P9: I would say probably more tension in my hands and my jaw. Lots of teeth clenching as 
well as that, tension headaches, more towards the eyes rather than the back of the head” 
P12: “But I did have a very bad back, obviously that's the carrying the child has had an 




Repetitive thoughts and rumination (n = 7)  
The key aspects of this theme related to cognitive rumination and repetitive thoughts. A 
study participant discussing these symptoms described the experience as “paralysing”  
P2: ““I tend to get... very stuck in thoughts, so sort of things go over and over again… for 
me it's almost paralysing, so instead of doing I just do a lot of thinking and a lot of 
inaction, so it's sort of paralysing in that respect” 
 
The experience of constant rumination appeared to be exhausting for some women:  
P6: “Oh yeah, there wasn’t a day when there wasn’t... there wasn’t a time for just... like, 
my brain was just going constant” 
Other themes in the anxiety domain ‘Worry and anxious apprehension’ included racing 
thoughts (n = 6) and worries about dear ones’ safety (n = 3), as shown in Table 9. 
 
ANXIETY DOMAIN 2: FEAR  
Feelings of fear, often accompanied by physical symptoms of hyperarousal and somatic 
activation (e.g. racing heart, sweaty hands) are common in phobic anxiety disorders such as 
Agoraphobia, Panic Disorder and Specific Phobias (APA, 2013). It was thus not surprising 
to find that this type of symptoms were also frequently reported by women with an 
experience of antenatal anxiety. The distinction between the ‘Fear’ and the ‘Worry and 
anxious apprehension’ anxiety domains is corroborated by the difference, well-documented 
in the research literature on anxiety disorders, between verbal-subjective symptoms of 
anxious apprehension typically characterised by anticipation of possible negative events on 
one hand, and symptoms of fearful mood, often associated with somato-visceral activation 
in response to a perceived imminent threat, on the other hand (Barlow, 2002: Craske et al., 







Feeling frightened or fearful (n = 9) 
This theme referred predominantly to the affective, emotional component of symptoms of 
Panic Disorder or phobic anxiety, which typically manifested in a generalised feeling of fear 
or terror.   
P12: “Everyone was like 'oh that's brilliant, you must be so happy' and I was just, like, 
really frightened the whole time” 
A woman described a sense of terror when asked about the most distressing feelings she 
experienced during pregnancy:  
P9: “Definitely sort of terror. And then I felt as if there was no sort of way out what I was 
feeling and I just imagine that I would feel like this for the rest of my life and this was the 
way my life was going to be and I couldn’t see a time where I wasn’t feeling anxious” 
 
Physical symptoms of hyperarousal and somatic activation (n=9) 
I inspected closely physical symptoms reported by study participants. In view of the research 
literature on antenatal anxiety discussed in previous chapter, suggesting that somatic 
symptoms might be a confounding factor in the assessment of anxiety symptoms during 
pregnancy, it was considered crucial to determine if and which physical symptoms women 
tended to attribute to anxiety rather than to normal changes of pregnancy. This section does 
not discuss physical symptoms of nervous or muscular tension, which were previously 
reported in the ‘Feeling tense or on edge’ theme.  
First, women were generally able to distinguish bodily sensations that they ascribed to 
pregnancy from other physical symptoms which were attributed to anxiety, as in this extract:  
P11: “I was getting the physical symptoms so typically if I was having these thoughts I 
would feel really sick, and I didn't experience any morning sickness or anything so the 
nausea was anxiety based” 
There were however, instances in which study participants were unsure whether somatic 
symptoms were pregnancy-related or anxiety-related, as for example in the case of 
symptoms such as heaviness in the chest, sweaty hands, and stomach issues. These 
symptoms, each only reported by a small number of women, were included in a separate 
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category of ‘contested symptoms’ (as discussed in 5.3.2), and subsequently excluded from 
the analysis of potential indicators of antenatal anxiety.  
The most common physical symptom of somatic activation that study participants ascribed 
to anxiety was by far a racing heart or palpitations, as described here:  
P1: ““Yeah, just like the, you know, really fast heartbeat and sweaty hands and just that 
feeling of impending doom” 
  P3: “palpitations were definitely... I think were definitely due to that.  I mean, obviously 
you get stomach issues anyway, you get heartburn and all these sorts of things, but I didn't 
actually really have that too bad with the first two pregnancies, but with this one I did, 
so...” 
P7: “Yeah my heart is definitely, not necessarily my breathing but I do notice a racing   
heart” 
There were a number of cases in which palpitations or an excessively fast heartbeat were 
linked to panic attacks, as illustrated in the next theme.  
 
Severe or uncontrollable anxiety (n = 7)  
This theme related to accounts of extremely heightened anxiety, typically perceived as 
distressing and uncontrollable. It is distinct from the ‘Feeling frightened or fearful’ theme 
as extracts included in this theme essentially describe anxiety symptoms at their peak, as in 
the case of a panic attack or other acute anxiety symptoms. Five women reported 
experiencing panic attacks during pregnancy (none with a previous history of panic attacks), 
as illustrated here:  
P3: ““I was having panic attacks just… yeah, you know, that was just normal kinda thing” 
P6 : “I wouldn't sleep, would have nightmares... like, my husband would find me at three 
o'clock in the morning at the bottom of the bed having panic attacks” 
In other cases, women did not experience full-blown panic attacks, but found it particularly 
difficult to control feelings of anxiety, as shown here:   
P2: it was a bit like when I moved house I had a sort of total meltdown, was totally 
anxious, worried about whether I'd made the right decision, everything kind of escalated 
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really to a point where it was... my thoughts were just really dire, you know, to the point of, 
you know, 'I don't want this baby anymore, why am I pregnant, this was a stupid idea'” 
P11: “So my anxiety had been gradually increasing but it wasn’t until… about 32 
weeks...that point that it was just off the scale” 
As evident in these extracts, the fact that anxiety was perceived as extremely heightened or 
uncontrollable could result in significant distress. Other themes categorised within the ‘Fear’ 
domain included a feeling of impending doom (n = 5) and other physical symptoms (n = 3). 
 
ANXIETY DOMAIN 3: PREGNANCY-RELATED ANXIETY 
Pregnancy-related anxiety was extensively discussed in Chapter 2. The themes identified in 
this study relating to concerns and fears specific to a current pregnancy appeared to reflect 
largely those described in the research literature on pregnancy-related anxiety discussed 
earlier and the symptoms identified through the systematic review presented in the previous 
chapter. Fear of childbirth and worries related to the health or safety of the unborn baby were 
the two key themes of pregnancy-related anxiety experienced by the majority of women who 
participated in the study. Persistent or intense worries around the possibility of miscarriage 
were reported by half of women in the sample.  
Worried about the baby’s health or safety (n =10) 
This was the most common worry reported by women within the anxiety domain of 
pregnancy-related anxiety. Once more, it can be reasonable to expect that worries around the 
health or safety of the unborn baby are considerably common during pregnancy. However, 
as in previous instances regarding general anxiety symptoms, the problematic aspect 
appeared to be related to the intensity or frequency of the symptoms. A study participant 
who was asked which aspects of anxiety during pregnancy was the most distressful for her 
commented: 
P11: “Thoughts that the baby wasn’t going to be well were really distressing.  The typical 
anxiety symptoms that I had were seeking reassurance, so I was saying to my husband 'oh 
I've not felt kicking in a couple of hours' and obviously he would have to kinda talk me 
down and say 'drink some water, lie on your side' do all that typical stuff, but yeah I was 
really conscious, probably more so of watching myself for movements and really focused in 
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on looking for movements, and obviously sometimes the more you focus on something the 
more it doesn't happen.” 
Some women reported persistent feelings of worry and tension which were characterised by 
intense anxiety, as in this instance:   
P3: ““you know, I literally felt like I was spending my day just holding my breath, you 
know, and every day was like 'right, we've got through another day with this baby still 
alive and kicking' kinda thing, you know, that was the stage that I got to” 
For others, the feeling was perhaps less intense but still described as “really uncomfortable”:  
P12: ““It was something I couldn’t put my finger on, I just felt really uncomfortable but I 
did have worries about my daughter, I was sure that something was going to be wrong 
with her, that she was going to have a condition of some sort or wouldn't reach term” 
 
Fear of childbirth (N = 8) 
As previously discussed in other chapters, fear of childbirth experienced over the course of 
pregnancy is one of the most commonly reported symptoms of pregnancy-related anxiety. 
For the analytic purpose of this study, it was important to identify characteristics (e.g. 
intensity, frequency, specific focus) of fear of childbirth that could be used to distinguish it 
from the arguably much more common but less problematic worries that can be experienced 
regarding labour and delivery.  
Some women reported a specific fear that something bad would happen to the baby during 
childbirth, which understandably was a considerable source of distress:  
P7: “I think of all the things that could happen during the birth the baby could, you know, 
so... I just can't seem to not think of the bad things and I can't seem to picture, these bad 
thoughts I can seem to or images if you like, I can't seem to picture a happy one.” 
A woman with a previous experience of a particularly traumatic childbirth (which resulted 
in diagnosed Posttraumatic Stress Disorder), described how she felt “petrified” in the current 
pregnancy about the prospect of giving birth again.  
P5: “I am petrified about actually giving birth this time and I'm a lot less anxious about, 
you know, just the day to day pregnant woman” 
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Other themes included in the ‘Pregnancy-related anxiety’ domain were worries around 
future parenting (n = 6), worry about the possibility of miscarriage (n = 6) and fear for own 
health (n = 4)  
 
ANXIETY DOMAIN 4: GENERAL DISTRESS  
There is a vast research literature documenting the relatively common occurrence of 
comorbid anxiety and depressive symptomatology, both in the general population and during 
the antenatal period (Sanderson, Beck & Beck, 1990; Lamers et al., 2011). Most of the 
symptoms reported by women in this study were clearly related to anxiety symptomatology, 
as detailed in the previous sections. There were, however, several other symptoms reported 
by women such as feeling guilty, upset, overwhelmed, or a general sense of being unable to 
cope, which could not be categorically ascribed to symptoms of an anxiety disorder (or 
pregnancy-related anxiety). These symptoms of general distress were included as one of the 
domains potentially indicative of antenatal anxiety, based on the well-established tripartite 
model of anxiety and depression by Clark and Watson briefly discussed in Chapter 4 (1991). 
In their influential model the authors proposed that while depression and anxiety are 
characterised by distinct features (i.e. anhedonia and absence of positive affect in depression; 
anxious apprehension and physiological tension in anxiety disorders), they also share a non-
specific component of General distress, which can include symptoms such as feeling uneasy, 
irritable, guilty or overwhelmed. The rationale for including symptoms of general distress 
here (if they were reported by a sufficient number of women) is based on two considerations. 
In the first place, as noted above coexistent depression and anxiety is common in the 
antenatal period. It can thus be expected that some women experiencing problematic 
antenatal anxiety will also suffer from symptoms of general distress. Secondly, the tripartite 
view of anxiety and depression implies that an accurate assessment of either depressive or 
anxious symptomatology requires the consideration of both the unique and the common 
elements of the syndromes (Clark & Watson, 1991). The key themes related to the ‘General 






Feeling upset or distressed (n = 10) 
This theme was initially named ‘Feeling distressed’ in the phase of preliminary coding. 
However, at a closer inspection of the extracts included in this code it appeared clear that the 
term ‘upset’ was also a useful descriptor of the content of this theme. The following extract 
exemplify this theme: 
P7: “I was hysterically crying and I'm not actually someone who cries a lot… So I found 
that very distressing as well, crying a lot, that upset me even more which didn't help, which 
spiralled more.” 
In some instances, study participants felt distressed in relation to specific situations:  
P11: “Social situations, my cousin's baby shower was really difficult because there was 
loads of people there and because I was pregnant too people were making comparisons 
and I found that comparisons between us, like, 'oh my god you're so much bigger than her', 
that was really quite stressful.  People that have never before or never would before 
comment on your body and how you look.” 
Another woman described becoming very upset and feeling that her reactions were 
excessive:  
P11: “Yeah, I would get quite hysterical, excessive crying and I know that crying obviously 
when your hormones are changing and things like that happens, but it was excessive.” 
 
Feeling overwhelmed (n = 8) 
A sense of feeling generally overwhelmed was often reported by women with experience of 
antenatal anxiety. This extract illustrates how even a simple choice such as deciding which 
friend to call could lead a study participant to feel overwhelmed: 
P2: “it's like 'well what am I going to do and who do I ring?' I have got lots of friends but 
that in itself becomes an anxiety of 'who do I ring, who should I go and see, should I go 






A sense of mental exhaustion was also evident in these two accounts:  
P6: “But, like, you don't, everybody just expects you to be so happy and 'oh you're 
pregnant and it's wonderful' and I just hated every single second of it, just cause of the way 
it made me feel, I mean, I was fine with him, I wasn’t sick, I wasn’t... didn't feel generally 
unwell, it was more a kinda mental... like, an emotional tiredness, mental tiredness” 
P10: “Yeah, I had loads, loads of different feelings, you know, fear, anxiety, panic, being 
overwhelmed, like, tiredness cause I was so shattered because obviously your mind's going 
into overdrive.  There was just so much going on it was horrible.” 
 
Feeling uneasy (n = 8) 
A considerable proportion of study participants also reported a persistence sense of unease, 
as in this example:  
P9: “I mean, even at a time where I wasn’t worrying about something I would have this 
general sense of unease because I was waiting for the next thing” 
Remarkably similar words were used by another woman to describe how she generally felt:   
P1: “I also had just a general feeling of unease” 
 
Other themes included in the domain of ‘General distress’ included feeling unable to cope 
(n = 6), feeling irritable or snappy (n = 6), feeling guilty (n = 5), being self-critical (n = 5), 
loss of control (n = 4) and feeling indecisive (n = 4). 
 
ANXIETY DOMAIN 5: ANXIETY-DRIVEN BEHAVIOURS 
The final anxiety domain presented here comprised a range of behaviours that women used 
in the hope of reducing or keeping under control anxiety levels. However, only one theme 
was reported by more than half of the women in the sample, and consequently only extracts 
from this theme are presented here. Other anxiety-driven behaviours reported by women are 
listed in conclusion of this section.  
Avoiding specific places or situations (n = 7) 
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Behavioural avoidance is a common characteristic of many anxiety disorders (e.g. Panic 
Disorder, Social Phobia). Social situations appeared to be particularly anxiety-provoking for 
some of the study participants and at times entirely avoided, as illustrated in these two 
extracts:  
P8: “you know, I stopped... I also stopped, like, my social circle and for me, like, you 
know, I'm always the person who's involved with the parent council at schools, I'm the one 
who volunteers for things, d'you know, so it was all of that kinda went as well, so it was a 
real sense of kinda identity loss in that way” 
P6: “I kinda stopped going out to like shopping centres and into town, like, into busy 
places, I couldn’t... I just couldn’t cope with people round me” 
In other instances, women avoided specific places as they anticipated that they could trigger 
distressing levels of anxiety. This is exemplified by this account:  
P6: “I couldn’t even go to the shops and stuff, like, even to do a supermarket shop, I used 
to have to leave cause I would get so overwhelmed, everything was just... totally, like, 
going to the shops, that's something you know... you nip in and out all the time don't you, 
don't even think about it, I couldn’t even do a full shop” 
 
Other anxiety-driven behaviours included themes such as reassurance seeking (n = 5), 














The interviews described in this chapter explored the experience of problematic anxiety 
symptoms during pregnancy, as well as several factors useful to differentiate between normal 
experiences of anxiety and worries in pregnancy as opposed to elevated levels of anxiety 
which would indicate the need for specific support. A range of anxiety symptoms, as 
discussed in detail above, were identified as potentially important indicators of antenatal 
anxiety. A considerable overlap was found among the affective, cognitive, behavioural and 
somatic content areas of the construct of antenatal anxiety identified through the systematic 
review presented earlier and the qualitative interviews discussed here. Virtually all 
symptoms and anxiety domains identified in the systematic review could be categorised 
within one of the five higher-order anxiety domains which were used to describe the findings 
of the qualitative interviews. Evidence from these two studies was subsequently combined, 
using predefined criteria to evaluate the strength of evidence for each content area to be an 
important domain of the target construct. The following chapter presents a conceptual and 
an operational definition of the construct of antenatal anxiety, based on the findings from 
these two studies, as well as the process of generation of an initial item pool to reflect the 
proposed construct. As noted in Chapter 3, this phase of item generation occurred 
simultaneously with a number of decisions that were taken in relation to the format of 
























Chapter 6 – Construct definition, generation of an item pool and 
preliminary item reduction 
 
6.1 Introduction 
This chapter describes Phase 1 and the initial stages of Phase 2 of the research, as outlined 
in Chapter 3 and in Figure 3 below. Phase 1 was informed by the studies presented in the 
previous two chapters and consisted of developing a construct definition of antenatal anxiety 
(Section 6.2) and generating an initial pool of candidate items to reflect this target construct 
(Section 6.3). In the first half of this chapter, the outcomes of Phase 1 are presented. During 
the process of item generation, a number of decisions were also made in relation to the format 
of measurement of the scale. These important considerations, which directly informed item 
writing, are also discussed in section 6.3. In the second part of the chapter, the initial stages 
of Phase 2 are presented. These consisted of preliminary item refinement based on inputs 
from women with experience of perinatal mental health problems (MMHS Change Agents) 
and experts in the field (Section 6.3.3); and the stage of initial item reduction via a Delphi 
study with experts in the area of perinatal mental health (Section 6.4).  
 
Figure 3 – A reminder of the phases and stages of the research 
 
• Construct definition of antenatal anxiety 
• Generation of initial item pool
• Decisions on format of measurement
PHASE 1
Scale development 
• Consultations with key informants
• Item reduction and refinement




• Psychometric validation of the screening 
accuracy (criterion validity), internal 
consistency, construct validity and factor 






6.2 Conceptual and operational definitions of the construct of antenatal 
anxiety  
In this section, a conceptual, formal definition of the construct of antenatal anxiety is initially 
provided. A more detailed, operational definition, which was instrumental to the generation 
of an initial item pool, is subsequently also presented. This latter operational definition, in 
which the different content areas of the construct are delineated, should be considered as a 
specification of the conceptual definition rather than a distinct description of the construct. 
As pointed out earlier in this thesis, a thorough review of the literature related to the construct 
of interest and interviews with the target population are two commonly recommended 
sources of evidence that can be used to inform construct definition and item generation 
(Turner et al., 2007; DeVellis, 2012). In particular, theoretical and empirical evidence from 
these sources can provide the basis for articulating the conceptual boundaries of the 
construct, clarifying its key content domains, and ultimately contribute to enhance different 
forms of scale validity, such as face, content, and construct validity (Clark & Watson, 1995; 
Netemeyer et al., 2003; Kline, 2005; DeVellis, 2012). In this research, evidence from both 
the systematic review of the psychometric literature on antenatal anxiety and the qualitative 
interviews with women with experience of problematic anxiety symptoms during pregnancy 
was used to inform the conceptual and operational definitions of the construct of antenatal 
anxiety presented here.  
As noted in conclusion of the previous chapter, a considerable overlap was found between 
problematic anxiety symptoms identified through these two studies. In particular, a range of 
symptoms which could be categorised into five broad symptom domains emerged as relevant 
indicators of antenatal anxiety. This is further discussed in 6.3 in relation to the generation 
of the initial item pool. Here, based on evidence from the research literature on antenatal 
anxiety (as per Chapter 2, 4) and on interviews with the target population (as per Chapter 5), 








Conceptual definition of antenatal anxiety 
Antenatal anxiety can be defined as the experience of clinically significant symptoms2 of 
anxiety in pregnant women. The term clinically significant is used here to indicate that the 
symptoms are sufficiently problematic to:  
A) be perceived as distressing  
and/or 
B) have a negative impact on at least one area of individual functioning (e.g. daily 
routine, social relationships, occupational functioning).  
Relevant symptom domains of the construct of antenatal anxiety are: Worry and anxious 
apprehension, Fear, Pregnancy-related anxiety, General distress, and Anxiety-driven 
behaviours. Antenatal anxiety can manifest as the experience of symptoms in one or more 
of these domains. A further specification is that, in order to qualify as antenatal anxiety: 
C) symptoms must be experienced for a sufficiently prolonged period of time (i.e. not 
limited to a temporary reaction to a specific event or situation).  
 
This conceptual definition of the construct of antenatal anxiety has two key implications. 
Firstly, the criteria A, B, and C in this definition are instrumental in operating a distinction 
between pregnant women who may be experiencing occasional, non-problematic worries 
and anxieties from pregnant women experiencing distressing and persistent symptoms of 
anxiety. Secondly, evidence from the qualitative interviews presented in Chapter 5 indicated 
that the co-occurrence of symptoms in two or more of the symptom domains listed above is 
not uncommon in pregnant women experiencing problematic anxiety symptoms. There 
were, however, also frequent instances in which symptoms specific to a single domain (e.g. 
Pregnancy-related anxiety or Worry and anxious apprehension) were largely predominant 
and nonetheless caused significant distress. Consistent with this observation, in the definition 
proposed, even only one of these symptom domains is sufficient to be categorised as 
antenatal anxiety (on condition that either or both criteria A and B, as well as criterion C, 
are met).  
 
                                                          
2 As specified in the operational definition provided below 
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Operational definition of antenatal anxiety 
As previously discussed in the Method chapter, in scale development the phase of construct 
definition is followed by the operationalisation of the construct, which essentially 
corresponds to the translation of the construct definition into an initial list of items that 
comprehensively reflect all facets of the target construct (Kline, 2005). A more thorough, 
detailed definition of antenatal anxiety, which specified a range of possible symptoms of the 
construct, was thus required in order to inform the generation of a pool of candidate items 
for its assessment. An operational definition of the construct was therefore proposed. This 
includes the formal definition presented above, and additionally a list of all the key facets 
(i.e. symptoms) of the construct identified as potentially accurate indicators of antenatal 
anxiety in the two studies presented earlier in the thesis. Specifically, the following 
symptoms were identified through the systematic review and the qualitative interviews as 
having moderate or strong evidence of being relevant indicators of antenatal anxiety in at 
least one of the two studies:  
 Excessive or generalised worry 
 Nervous or motor tension, feeling on edge  
 Repetitive thoughts and rumination  
 Feelings of panic or intense fear 
 Uncontrollable or severe anxiety, potentially accompanied by symptoms of somatic 
activation (in particular a racing heart)  
 Specific symptoms of general distress (e.g. feeling overwhelmed, feeling unable to 
cope) 
 Specific symptoms of pregnancy-related anxiety (i.e. fear of childbirth, excessive 
worry about the baby’s health or the possibility of miscarriage, anxious apprehension 
about future parenting, fear for own health).  
 Behavioural avoidance of specific places or situations  
 
Perhaps not surprisingly, most of the symptoms listed in this operational definition as key 
indicators of antenatal anxiety, based on the evidence discussed in Chapter 4 and 5, 
correspond to symptoms of anxiety disorders as described in the general population. This is 
entirely consistent with the general evidence, well-documented in the research literature, that 
anxiety disorders as they present in the general population are also relatively prevalent 
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during pregnancy (Heron et al., 2004; Marchesi et al., 2016; Dennis et al., 2017). This 
operational definition, however, also introduces some key distinctive features of the 
construct of antenatal anxiety. First, it includes symptoms of pregnancy-related anxiety, thus 
implying that anxiety scales developed for the general population cannot be reliably used for 
a comprehensive assessment of antenatal anxiety, as they do not include symptoms that are 
specific to pregnancy. Another relevant characteristic of this operational definition is the 
absence of physical symptoms, with the exception of a racing heart. This is also in line with 
the findings presented earlier, which appeared to confirm the limitations of using somatic 
symptoms in the assessment of antenatal anxiety, as discussed in Chapter 2.   
Once an operational definition of the target construct is formulated, the subsequent stage in 
scale development consists in the development of an initial pool of candidate items that 
comprehensively reflect all facets of the construct (DeVellis, 2012). The following section 
discusses the process of generation of an initial item pool for the assessment of the construct 
of antenatal anxiety. This discussion is preceded by an overview of a number of important 
considerations in relation to the desired format and structure of the final scale, as well as to 














6.3 Formulation of an initial item pool 
6.3.1 Issues and considerations related to item writing and scale format  
Before proceeding to present and discuss the stage of generation of an initial pool of 
candidate items for the assessment of antenatal anxiety, it is important to discuss briefly a 
number of issues that scale developers need to consider at this stage, in particular in relation 
to item writing and the desired format and length of the scale. Decisions concerning these 
aspects of scale development are critical as they directly guide and inform the process of 
item generation and can also have a considerable impact on several forms of scale validity. 
A relatively large body of literature has examined each of these issues in great detail 
(Netemeyer et al., 2003; Streiner & Norman, 2008; Furr, 2011) and they have all been 
carefully considered as part of the work discussed in this thesis. Here, only a brief overview 
of these aspects of scale development is presented in order to provide a rationale for the 
decisions made in relation to the development of the scale documented in this thesis.   
Scaling response and response format: Issues related to these aspects of scale development 
include those related to the choice of the scaling response (e.g. Likert scale, visual analogue 
scale), as well as to other characteristics of the scale such as its focus of assessment (e.g. 
intensity, frequency, severity) and the type and number of response options for scale items. 
In relation to scaling response, for the reasons discussed earlier in the thesis, the Likert scale 
was chosen as the format for the antenatal anxiety scale developed in this research. Likert 
scales, also commonly known as rating scales, consists of the sum of responses on a number 
of Likert items. A Likert item (hereafter referred to as scale item, or simply item) is typically 
a declarative statement related to the target construct. This is followed by a number of 
response options or levels. Respondents are asked to assign a quantitative value to one of the 
response options to indicate the degree of endorsement or agreement with the statement 
(Netemeyer et al., 2003; DeVellis, 2012). An important aspect to consider in Likert scales is 
the focus of assessment. This refers essentially to the issue of what a respondent is asked 
about (Rose & Devine, 2014). Both the instructions given to respondents (e.g. ‘Please 
indicate how much…’) and the type of response categories (e.g. ‘Not at all’; …; ‘Very much’) 
dictate the focus of the assessment. In rating scales measuring specifically psychological 
symptoms, individuals can be asked about their experience of symptoms in a number of 
ways. Common response formats are those focused on frequency (e.g. never to always), 
extent or degree (e.g. not at all to very much) which can be used to measure either severity 
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or impact, and similarity or agreement (e.g. most like me to least like me).  Of importance is 
also the issue of the number of response options given to respondents. Likert-type scales 
typically vary between three and ten options (Furr, 2011). One might argue that a desirable 
quality of a psychological scale is its variability, and accordingly that generally a higher 
number of response options would be preferable to capture individual differences. However, 
the ability of respondents to discriminate in a meaningful way between more than six or 
seven categories is questionable (Abell et al., 2009) and many Likert scales used in clinical 
practice or research have between four and seven response levels. It has been suggested that 
an upper practical limit for the usefulness of a scale can be reasonably set at seven response 
categories, and there is evidence that five response options might represent the optimal trade-
off between scale precision and accuracy on one hand, and practicality and cognitive burden 
placed on respondents on the other hand (Streiner & Norman, 2008). For the scale developed 
as part of this research, a five-point Likert scale, with the focus of assessment on frequency 
of symptoms based on a temporal reference (i.e. ‘Never’ to ‘Always’) was chosen as the 
format of the scale. The decisions made in relation both to the focus of assessment and to 
the number of response levels aspects were guided by the PROMIS anxiety item bank, as 
documented in detail in the following section on sources of item writing.  
 
Sources of item writing:  
The sources that scale developers use for writing items are of considerable importance, and 
to maximise face, content and construct validity they can be generated from a range of 
sources, which should ideally include the relevant literature, intended respondents and expert 
opinion (Rattray & Jones, 2007; DeVellis, 2012). A number of scholars recommend 
considering existing scales or item banks as a valuable source for the generation of an initial 
item pool (Kline, 2005; Streiner & Norman, 2008). In the early phases of the PhD, I became 
aware of the PROMIS (Patient-Reported Outcomes Measurement Information System) 
anxiety item bank (Pilkonis et al., 2011). PROMIS is a research initiative by the US National 
Institutes of Health (NIH) designed to improve self-report scales in healthcare and health 
research using state-of the-art psychometric approaches (Riley, Pilkonis & Cella, 2011). A 
range of item banks have been developed for the measurement of both physical and mental 
health (e.g. fatigue, pain intensity, depression) and designed to be applicable to a range of 
populations. All item banks were constructed based on extensive development work 
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including reviews of existing scales, qualitative assessment by intended respondents and 
experts, cognitive interviewing and repeated psychometric evaluation of items (Riley et al., 
2011). These item banks, which are freely available for partial or full use (as long as scale 
items are not altered), have been described as arguably the most advanced attempt to date in 
the application of psychometric methods to health-related assessment (DeVellis, 2012; 
Smith & Jensen, 2019).  
The specific PROMIS Anxiety item bank consists of 29 Likert items enquiring about a range 
of symptoms of anxiety disorders (Pilkonis et al., 2011). Examples of scale items are ‘I Felt 
terrified’ or ‘I had difficulty calming down’. The possibility of using the PROMIS anxiety 
item bank as one of the sources for the initial item pool was discussed with my supervisors. 
The item bank was examined and, considering also the robust evidence-base which informed 
its development, it was determined that several PROMIS anxiety items could be used for all 
the non-specific symptoms of antenatal anxiety identified as relevant indicators of the 
construct, if they were adequately represented by one of the PROMIS anxiety items. 
PROMIS items eventually formed approximately one quarter of the initial pool of candidate 
items for the assessment of antenatal anxiety. For all the other symptoms which were not 
appropriately represented in the item bank, items were written de novo. Various authors have 
indicated that the wording of items should reflect, as far as possible, the terms used by 
individuals from the target population (Kline, 2005; Streiner & Norman, 2008). 
Consequently, these items were generated based on the findings of the psychometric 
systematic review and, when appropriate, on the wording used by interviewed women and 
phrased to be consistent with the included PROMIS items. Expert opinion from health 
professionals working in the area of perinatal mental health was also sought as an additional 
source of item generation (6.3.3, 6.4).  For the scale developed in this research, as noted 
earlier, the choice of the focus of assessment and number of response levels were also based 
on the PROMIS Anxiety item bank, primarily to maintain consistency with the PROMIS 
items included in the item pool. It was thus decided to use the PROMIS scaling response and 
number and type of response options, which are also based on rigorous development work, 
as the format for the antenatal anxiety scale. Specifically, a 5-point Likert-type scale 
measuring frequency of symptoms over the past week, with the response options being 
‘Never’, ‘Rarely’, ‘Sometimes’, ‘Often’ and ‘Always’, was chosen as the scale format for the 




Clarity and comprehensibility of scale items  
Clarity and comprehensibility are essential rather than desirable qualities of item wording. 
Some authors have argued that the clarity of items should be considered a basic psychometric 
property in scale development and validation (DeVellis, 2012). The issue of clarity and 
comprehensibility of scale items can be broken down into a few different considerations, 
including: Are items worded in a way that makes them easily comprehensible to intended 
respondents? Are they as unambiguous as possible (i.e. likely to be understood in the same 
way by all individuals)? Is the structure, syntax and grammar of items sufficiently simple so 
that minimal cognitive burden is placed on respondents?  
The PROMIS anxiety items included in the initial item pool were generated consistently 
with best practice in item generation. All the further items written de novo for inclusion in 
the item pool were also generated taking into account widely accepted principles of item 
writing (Streiner & Norman, 2008; Abell et al., 2009). For instance, it was considered that 
the scale needed to be relevant across a range of levels of literacy and education (McHugh, 
Rasmussen, & Otto, 2011). For this reason items were kept as short as possible, both in 
relation to overall item length and to the length of individual words. They were also 
formulated using simple syntax and grammar, jargon-free language, and with the aim of 
being directly relevant to the target population, as this issue of face validity is known to 
increase respondents’ motivation to answer accurately (Mokkink et al., 2010a). It is also 
considered best practice to avoid specific types of items such as double negatives and 
double-barrelled items (i.e. items containing more than one central idea), as they have been 
shown to compromise item clarity (Bowling, 2014). Similarly, it was important to avoid 
qualifiers, as well as vague or ambiguous terms. Once an initial item pool was generated, the 
wording of all newly devised items was reviewed by my supervisory team as well as by other 
key informants, as further discussed later in the chapter.  
 
Scale length and clinical utility 
As noted in Chapter 1, since the early stages of this research one of the objectives was to 
develop a screening scale for the assessment of antenatal anxiety that was potentially feasible 
to implement in routine antenatal care. With this objective in mind, the full NICE guideline 
on antenatal and postnatal mental health (2014) was consulted to examine which type of 
screening scales for perinatal mental health problems were considered appropriate for 
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potential implementation in maternity care settings. The Guideline Development group 
limited their review “to instruments likely to be used in UK clinical practice that is, ‘brief 
instruments’, defined as those which are less than 12 items” (NICE 2014, p.84). This was 
the primary reason for aiming to develop a scale which contained no more than 11 items, in 
order to make it relevant and potentially applicable to the context of UK clinical practice. 
Both in research and clinical settings, shorter scales are also generally preferable as they tend 
to have shorter administration time and place less cognitive demand on respondents, thus 
providing a reasonable compromise between measurement accuracy and projected burden 
of use (Abell et al., 2009; Rose & Devine, 2014).  
The next section discusses the process of generation of a pool of candidate items and 
provides a list of all the 52 items that were included in this initial item pool.  
 
6.3.2 Formulation of a pool of candidate items 
As DeVellis (2012) notes, ultimately the psychometric properties of a scale are directly 
determined by the items that constitute it. The fundamental importance of devising items 
that reflect the scale purpose and are clear and relevant to the target population cannot thus 
be underestimated. It has been noted several times in this thesis that scale items in the initial 
item pool should comprehensively reflect all facets of the construct of interest (Clark & 
Watson, 2003; Furr, 2011). Further procedures, which can include the use of expert opinion 
and preliminary psychometric analyses, can subsequently be used to reduce the number of 
items.  Consequently, although the final target was to produce a scale shorter than 12 items, 
the initial set of candidate items included considerably more items.   
The findings from the psychometric literature on antenatal anxiety and the qualitative 
interviews with women with experience of the target construct were combined in order to 
represent in the initial item pool the entire range of anxiety symptoms identified as 
potentially important indicators of antenatal anxiety. All symptoms with moderate or strong 
evidence for their importance as indicators of antenatal anxiety in at least one of the studies 
were considered. An evaluation of the strength of evidence for all identified symptoms was 
presented in conclusion of the two chapters (Appendix 7, section 5.3.2). This evidence was 
considered when determining the relative importance, and proportional representation, of 
different symptoms and symptom domains of the construct in the initial item pool. While a 
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precise numerical rule was not applied, some basic principles to determine the proportional 
representation of different symptoms in the item pool were used, as follows:  
 Symptoms with strong evidence in both studies were represented in the item pool by 
multiple items 
 Symptoms with strong evidence in one of the two studies, or moderate evidence in 
both studies, were represented by one or more items 
 Symptoms with moderate evidence only from one of the two studies were discussed 
with the supervisory team and a decision was made on whether to include one item 
to represent it.  
 
A total of 52 items were included in the item pool. This initial pool of candidate items 
included 15 items from the PROMIS anxiety item bank, which were considered to accurately 
reflect specific facets of the construct of antenatal anxiety and be applicable to a pregnant 
population, and a further 37 items which were generated in order to comprehensively 
represent all facets and symptom domains of the target construct. These new items were 
written according to the principles of item writing discussed above and worded to be 
consistent with PROMIS items. The list of items is presented (Table 11) according to the 
five core symptom domains discussed in the definition of the construct of antenatal anxiety 
discussed earlier. All PROMIS items, mainly included in the ‘Worry and anxious 












Table 11 – Initial pool of candidate items for the assessment of antenatal anxiety 
Worry and anxious  
apprehension 
 
Fear  General 
 distress 
I felt tense 
 
I felt on edge 
 
I had difficulty 
 calming down (P) 
 
I felt something awful would 
happen (P) 
 
I felt fearful (P) 
 
I felt scared 
 
I felt frightened (P) 
 
I felt panicky for no good 
reason (P) 
I felt distressed 
 
I felt upset (P) 
 
I felt overwhelmed 
 
I felt uneasy (P)                                                                         
 I felt worried (P)                                                                                                                                  I had sudden feelings of
panic (P) 
 
I was much more
irritable than usual                                        
My worries overwhelmed me (P)                                                      
 
I had sudden feelings of 
panic (P) 
I felt unable to cope                                                                   
I worried more than usual                                                                  I felt really anxious I felt like I needed help 
for my anxiety 
Many situations made me worry 
(P)                                                  
 
I had a racing or pounding 
heart  
I felt like I was losing 
control 
I found it hard to stop worrying                                                         I had a feeling of 
impending doom 
I felt guilty 
I expected the worst to happen 
 
 I was harsh with myself 
I had repeated thoughts 
 
 I felt I had lost my 
confidence 
I had racing thoughts      
 
 I felt indecisive 
I found it hard to focus on 
anything other than my anxiety 
(P)                                                                                                               
 
  
Pregnancy- related anxiety  Anxiety-driven           
 behaviours 
I felt scared about giving birth 
 
I worried about the birth 
 
I was afraid of the pains of contractions or 
delivery 
 
I worried about losing my baby          
 
I worried about my health 
 I avoided certain places or 
situations 
 
My anxiety stopped me from doing 
things 
 
I avoided people 
 
 
I felt the need to keep checking if my 














Consistently with the recommendations that a pool of candidate items should be over-
inclusive, the item pool was characterised by a certain degree of item redundancy, 
particularly for symptoms found to be central in the target construct, such as problematic 
worry. It also included items only marginally related to the construct of interest. As 
previously mentioned, in later stages of scale development the contribution and inputs of 
key informants such as experts in the field or intended respondents (which may be asked to 
consider factors such as items’ content, wording, clarity and acceptability), as well as pilot 
psychometric testing, can all be used to reduce the number of items in order to produce a 
final, shorter scale with robust psychometric properties. The initial stage of item revision 
and refinement is presented in the next section.  
 
6.3.3  Preliminary revision of the item pool based on key informants  
Before the process of initial item reduction based on expert opinion, which is detailed in the 
following section (6.4), the initial pool of candidate items for the assessment of antenatal 
anxiety was subject to a preliminary revision based on inputs from the target population and 
experts. For this purpose, three MMHS Change Agents were invited to review all the items 
included in the initial item pool and provide feedback on their wording, clarity and 
acceptability. Specifically, they were asked, with two separate questions, to rate how clear 
and acceptable each item was on a scale from 1 to 10 (e.g. 1= not clear at all to 10 = perfectly 
I had negative thoughts about childbirth       
                            
I sought reassurance from friends, 
family or health professionals 
I worried something will go wrong with the 
birth  
                  
 
I worried about my baby’s health                                             
I felt scared that I couldn’t feel my baby 
moving                     
 
 
I worried that something may be wrong 
with my baby 
 
 
I was anxious about not being able to cope 
with the new baby 
 
I worried about my own appearance 
 





clear”). They were also asked to suggest an alternative wording for items that were not 
considered sufficiently clear. Feedback and suggestions for modifications were gathered via 
email. The vast majority of items received a rating of 9 or 10 in relation to their clarity and 
acceptability. The wording of four items was modified based on their feedback:  
 “I had racing thoughts” was changed to “My mind was racing” 
 “I had repeated thoughts” was changed to “Thoughts got stuck in my head” 
 “I felt really anxious” was changed to “I felt extremely anxious” 
 “I felt I had lost my confidence” was changed to “I did not feel like myself” 
In a subsequent phase, the same three Change Agents also contributed to the design of the 
final version of the scale, by providing feedback on consecutive versions of the scale.  
In order to maximise the chances that the item pool comprehensively reflected the range of 
anxiety symptoms that can be experienced during pregnancy, two clinicians with specific 
expertise in perinatal mental health (a Clinical Psychologist and a Nurse Consultant in 
Perinatal Mental Health) were also invited to review the item pool. They were specifically 
asked whether they considered any content areas to be missing from the initial list of items, 
and in case to suggest further items for inclusion in the initial item pool. Three further items 
were suggested:   
 “I have felt so anxious that I had thoughts about terminating the pregnancy”  
 “I worried whether having a baby is the right thing for me at this time in my life” 
 “I felt that my anxiety made me act impulsively” 
 









6.4 Using expert opinion to reduce the initial item pool: a Delphi study 
The first part of this chapter documented the process of definition of the construct of 
antenatal anxiety and the subsequent generation of a large item pool based on the evidence 
from the studies reported earlier (Chapters 4 and 5) in the thesis. The inputs and feedback of 
key informants, aimed to improve the clarity and acceptability of items, as well as to ensure 
that all key facets of the target construct were adequately represented, was also briefly 
discussed. In this second part of the chapter, the process of initial reduction of the number 
of items based on expert opinion is presented. As discussed in the Method chapter, this stage 
is often required in scale development to reduce the original item pool to a scale of 
reasonable length before preliminary psychometric testing can be carried out on a sample of 
individuals from the intended population of respondents (Abell et al., 2009; Furr, 2011). The 
key objective of this phase was thus to discard items considered to be less relevant for the 
assessment of the target construct, as well as problematic items. In scale development, the 
involvement of individuals with specific expertise in the area of the target construct to 
support this process of item reduction is recommended by a number of authors (Netemeyer 
et al., 2003; Streiner & Norman, 2008; DeVellis, 2012). In particular, it has been suggested 
that expert opinion can significantly enhance the face, content and construct validity of the 
final scale (Clark & Watson, 2003; Simms, 2008). In the development of a scale aimed to 
assess a psychological construct, health professionals with clinical knowledge of the target 
condition are clearly well-placed to evaluate the relevance and appropriateness of items in 
assessing the condition of interest (Streiner & Norman, 2008). Their views in scale 
development can thus be used to inform the selection of items that are judged to be 
sufficiently relevant to the measurement of the target construct, and discard those that are 
considered problematic (e.g. unclear or ambiguous), redundant or that simply are not deemed 
to tap into an important aspect of the target construct (Abell et al., 2009).  
In this research, expert opinion was sought to support this initial phase of item reduction. 
Specifically, a range of health professionals working in the area of perinatal mental health 
in Scotland participated in a Delphi study, and were asked to rate all items in the initial item 
pool in relation to their importance as indicators of antenatal anxiety. The Delphi technique 
is one of a range of consensus methods that can be used to consult experts and systematically 




6.4.1 Method  
The Delphi method is one of the most popular consensus methods used to gather the opinion 
of experts and establish an adequate level of consensus in relation to a specific topic under 
investigation (Hsu & Sandford, 2007). The Delphi technique has a number of possible 
variations, also known as modified Delphi studies. However, it generally involves a group 
of individuals with expertise in a subject area taking part (often remotely) in two or more 
rounds of questionnaires in order to provide their expert opinion in relation to one or more 
topics of interest (Iqbal & Pipon-Young, 2009). Questionnaires typically take the form of 
Likert-type scales listing a number of study items. Depending on the focus and objectives of 
the Delphi, study items presented to experts can be as varied as research priorities, issues to 
be addressed in a specific area of healthcare or a pool of candidate items in scale 
development (Waggoner et al., 2016). Subject experts (also known as Delphi panellists or 
simply panellists) are asked to give their views on the topic of interest, in an anonymous 
form, by rating each of the study items according to a given criterion, often related to the 
items’ importance, relevance, or some other parameter of significance.  After the first round, 
experts are provided at each subsequent round with individualised feedback comprising a 
statistical summary of the ratings of all panel members in an anonymous form, as well as a 
reminder of their own ratings (Hsu & Sandford, 2007). At this stage, panellists are given the 
opportunity to reconsider and change their initial responses. The iterative component of the 
Delphi (i.e. more than one round) thus provides a means for consensus building through 
anonymous feedback on the collective opinion of the group (Gill et al., 2013). Consensus is 
generally achieved when a predefined level of agreement is reached by a sufficient number 
of experts (Hsu & Sandford, 2007). For the specific aim of item reduction, which was the 
primary objective of this phase, the Delphi method appeared to be particularly suitable 
among other consensus methods. Its features of anonymity (face-to-face contact is not 
required, thus minimising the influence of dominant individuals in group dynamics), 
iteration through statistical feedback aimed to build consensus of opinion, and the possibility 
of conducting a Delphi study via an online platform (e-Delphi), all contributed to the choice 
of this technique for the purpose of initial item reduction based on expert opinion.  
As noted above, there are a number of variations to the Delphi method. The classical Delphi 
process generally makes use of an open-ended questionnaire in the initial round to facilitate 
the generation of ideas. In this case, three rounds of Delphi are typically considered optimal, 
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with the second and third round conducted using structured questionnaires generated based 
on the information gathered in the initial round (Gill et al, 2013). However, it is a common 
modification of the Delphi technique to start directly with a structured questionnaire, when 
this is based on previous research such as an extensive review of the literature, and plan to 
conduct two or three rounds in total (Alexander, 2004; Iqbal & Pipon-Young, 2009). A third 
round may be considered if the level of consensus is not deemed sufficient following 
conclusion of the second round (Gill et al., 2013). In this research, both the systematic review 
and the qualitative interviews that informed the generation of the initial item pool were 
considered to provide a robust theoretical base for the structured questionnaire in round one. 
It was thus decided to conduct a multi-round e-Delphi and start with the item pool generated 
through the two studies presented earlier as the initial set of study items in round one. An 
advantage of conducting, when appropriate, a two-round Delphi also relates to the potential 
issue of attrition of Delphi panellists. It has, in fact, been noted that panellists’ response rates 
can quickly be compromised when more than two rounds are conducted (Hsu & Sandford, 
2007).  
In conclusion of this section, the aim of this e-Delphi was to reduce the number of items in 
the initial item pool by selecting only those who achieved a sufficient level of consensus 
among expert panellists regarding their importance as indicators of antenatal anxiety. Other 
specific methodological choices made in preparation for this study, such as those related to 
the type and optimal number of experts to be recruited, the procedure for data collection and 
the criteria chosen to determine an acceptable level of consensus are discussed in the 
following sections.  
 
6.4.2 Sampling and recruitment of Delphi panellists  
The selection of an expert panel for a Delphi study is a task that needs to be considered with 
attention, as the credibility of the findings obtained is directly dependent on the relevance of 
the knowledge and experience of individuals participating in the Delphi process. In health 
research, it has been indicated that an expert can be ”any person with experience and 
knowledge of a particular topic” (Cantrill, Sibbald, & Buetow, 1996, p.69). While the inputs 
of women with experience of antenatal anxiety were considered in a previous stage of scale 
development (Chapter 5), this phase of item reduction focused on the contribution of 
individuals with clinical expertise in the area of perinatal mental health.  
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A convenience sampling technique was thus adopted to recruit health professionals with 
specific expertise in the area of perinatal mental health to take part in this e-Delphi. The 
collaboration established with members of Maternal Mental Health Scotland in the early 
stages of the PhD proved to be, once again, particularly beneficial to the research. Experts 
taking part in the e-Delphi were, in fact, recruited through the mailing list of MMHS. The 
mailing list contained email addresses of 38 individuals, including a range of professions 
working in relevant roles in the area of perinatal mental health in Scotland (e.g. psychiatrists; 
clinical psychologists, mental health nurses; health improvement officers). I was introduced 
to the Secretary of MMHS by the MMHS Change Agents’ coordinator. The Secretary agreed 
to forward an invitation email for the e-Delphi to all health professionals included in the list. 
While they were all approached as potential recruits through this introductory email, it was 
also considered important to limit participation to individuals with significant expertise in 
the area of interest. It was thus decided to consider eligible only individuals with at least two 
years of experience in a professional role in the area of perinatal mental health. Subsequently, 
the following inclusion criteria were used to recruit expert panellists for this e-Delphi:  
 Individuals subscribed to the mailing list of Maternal Mental Health Scotland in a 
professional capacity   
 At least two years of experience in a clinical or other relevant role in the area of 
perinatal mental health  
With regard to the optimal number of experts taking part in a Delphi, Linstone and colleagues 
(2002) suggest that between 10 and 50 experts can be generally considered sufficient. It has 
also been noted that when there is a relative homogeneity with regard to the range of 
expertise among panellists and the topic under investigation, a total of 10 to 15 experts can 
be considered adequate (Hsu & Sandford, 2007). In this study, it was considered that the 
mailing list of MMHS with its approximately 40 health professionals was an appropriate 
sampling frame, even when taking into account that a proportion of them may have not been 
eligible and that others would not complete the entire Delphi process.  
Recruitment took place over the course of three weeks. In an introductory email forwarded 
by the Secretary of MMHS to all professionals in the mailing list, potential participants were 
given information about the general aim of the research and specifically about the eDelphi. 
Attached to this introductory email were a leaflet briefly introducing the e-Delphi (Appendix 
11) and a summary of the study. The invitation email made clear that recruitment was limited 
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to professionals with at least two years of experience working in the area of perinatal mental 
health. All potential recruits were invited to contact me for any questions or clarifications.  
 
6.4.3 Data collection and analysis 
Data collection  
The use of web-based platforms to conduct Delphi studies (e-Delphi) has become 
increasingly common in research studies (Boulkedid et al., 2011; Gill et al., 2013rs). 
DelphiManager, a web-based system developed by the COMET initiative 
(http://www.comet-initiative.org/delphimanager/) at the University of Liverpool and 
specifically devised to facilitate the set up and management of Delphi surveys, was used in 
this study. The study was launched by circulating an email to all potential recruits with a 
link to the registration page of DelphiManager. This page was set up to collect basic 
information on potential participants (job role, professional background, expertise in 
perinatal mental health in years) and to determine inclusion in the study. Those who 
indicated less than two years of clinical or other relevant experience in the area of perinatal 
mental health received an automatic message in which they were reminded of the inclusion 
criteria and thanked for their interest in the study. Completion and submission of the 
registration form was considered to indicate consent to take part in the e-Delphi. All experts 
who met the inclusion criteria and completed the registration form were automatically sent 
a secure, individualised link to take part in the first round of eDelphi and were informed that 
they had two weeks to complete this initial round.  
The individualised link allowed experts to access the homepage of the eDelphi (Appendix 
12). This included a brief summary of the study and description of the Delphi process, as 
well as specific instructions to complete the first round. As it can be seen in the second page 
of the appendix, information provided to panellists also included a list of points to consider 
when completing the eDelphi. The eDelphi was set up so that the entire list of items in the 
initial item pool was presented to experts in each round, asking them to score each item on 
a Likert scale. Specifically, Delphi panellists were asked to “rate each item according to 
how much you consider it to be an important indicator of problematic anxiety in pregnant 
women”. The Likert scale was set on a scale ranging from 1 to 9 divided into three response 
categories, with 1-3 indicating ‘limited importance’, 4-6 indicating that the item was 
‘important but not essential’, and 7-9 to indicate items considered ‘essential’.  
150 
 
The use of the DelphiManager platform greatly facilitated the data collection process. The 
system has an inbuilt functionality to calculate the distribution of scores for a particular 
round. The score distribution of the whole group, alongside a reminder of their own score, 
is thus automatically displayed to each panellists at every subsequent round. In the second 
round experts, having been shown the distribution of scores and a reminder of their own 
score for the previous round for each item, were asked to reflect on the group opinion and 
their own ratings, and rescore all the items using the same instructions of the initial round.. 
Although, as documented earlier in the chapter, the inputs of two experts in relation to any 
item missing from the initial item pool had already been sought prior to this e-Delphi, it was 
also considered important to ask Delphi panellists whether they considered any key 
symptoms of the target construct to be missing, and in case suggest one or more items that 
would adequately reflect it. Although the first round was based on a structured questionnaire 
(i.e. the initial item pool), panellists were thus also invited through a free text box (only for 
the first round) to suggest any additional item referring to a specific indicator of antenatal 
anxiety that they considered to be missing.  
Eventually only two rounds of eDelphi were required, according to the pre-defined criteria 
discussed in the following section. Following the calculation of scores for the second round, 
all participants were automatically emailed a link to a “Thank you” page on DelphiManager, 
and were given the option to indicate whether they wanted to be sent a summary of the 
research following its completion. Confidentiality was preserved at all times.  
 
Data analysis 
Descriptive statistics were used to examine information on the general composition of the 
expert panel, including the panellists’ job role, professional background and expertise in 
years. With regard to the ratings that experts assigned to all study items, the mean, median 
and mode scores for all items both for round 1 and round 2 were calculated. The selection of 
items for further psychometric testing, however, was based solely on the results of round 2. 
Further, relevant statistics that were also calculated in round 2 were the number and 
proportion of panellists who scored an item in the 7-9 range, the category indicating items 
considered ‘essential’. A free text box available to experts in the first round was also 
examined for any items suggested for inclusion in the item pool. 
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As discussed earlier, expert opinion in the specific case of the development of psychological 
scales can be used to obtain a quantifiable rating of the relevance of each item to the 
assessment of the condition of interest, and consequently inform the selection of items that 
are judged to be adequately relevant for its measurement, according to pre-defined criteria 
for determining consensus. This was the primary aim of this study. Several authors point out 
that in the literature on the Delphi method there is no consensus with regard to how to 
establish when consensus is achieved (Waggoner et al., 2016). While this may appear 
slightly ironic, it implies that researchers using this technique are required to decide from 
the outset of a study the rules for determining when consensus is reached and which statistics 
should be considered relevant (e.g. central tendency, dispersion, ranges) to determine it. An 
additional point to consider is that these choices will primarily depend on the focus and aim 
of the study, and in particular on whether the main objective is to establish consensus in a 
positivist sense (as opposed to a lack of consensus) or the extent and nature of consensus 
(Linstone & Turoff, 2002).  
The main statistics used in Delphi studies to present and analyse the collective judgment of 
a group of experts are those of central tendency (mode, mean, media) or variation (ranges 
and standard deviations) (Hasson, Keeney, & McKenna; 2000). The proportion of ratings 
falling within a given range has also been suggested as a workable alternative to determine 
whether a certain level of consensus is achieved (Hsu & Sandford, 2007; Gill et al., 2013). 
Consequently, results can be presented in different ways depending on the statistical 
summaries of interest and the approach chosen to establish adequate consensus.  
The criteria utilised in this study were determined in consultation with a colleague with 
specific expertise in the Delphi method, and primarily based on considerations related to the 
objectives of the study itself. First, the initial reduction of the item pool presented here aimed 
to obtain a shorter list of items for preliminary psychometric testing on a sample of intended 
respondents. However, it was considered important to retain a sufficient number of items for 
this phase of further preliminary testing (Kline, 2005; DeVellis, 2012). This implied that the 
level of consensus required for item selection to the next phase needed to be strict enough to 
ensure the credibility and scientific robustness of the process, while sufficiently broad to 
allow items with only adequate evidence of importance to be tested further on a sample from 
the target population.  
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Specifically, the following two criteria were used to determine whether an item was 
considered sufficiently important by the Delphi panellists as an indicator of antenatal 
anxiety:  
 An average rating of at least 6.50.   
 More than 50% of panellists rating the item in the ‘essential’, 7-9 category.    
 
It was considered that these criteria ensured that items selected for pilot testing were 
considered essential by a substantial proportion of experts (i.e. > 50%) while also 
guaranteeing that the panel as a whole judged the item to be sufficiently important (average 
score across all panellists ≥ 6.50). These criteria were applied to experts’ ratings following 
completion of round two, and once established that a sufficient number of items achieved 
the pre-defined level of consensus to be selected for the next phase of psychometric testing, 














6.5 Results: reaching consensus on a preliminary version of the scale 
The two rounds of this e-Delphi were completed over slightly less than five weeks. A total 
of 26 health professionals agreed to take part in the first round and were eligible to 
participate, from an initial sampling frame of 38 individuals. However, only 22 of the 26 
panellists who started the first round completed it by rating all items. The remaining 4 
panellists were sent two reminders during the course of two weeks, and although the majority 
(n = 3) had started rating the items none of them completed them all. The incomplete ratings 
of these 4 panellists were not included in the summary statistics of the first round, and it was 
decided in consultation with my supervisors not to invite them to the second round. As a 
result, only the 22 panellists who rated all the items were considered for the second round. 
Round two was launched two days after the conclusion of the first round, and the remaining 
experts were sent a further individualised for the completion of the second round. This final 
round, which also took place over the course of two weeks, was eventually completed by 16 
panellists. As discussed earlier, while all study data was analysed, only the ratings of these 
experts who completed both rounds were considered to determine whether consensus was 
achieved following two rounds of eDelphi.   
The experts who took part in this study included health practitioners from a range of 
disciplines (e.g. psychiatry, clinical psychology, midwifery, mental health nursing), all with 
clinical knowledge or other significant expertise in the area in perinatal mental health. This 
is further detailed in Table 12 in the following page, which presents some key characteristics 
of the 16 professionals with expertise in perinatal mental health who completed both rounds 
of eDelphi. The ‘Job title’ and ‘Professional background’ categories were entered in free text 
boxes, while ‘Years of experience in perinatal mental health’ had five possible options; 0-1; 
2-3; 4-6; 7-9 and 10 or more. The 0-1 option is not represented among the 16 panellists who 
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17 GP Medical Doctor 10 or more 
18 Charge Nurse Mental health 
nursing 
10 or more 
19 Specialist Midwife in 
Perinatal Mental 
Health 
Midwifery 7-9  
20 Consultant 
Psychiatrist 
Medical Doctor 10 or more 
















As discussed earlier, the instructions for panellists in the first round also asked them to 
suggest items to cover key areas of the construct of interest that they considered to be 
missing. In the course of the first round, four additional items were suggested by four 
panellists. These were: “I did not feel worthy of being a mother”; “I felt that my anxiety 
made me argue with loved ones”; “I felt so anxious that I had thoughts of ending my life” 
and “I needed someone to support me with my anxiety”. The fact that only four items were 
suggested for inclusion in the second round would appear to suggest that the initial, 55-item 
pool of candidate items was sufficiently comprehensive to represent at least the vast majority 
of key symptoms and indicators of the construct of antenatal anxiety in the views of experts 
taking part in the eDelphi. Consequently, while 55 items were presented to panellists in the 
first round, the four additional items suggested by experts during this round were included 
in the second and final round bringing the total to 59 items.  
For reasons of brevity, only the 30 items which achieved an adequate level of consensus 
according to the criteria discussed above are presented here (Table 13), with their mean 
scores in round two, and the proportion of panellists who scored each item in the 7-9 
category. Items suggested by experts during round one are highlighted as (NEW ITEM). 















Table 13 – Mean scores of top 30 items in round two (n = 16) and number of panellists 
rating the item in the 7-9 range  
 
                                   
                             Scale item 
 
Mean score in 
round 2 
(Range 1-9) 
No. and % of 
panellists 
rating the item  
as ‘Essential’  
(n = 16) 
“I felt so anxious that I had thoughts of 
ending my life” (NEW ITEM) 
8.37 15 (94%) 
“I found it hard to focus on anything other 
than my anxiety” 
8.00 13 (81%) 
“I have felt so anxious that I had thoughts 
about terminating pregnancy” 
8.00 15 (94%) 
“I could not control my anxiety” 7.94 16 (100%) 
“My worries overwhelmed me”  7.87 15 (94%) 
“I felt detached from pregnancy and the 
baby” 
7.81 15 (94%) 
“I felt that my anxiety made me act 
impulsively” 
7.56 15 (94%) 
“I felt extremely anxious”  7.50 16 (100%) 
“I had a feeling of impending doom” 7.50 16 (100%) 
“I had a racing or pounding heart”  7.37 11 (69%) 
“I felt something awful would happen” 7.25 15 (94%) 
“I felt unable to cope” 7.25 15 (94%) 
“I felt like I was losing control” 7.25 16 (100%) 
“I did not feel worthy of being a mother”  
(NEW ITEM) 
7.25 13 (81%) 
“I felt panicky for no good reason”  7.12 15 (94%) 
“I had sudden feelings of panic” 7.12 16 (100%) 
“I felt overwhelmed” 7.06 11 (69%) 
“My mind was racing” 7.06 13 (81%) 
“I avoided people” 7.06 14 (87%) 
“My anxiety stopped me from doing things” 7.00 11 (69%) 
“Thoughts got stuck in my head” 7.00 12 (75%) 
“I felt like I needed help for my anxiety” 6.87 13 (81%) 
“I worried that something may be wrong with 
my baby 
6.81 13 (81%) 
“I needed someone to support me with my 
anxiety” (NEW ITEM) 
6.81 10 (62%) 
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“I have felt scared about giving birth” 6.75 12 (75%) 
“I have had negative thoughts about 
childbirth” 
6.69 11 (69%) 
“I did not feel like myself” 6.62 10 (62%) 
“I worried about losing my baby” 6.56 11 (69%) 
“I worried more than usual” 6.50 9 (56%) 






















As a result of this phase of the research, the 30 items reaching an adequate level of expert 
consensus in relation to their importance as indicators of antenatal anxiety were selected to 
be included in a preliminary version of the scale. The 30 items selected through the eDelphi 
are extensively commented in the next chapter, which documents the process of pilot 
psychometric testing of this preliminary version of the scale on a population of intended 
respondents.  
Following the Delphi study presented in this chapter, in consultation with my supervisors it 
was also decided to name the scale Stirling Antenatal Anxiety Scale (SAAS). The word 
‘antenatal’ was preferred to ‘pregnancy’ to highlight that the scale aimed to assess symptoms 
of anxiety in the antenatal period, but was not limited to symptoms of pregnancy-related 
anxiety. In the following chapters, the scale is thus at times referred to as 30-item SAAS (i.e. 
the preliminary version of the scale tested in Chapter 7), and 10-item SAAS or simply SAAS 




Chapter 7   Pilot study: preliminary psychometric testing and 
further item reduction 
 
7.1 Introduction  
This chapter presents the first of two psychometric studies that were conducted in conclusion 
of the research. Here the final stage of Phase 2, consisting of further item reduction through 
psychometric testing is discussed, while the following chapter presents the preliminary 
psychometric validation of the final version of the SAAS.  A total of 236 pregnant women 
were recruited to take part in these two cross-sectional surveys. This chapter specifically 
documents the stage of pilot psychometric testing (Pilot study) which was carried out by 
administering the 30-item version of the SAAS resulting from the eDelphi to a sample of 62 
pregnant women, with the aim of reducing it to a shorter, psychometrically robust version of 
the scale. The final psychometric validation study presented in the subsequent chapter shared 
many similarities with the pilot study presented here in relation to setting, sampling, 
recruitment and part of the data collection procedures. When this was the case, this is 
indicated in the following sections.  
In scale development, before the phase of initial psychometric validation of the measure, it 
is important to ensure that sufficient pilot work is conducted so that only items with the most 
robust psychometric performance are included in the final version of the scale (Rattray & 
Jones, 2007; Streiner & Norman, 2008). Item analysis is central in this stage of psychometric 
testing. Preliminary psychometric testing through item analysis is specifically aimed to 
refine the scale by discarding items which do not significantly contribute to improve its 
psychometric properties, while retaining those that are psychometrically robust and appear 
to adequately capture the target construct (DeVellis, 2012). Considerations related to item 
content, clarity and acceptability to the target population should also inform this phase 
(Streiner & Norman, 2008). Item reduction in pilot testing is thus based on a dynamic and 
iterative process of examination and comparison of each item’s psychometric performance 
and content (Worthington & Whittaker, 2006). In this instance, the main challenge was to 
produce a scale which needed to be at the same time relatively short (≤ 11 items), 
psychometrically robust and able to preserve a range of key facets of the target construct of 
antenatal anxiety. The process of discarding items is mainly quantitative in nature, being 
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predominantly based on the analysis of statistical parameters of each individual item (e.g. 
item-total, inter-item correlations, response distributions), and the relevance of these and 
other statistical indicators is discussed in detail in the Data analysis section of this chapter. 
As noted above, in relation to the more qualitative aspects of item analysis, this pilot study 
also served the purpose of identifying any potential issues in relation to item clarity and 
acceptability to the target population. 
 
7.2 Study aim and objectives 
 
The aim of this pilot study was to reduce the 30-item pool of the SAAS through psychometric 
testing on the target population and produce a shorter, psychometrically robust version of 
the scale.  
There were also several secondary aims, which included:   
1) To assess the ease of completion, clarity of instructions and acceptability of this 
preliminary version of the SAAS in the target population 
2) To identify any items that, based on respondents’ feedback, were unclear or were not 
considered acceptable for use in routine antenatal care 












7.3 Method  
This study was conducted using a cross-sectional survey design. In cross-sectional surveys, 
all observations are made at one single point in time. It is a particularly popular method in 
the social and psychological sciences, as it can be used to gather data from relatively large 
samples in a time- and cost-efficient way (Bowling, 2014).  In relation to the data collection 
method, an online survey was initially considered. However, because of the nature of the 
sample and of the topic under investigation, a postal survey was preferred. Women were 
initially approached and given study booklets by midwives, and this enabled midwives to 
apply the study inclusion and exclusion criteria and determine study eligibility for all women 
approached as potential study participants. The initial contact between potential recruits and 
midwives also ensured that women were given sufficient information regarding the study 
(De Vaus, 2014). As noted above, for the specific purpose of this study, item analysis was 
central throughout the phase of item reduction. The following sections discuss sampling and 
sample size, the recruitment procedure and the stages of data collection and analysis of the 
pilot study. In cases in which the study methods are the same used for the validation study 
presented in the following chapter, this will be indicated.  
 
7.3.1 Sample and recruitment procedure 
All women taking part in both the pilot and validation studies were initially approached by 
midwives from hospital and community antenatal clinics in Glasgow, according to the 
method and procedure presented in the following sections. These include the study setting, 
sampling and sample size, recruitment procedure, ethical considerations, and data collection 
and analysis. Both the study setting and the recruitment procedure were the same for the 
pilot and the validation study.  
Setting 
Both studies were planned in consultation with the Chief Midwife and the Lead Midwife 
Community and Outpatient Services for NHS Greater Glasgow & Clyde (GG&C). In an 
initial meeting arranged by my first supervisor (HC), the aims and recruitment targets for 
the two studies were discussed and the Princess Royal Maternity was recommended as an 
appropriate site because of its capacity, with over 6500 births each year. Because of the 
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relatively challenging recruitment targets (pilot study n = 50; validation study n = 200, as 
further detailed below), and following further discussions with my supervisors and with 
maternity care managers in NHS GG&C, it was decided to include also the Queen Elizabeth 
University Hospital as a second recruitment site. Both sites had the additional benefit of 
providing a number of hospital and community antenatal clinics in different parts of the city. 
The inclusion of a second site thus allowed to reach a considerably larger number of women 
as potential recruits, as well as to increase the representation of participants from different 
areas of Glasgow, a city characterised by significant health and socio-economic differences.  
 
Sampling and sample size  
The sampling technique initially planned for both the pilot and the validation study was 
convenience sampling, with the intention to recruit an equal number of women representing 
the three trimesters of pregnancy. However, the vast majority of women who took part in 
the two studies were recruited in their second or third trimester of pregnancy, as further 
detailed below. While the reasons for this are likely to be varied, discussions with midwives 
suggested that introducing the study to women during the antenatal booking appointment, 
the only one typically occurring during the first trimester (i.e. before the end of the 12th 
gestational week), was particularly challenging because of the amount of other areas to cover 
in this initial appointment. Once it became clear that recruiting women in the first trimester 
was likely to be unfeasible, midwives were asked to consider as potential recruits all women 
attending the clinics and meeting the inclusion criteria, until a target quota was reached for 
each site.  
In relation to sample size for this pilot study, as noted above the recruitment target was set 
to 50 study participants. A combination of methodological and practical reasons informed 
this choice. The aim of this pilot study was to conduct item analysis, which is focused 
primarily on the psychometric performance of individual scale items. For this specific 
purpose, some authors have indicated 30-40 subjects as sufficient to allow the calculation of 
parameter estimates at the item level (Mooney & Duval, 1993). However, others have shown 
that it is only above 50 participants that the impact of sample size on item statistics become 
minimal (Johanson & Brooks, 2010). A practical criterion of sufficient information with 
minimum use of health professionals and study participants’ time was also adopted.  
Inclusion and exclusion criteria 
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The following criteria were used in both the pilot and the validation study to determine study 
eligibility:  
Inclusion criteria 
- Women who at the time of recruitment are pregnant between 6 and 38 gestational weeks  
- At least 18 years of age 
- Receiving routine prenatal care 
- Level of English sufficient to understand and complete questionnaires in lay language. This 
was gauged by midwives recruiting participants 
- Able to provide written informed consent to take part in the study  
 
Exclusion criteria 
- Major medical or obstetrical complication of pregnancy, as defined by the clinical 
judgement of the midwife providing antenatal care  
- Severe cognitive impairment  
- Current severe mental health disorder (any psychotic illness or bipolar disorder)   
 
Recruitment procedure  
Similarly to the qualitative interviews, ethical and management approval was sought and 
obtained from the South East Scotland Research Ethics Committee 02, and additionally from 
the Research & Development service of the NHS Greater Glasgow & Clyde (GG&C) Health 
Board (Appendices 1 and 2) for both the pilot and validation study. Thanks to the Chief 
Midwife for NHS GG&C, I was introduced to the approximately ten Senior Charge 
Midwives (SCMs) working in maternity care in the Glasgow area, each coordinating a team 
of 10-20 midwives. Both in preparation for the two studies and during the recruitment phase, 
I attended a number of their bi-monthly meetings, which provided the opportunity to plan 
collaboratively part of the recruitment procedure, as well as to monitor recruitment and 
address any issues which were identified. All midwives involved in recruitment were given 
study booklets and provided with information about the study by their SCM. Additionally, 
164 
 
information sheets with instructions on how to recruit study participants were also provided 
to all midwives, both for the pilot and the validation study (see Appendix 13 for an example). 
During recruitment for the pilot study, midwives were given a total of 300 study booklets 
over the course of seven weeks. Recruitment was interrupted once the required number of 
questionnaires were returned by post to the study office (NMAHP Research Unit, University 
of Stirling).  
In the initial recruitment phase, women attending antenatal clinics and meeting the inclusion 
criteria were verbally informed of the study by a midwife part of their direct healthcare team. 
If a woman showed interest in taking part in the research, her midwife provided her with a 
study pack. The study pack contained an invitation letter, the information sheet, a consent 
form, a study questionnaire, and a pre-paid/pre-addressed envelope.  Interested participants 
were instructed to post the questionnaire and consent form to the study office using the pre-
paid, addressed envelope provided. The study documents were all reviewed by three of the 
MMHS Change Agents before ethical approval was sought, and modifications to the 
information sheet were made based on their feedback 
 
Ethical considerations 
Considerations related to obtaining informed consent from study participants, minimising 
any burdens and risks and safeguarding the confidentiality of sensitive information were 
previously discussed in 3.4.1, 3.4.2 and 3.4.3. Here some further ethical considerations are 
discussed. As noted above, all women taking part in either the pilot or the validation study 
were approached during routine antenatal clinics by midwives who were part of their direct 
healthcare team. Midwives approaching all potential recruits gave women a brief 
explanation of what the study involved, including what they would be consenting to. The 
information sheet given to all women taking part in both studies (see Appendix 3 for an 
example) included information and contact details for accessing support in case they felt 
distressed as a result of completing the self-report scales. Advice in relation to health 
professionals that could be contacted in order to discuss further any potential issues and in 
case access relevant support, and an out of hours contact number were also provided. 
The procedures that were followed to safeguard the confidentiality of sensitive information 
gathered from study participants in the two studies are also presented here:  
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 Identifiable information contained on paper was returned by post in the form of 
consent forms and reply slips with participants’ names and contact details. After a 
unique code was assigned to each participant, this identifiable information was 
separated from other study data (i.e. the completed scales and demographic/obstetric 
information) and kept in a locked filing cabinet.  
 Information on the outcome of the diagnostic interview conducted in the validation 
study was electronically transferred from the researcher using only unique participant 
codes.  
 Once interviews were completed, reply slips with participants’ names and contact 
details were securely disposed of, consistently with Principle 5 of the Data Protection 
Act (1998). 
 
7.3.2 Data collection  
62 questionnaires and consent forms were returned between August and October 2017, thus 
slightly exceeding the recruitment target (n = 50). As 300 study booklets were given to 
SCMs, the response rate was 20.6%. While this was a relatively low response rate, it is not 
uncommon in studies using postal surveys (Aday & Cornelius, 2006; Sahlqvist et al., 2011). 
Moreover, this estimate may not be completely accurate as it was not possible to gather 
precise data on the number of study booklets that were handed out in total. This was mainly 
due to the fact that midwives carried study booklets with them in a number of different 
antenatal clinics, and it was thus unfeasible to keep track of the number of study booklets 
distributed by each midwife.  
The study booklet included an invitation letter, information sheet, consent form and a 
questionnaire (see invitation letter and questionnaire in Appendices 14 and 15). The main 
section of the questionnaire, as shown in Appendix 15, consisted of the 30-item version of 
the SAAS. In relation to other data gathered for this pilot study, it was decided not to ask 
participants for detailed socio-demographic information not strictly required for the aims of 
the study. However, three questions were asked to collect information on participants’ age, 
current gestational week and parity (i.e. whether this was the first pregnancy or not). At this 
final stage of scale development, it was also considered important to gather participants’ 
feedback in relation to specific aspects of the scale. Three further questions were thus asked 
to evaluate the scale’s overall ease of completion, clarity of instructions and acceptability 
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for use in maternity care. Specifically, women were asked to indicate: “How easy was the 
questionnaire to complete?”, “How clear were the instructions?” and “Would you find it 
acceptable to complete a questionnaire like this as part of routine antenatal care?” 
(Appendix 15).  Participants could answer these three questions on a scale from 1 to 10, with 
1 representing the worst rating. Finally, a free textbox was also included for any comments 
that women had regarding the scale itself or specific items within the scale. In particular, 
participants were asked to comment on items that they found to be unclear. 
 
7.3.3 Data analysis  
All data from the questionnaires were initially entered onto a Microsoft Excel Spreadsheet. 
A simple codebook was developed in order to list all variables, assign names to each 
variable, specify how each of the variables was measured (e.g. ordinal, interval), and indicate 
what each numeric code for a given variable represented (Brace, Kemp & Snelgar, 2013). 
The 30 items included in the scale were considered at the interval level of measurement 
(Streiner & Norman, 2008). Other variables included the three pieces of information on a 
respondent’s age, current week of pregnancy and reproductive history, as well as the ratings 
related the scale’s ease of completion, clarity of instructions and acceptability for use in 
antenatal care. Data were subsequently transferred onto SPSS software (version 23). In 
relation to missing data, it was decided not to include in the data analysis questionnaires in 
which more than one item response was missing. If only one item within the 30-item scale 
was not scored by a respondent, the median score for all other items for that respondent was 
used to replace the missing value (Bland, 2000). Initially, descriptive statistics were 
calculated to summarise the respondents’ characteristics. These included means, standard 
deviations and ranges. Means and frequency distributions for the responses to the three 
questions regarding the participants’ general feedback on the questionnaire were also 
calculated. All relevant data were subsequently summarised and tabulated, and are presented 
in the Results section.   
Despite the literature on scale development does not provide precise criteria to inform the 
selection of items to be included or discarded (DeVellis, 2012), the item reduction phase was 
based on guidelines and recommendations provided in a number of psychometric textbooks 
(Kline, 2000; Costello & Osbourne, 2005; Streiner & Norman, 2008; Abell et al., 2009; Furr, 
2011). A constructive approach (Abell et al., 2009) was used in this phase of item reduction 
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to discard items based on several criteria. The section below describes the statistical analyses 
that were conducted and the criteria used to inform the selection of items. 
 Mean score, standard deviation and range for each item 
These descriptive parameters were calculated and the mean score for each item is reported 
in a summary table. While the mean score of an item in a scale assessing frequency of 
symptoms can provide initial information regarding how common a symptom measured by 
a specific item is in a given sample, this parameter was secondary in determining which 
items to include or exclude from the final version of the SAAS. As indicated below, there 
were other indexes more relevant to this purpose.  
 Response distributions  
Frequency analyses were conducted to evaluate response distributions at the item level. 
Response distributions indicate the proportion of respondents who endorse each response 
category for each individual item, and are thus also known as endorsement frequencies. As 
noted earlier, participants scored each item of the 30-item SAAS on a 5-point Likert scale 
ranging from “1 = Never” to “5 = Always”. The analysis of endorsement frequencies for 
each item enables the identification of items showing floor or ceiling effect (DeVellis, 2012). 
These effects refer to cases in which the lower or higher response option is selected by a 
remarkably large proportion of participants, thus indicating a lack of discriminative power 
(Turner et al., 2007). The criterion used in this analysis was to discard items for which a 
single response option was endorsed by > 90% of respondents (Turner et al., 2007; Streiner 
& Norman 2008). Endorsement frequencies of participants scoring at the minimum or 
maximum for each item were thus examined. Furthermore, response distributions for 
specific items were also inspected in cases in which two or more items assessing a similar 
facet of the target construct had other comparable psychometric properties. In these 







 Corrected item-total correlations 
Item-total correlation refers to the degree of correlation of a given item with the total scale 
score (Coolican, 2009). A corrected item-total correlation is the correlation of an item with 
the total score omitting that item, as its inclusion would lead to an artificially inflated score 
(Hunsley & Mash, 2008). A high corrected item-total correlation is a particularly desirable 
attribute in an item, as it indicates that the item is measuring the same underlying construct 
assessed by the full scale (DeVellis, 2012). Conversely, it can be assumed that items with 
low corrected item-total correlations are not measuring adequately the target construct, and 
may well be measuring a different construct (Kline, 2000). Various authors seem to converge 
on the recommendation that items with a corrected item-total correlation < 0.30 should be 
discarded (Clark & Watson, 1995; Kline, 2000; Abell et al., 2009). This criterion was 
therefore adopted in this study.  
Items with a high or moderately high corrected item-total correlation (i.e. > 0.70) were 
primary candidates for inclusion in the shorter version of the SAAS. However, it was also 
important to consider that it would be methodologically incorrect to simply select the top 
items ranked according to their corrected item-total correlations. This procedure would not 
generate the scale that best measures the latent construct, as it would increase internal 
consistency at the expenses of breadth of the construct measured (Netemeyer et al., 2003; 
Furr, 2011). This is primarily because the few items with the strongest correlations with the 
total score are very likely to be highly redundant. Current thinking thus indicates that a 
psychometrically robust scale should be mainly composed of items with moderate to 
moderately high correlations with the total score (Streiner & Norman, 2008; DeVellis, 2012). 
Pearson product-moment correlation coefficients were used to calculate corrected item-total 
correlations (Pallant, 2013). For reasons of brevity, for the remaining part of this chapter 
corrected item-total correlations will be referred to simply as item-total correlations. 
 
 Inter-item correlations 
An inter-item correlation is the correlation between two items within a scale. An inter-item 
correlation matrix was generated in SPSS and inspected to examine this form of correlation 
and identify items with a particularly high inter-item correlation, likely to indicate item 
redundancy (De Vaus, 2014). It has been suggested that items with an inter-item correlation 
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above 0.80 are very likely to be redundant and asking in essence the same or a very similar 
question (Kline, 2000). However, other authors have indicated that also marginally lower 
inter-item correlations may indicate a repetition of content between two items (Streiner & 
Norman, 2008). The criterion used in this study was to inspect all inter-item correlations 
equal or above 0.75 for suspect redundancy. Inter-item correlations were used to aid the 
selection of a single item when two or more showed other similar psychometric properties 
or had a clear overlap in content. In relation to inter-item correlations for the final scale, the 
main guiding principle was to generate a scale in which items showed correlations between 
0.2 and 0.8 (Netemeyer et al., 2003). This criterion was chosen based on the recommendation 
that a range of inter-item correlations are required to generate a scale that preserves the 
breadth of the target construct assessed (Furr, 2011). Similarly to item-total correlations, 
Pearson product-moment correlation coefficients were used as indexes of inter-item 
correlations. 
 
 Internal consistency 
At this preliminary stage of psychometric testing, this was the only parameter examined at 
the scale level. Factor analysis was not feasible because of the relatively small sample size 
(Pallant, 2013), and it was only conducted on the final version of the SAAS for the 
psychometric validation study. Internal consistency is an important aspect related to the 
reliability of a scale, which was discussed in Chapter 3. The importance of producing a scale 
with high internal consistency relies on the observation that a high value of internal 
consistency can be assumed to be an indication that all scale items are measuring the same 
latent construct (Tavakol & Dennick, 2011; DeVellis, 2012). High internal consistency is 
thus a particularly desirable characteristic of a scale, and the aim of this pilot study was to 
produce a shorter, internally consistent version of the SAAS.   
Internal consistency is commonly determined by calculating Cronbach’s Alpha (Cronbach, 
1951), a widely used measure of scale reliability expressed as a number between 0 and 1, 
with 1 indicating perfect internal consistency. The value of α is dependent on the magnitude 
of the inter-relatedness between scale items, and on the overall number of scale items, with 
longer scales typically producing higher values of alpha (DeVellis, 2012). Although there is 
no agreement on the value of Cronbach’s alpha that can be considered to indicate adequate 
scale reliability, the most commonly cited in the research literature is that indicated by 
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Nunnally of 0.70 (Nunnally, 1978). While this value is generally considered to be acceptable 
for scales used in research studies which focus their observations at the group level (e.g. 
comparing group means), other scholars have suggested higher alpha values for scales to be 
used in clinical settings to make decisions about individuals. Abell and colleagues (2009), 
for example, in the case of clinical applications indicate that alpha should be above 0.80, and 
other authors have suggested values closer to 0.90 (Nunnally & Bernstein, 1994; Hunsley & 
Mash, 2008; DeVellis, 2012). One of the goals of this pilot study was consequently to 
produce a final, shorter version of the scale with Cronbach’s alpha approximating 0.90.  
 
 Sub-analyses on the six pregnancy-related anxiety items.  
 
Further analyses were also separately conducted considering only the six pregnancy-related 
anxiety items included in the scale (items 5, 10, 13, 16, 24, 26) as a separate scale. As 
discussed in previous chapters, pregnancy-related anxiety has been indicated by some 
authors to be a distinct syndrome from general antenatal anxiety (Blackmore et al., 2016). 
However, it remains unclear whether this is the case (Bar-Shai et al., 2014). A different 
approach is to consider pregnancy-related anxiety as one dimension of the general construct 
of antenatal anxiety, rather than a distinct construct, as implied in the construct definition of 
antenatal anxiety proposed in the previous chapter. This sub-analysis served two specific 
purposes. Firstly, at least an acceptable level of internal consistency with a Cronbach’s alpha 
value > 0.70 (Nunnally, 1978) was hypothesised, as it would indicate that these items were 
significantly interrelated and indeed measuring a unitary dimension related to specific 
anxiety and worries about pregnancy. Secondly, of interest were also the inter-item and item-
total correlations among these six items. If one or more item were found to have only low or 
moderate correlations with other items in this shortened scale, this would provide further 
indications that the item does not reflect the theoretical core of the construct measured by 
other pregnancy-related anxiety items. Consequently, item-total and inter-item correlations, 
and the contribution of each item to the internal consistency of this PrA scale were all 
calculated and examined.  
The following section reports the findings from this pilot study, which informed the selection 




7.4 Results and selection of scale items for validation study 
7.4.1 Sample characteristics  
Recruitment took place over the course of seven weeks, between August and October 2017. 
62 pregnant women in total participated in the pilot study by returning the questionnaire and 
the consent form. As 300 study booklets were distributed, the response rate was 20.6%. As 
discussed earlier, convenience sampling was adopted as it became clear that recruiting 
women in the first trimester of pregnancy was highly challenging. As a result, the sample 
showed a fairly similar representation of women in their second (42 %, n = 27) and third (58 
%, n = 35) trimester of pregnancy (range 15-42), as illustrated in Table 14. Equally, women 
at their first pregnancy and women who had previously experienced pregnancy were 
represented in relatively similar proportions, with respectively 40% of nullipara and 60% of 
women at their second or subsequent pregnancy. This is consistent with maternity statistics 
both at the UK and at the Scottish level (respectively 42% and 43% of all live births were 
first births in 2017 (Office for National Statistics [ONS], 2017; NHS Information Services 
Division [ISD], 2017). The mean age of women in the sample was 32.1 years (range 21-40), 
slightly higher than the average age (30.1) at which women in Scotland give birth (NHS 
Information Services Division [ISD], 2017). 
 





















15 - 42 
Of which:    Frequency 
   (n = 62) 
% 
15 – 21 weeks  11   18 
22 – 28 weeks 16  26 
29 - 35 weeks 16 26 
36 or more weeks 19 30 
 
Percentages are rounded to the nearest integer  
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Feedback on the 30-item SAAS 
Feedback from respondents in relation to the scale’s ease of completion, clarity of 
instructions and acceptability for use in antenatal care was also sought. The three specific 
questions are reported in conclusion of the Data collection section above. Participants could 
answer these three questions on a scale from 1 to 10, with 1 representing the worst rating 
(e.g. in relation to ease of completion, 1 = ‘not easy at all’ and 10 = ‘extremely easy’). The 
mean, mode and median score for the three questions is presented in Table 15. 
 
Table 15 – Mean, median, mode and standard deviation for questions on feedback on 





1(No) - 10(Yes) 
Clear 
instructions 
1(No) - 10(Yes) 
Acceptable 
  1(No) -10(Yes) 
                         N  62 62 62 
    
Mean 9.66 9.84 9.60 
Median 10 10 10 
Mode 10 10 10 
SD  .82 .51 1.15 
                                       
 
 
As can be seen in the table, all descriptive parameters indicated that this 30-item version of 
the SAAS was considered extremely easy to complete, with clear instructions and highly 
acceptable to study participants. This is also illustrated by the number of women scoring 9 
or 10 to each of the questions (not reported in Table 15), respectively 57 for both ease of 
completion and acceptability (92%) and 60 for clarity of instructions (97%).  
With regard to missing data, only one participant missed an item score (item 4). As per the 





7.4.2 Item analysis and internal consistency 
The item reduction process which was used to generate the final version of the SAAS 
occurred in two stages, according to the criteria discussed earlier. In the first stage, item 
statistics were examined in order to discard the ones that clearly did not contribute to 
improve the psychometric qualities of the scale. This process was based primarily on the 
statistical parameters discussed in the Data analysis section. A comparative examination of 
both item content and psychometric properties was, however, necessary when the content of 
two or more items was considered to have a high degree of semantic or conceptual overlap. 
When this was the case, only one item was retained assessing a specific anxiety facet, in 
order to avoid redundancy in the final scale and maximise content and construct validity 
(Streiner & Norman, 2008; Abell et al., 2009). The second stage consisted of further 
examination and comparison among all items that were considered to have sound 
psychometric properties in the first stage. As noted earlier, in this subsequent stage, while 
psychometric properties continued to play an important role, other aspects including item 
clarity, length and the individual contribution of each item to a short measure that retained 
construct relevance and a sufficiently broad scope were also considered in order to inform 
the selection of items for the final version of the SAAS. In cases in which decisions regarding 
the inclusion or exclusion of an item from the final version of the scale were based solely on 
statistical analyses, these will be reported and commented. Additionally, when the selection 
of an item derived also from considerations related to its qualitative aspects (e.g. clarity, 
acceptability), this will be narratively discussed and motivated.  
Initially, mean scores, standard deviations and ranges for each item were examined. The 
mean score for each item is presented below in Table 16, which also reports the item-total 
correlation for each item. Endorsement frequencies for all items were also calculated and 
inspected. These, for reasons of brevity, are not presented in a table but discussed narratively, 


























1.  I worried more than usual  2.56 .66 
2. My anxiety stopped me from doing things 1.56 .71 
3. I had sudden feelings of panic  1.79 .60 
4. I had a racing or pounding hearth  1.79 .58 
5. I felt detached from pregnancy and the baby 1.50 
 
.44 
6. My mind was racing 2.55 
 
.62 
7. I was much more irritable than usual 2.77 .44 
8. I felt panicky for no good reason 1.79 
 
.70 
9. I did not feel like myself 2.08 .70 
10. I have felt scared about giving birth  
 
2.66 .42 
11. I felt that my anxiety made me act impulsively 
 
1.39 .68 
12. I found it hard to focus on anything else than my anxiety 
  
1.40 .75 
13. I worried about losing my baby 
 
2.45 .64 
14. I felt unable to cope 
 
1.47 .75 
15. I felt something awful would happen 
 
1.81 .61 
16. I worried that something may be wrong with my baby 
 
2.35 .63 
17. I felt like I needed help with my anxiety 1.42 .86 
18. Thoughts got stuck in my head 
 
1.92 .79 
19. I avoided people 
 
1.71 .77 
20. I have felt so anxious that I had thoughts about 
terminating my pregnancy 
      1.00  / 
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21. I could not control my anxiety 
 
1.29 .84 
22. I felt so anxious that I had thoughts of ending my life 
 
1.02 / 
23. I felt extremely anxious 
 
1.35 .81 
24. I have had negative thoughts about childbirth 
 
2.00 .41 
25. My worries overwhelmed me 
 
1.66 .77 
26. I did not feel worthy of being a mother 
 
1.37 .73 
27. I felt like I was losing control 1.48 .72 
28. I had a feeling of impending doom 1.31 .80 
29. I felt overwhelmed 
 
2.16 .75 
30. I needed someone to support me with my anxiety 1.60 .74 
 
All item-total correlations are expressed as Pearson’s r. 
 
At an initial inspection of mean scores and endorsement frequencies for all items, it was 
evident that item 20 “I have felt so anxious that I had thoughts about terminating my 
pregnancy” and Item 22 “I felt so anxious that I had thoughts of ending my life” had to be 
excluded from further analyses, as they were both characterised by a strong floor effect. Item 
20 showed no variance, with all sixty-two participants endorsing option “1=never”, while 
item 22 had extremely low variance, with only one out of sixty-two participants scoring 
“2=rarely” and the remaining sixty-one scoring “1=never”. As previously noted, items 
with particularly strong floor or ceiling effect (≥ 90%) should be discarded, as they lack 
discriminative power among respondents. Of note, neither of these items were formulated 
based on the systematic review or the qualitative interviews with women who had 
experienced antenatal anxiety discussed in previous chapters. Conversely, they were 
suggested for inclusion in the item pool during the Delphi study by health professionals with 
expertise in perinatal mental health. A possible explanation is that some of the health 
professionals taking part in the eDelphi may be used to work often with women with severe 
symptoms for whom these questions may have relevance. However, to screen for 
problematic anxiety symptoms in the general population of pregnant women they clearly did 
not appear to have sufficient discriminatory power. When an item shows no or extremely 
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low variance among respondents, it is recommended not to include it in analyses of item-
total correlations or internal consistency reliability, as it will clearly impact negatively on 
both parameters (Streiner & Norman, 2008). Item 20 and 22 were accordingly excluded 
before conducting further analyses at the item and at the scale level.   
At the scale level, Cronbach’s alpha as index of internal consistency was thus calculated for 
the resulting 28-item scale (after removing items 20 and 22), and was found to be α = 0.96. 
This particularly high level of internal consistency for this preliminary version of the scale 
provided an initial confirmation that the vast majority of items in the scale were 
homogeneous and thus likely to be measuring the same latent construct (Furr, 2011). 
However, some further considerations are required when interpreting such a high 
Cronbach’s alpha value. While, as noted earlier, it has been indicated that scales designed 
for clinical applications should have values of Cronbach’s alpha close to 0.90 (Hunsley & 
Mash, 2008; DeVellis, 2012), it has also been suggested that values significantly exceeding 
α = 0.90 are likely to result from scales which are either excessively long or that are 
characterised by a high degree of item redundancy (Brace, Kemp & Snelgar, 2013). This is 
arguably the case for this version of the scale and, as discussed in previous chapters, a degree 
of redundancy in the initial item pool was planned and thus expected. Such a high value of 
Cronbach’s Alpha (0.96) for the 28-item version of the scale, however, provided an excellent 
basis to aim to a shorter, version of the scale that retained a value of internal consistency 
recommended for use in clinical settings (approximately α = 0.90).  
At the item level, continuing with the analysis of endorsement frequencies of the 28 
remaining items, five items were scored “3 = Sometimes”, “4 = Often” or “5 = Always” 
by at least 50% of respondents. Specifically, these were item 1 “I worried more than usual“ 
(54.8%), item 6 “My mind was racing“ (51.6%), item 7 “I was much more irritable than 
usual“ (61.8%), item 10 “I have felt scared about giving birth“(62.9%) and item 13 “I 
worried about losing my baby“ (50%). Correspondingly, these were also the five items with 
the highest mean scores. Considering their endorsement frequencies, it can be reasonably 
assumed that these items tap into relatively common experiences of pregnancy and cannot 
thus be considered a reflection of problematic anxiety symptoms or poor mental health more 
in general. These items were consequently strong candidates to be discarded, but they were 




With regard to item-total correlations, notably the item with the highest item-total correlation 
was item 17 “I felt like I needed help for my anxiety”, with a correlation of 0.86 with the 
total score. This indicated that, among all items, this was the one with the best performance 
in predicting the total score. This, in turn, provided good preliminary evidence that the 28 
items as a whole were indeed measuring a latent construct related to problematic anxiety 
symptoms, considering that the item enquires about the perceived need for support around 
anxiety symptoms. The average item-total correlation for all items was moderately high 
(0.67). The inter-item correlation matrix (composed of 729 correlation values) was also 
visually inspected. For the vast majority, inter-item correlations showed values comprised 
between 0.30 and 0.70, well within the range specified earlier (0.20-0.80) (Netemeyer et al., 
2003). A number of inter-item correlations between two or more items were specifically 
examined while comparing the psychometric performance of multiple items. When these 
correlation coefficients, as well as other relevant item statistics (i.e. item-total correlations, 
response distributions) were used to inform the decision to retain or discard an item, these 
are reported and discussed narratively in the following section.  
 
7.4.3 Item selection process  
The section below documents the iterative process of examination and revision of items 
which resulted in the exclusion of a number of items, based on the criteria and item selection 
strategy previously presented. As noted above, following the exclusion of item 20 and 22 in 
the initial phase of analysis, the process of discarding items and selecting those for the final 
version of the SAAS occurred in two stages. During the first stage, 17 items were discarded 
and 13, including three pregnancy-related anxiety items, were retained for further 
examination, as detailed below. In the second stage, the 10 items included in the final version 
of the SAAS were selected based on considerations related to their psychometric qualities 
and the contribution of each item to a short measure that retained construct relevance and a 
sufficiently broad scope. In the section below, the first stage of the item selection process is 
initially presented. The analysis is discussed separately for each item, with items presented 
in the same order in which they were presented to respondents completing the scale. The 
only exception is for the six pregnancy-related anxiety items. The analysis of these six items 
is presented separately at the end of this section, although conducted similarly to the other 
items. The full wording of a scale item is only reported when it was considered important in 
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order to comment on its content. For reasons of brevity, in other instances items will be 
referred to only using their number (e.g. item 1) indicating their position in the scale. When 
this is the case, please refer to Table 16 for the full item wording.  
 
Item 1 – “I worried more than usual”  
Item 1 did not exhibit a particularly high correlation with the total score, being only the 18th 
highest item-total correlation out of the 28 items (0.65). As previously noted, an inspection 
of endorsement frequencies showed that item 1 was also one of the five items with more 
than 50% of respondents (54.6%) endorsing “3 = sometimes” or more frequently as response 
option. Although this item was included in the initial item pool, based on the systematic 
review and qualitative interviews, as a potential indicator of Generalised Anxiety Disorder 
in which excessive worrying is a key feature (APA, 2013), its endorsement frequencies 
would appear to indicate that the item taps into a relatively common experience of 
pregnancy. Other items in the scale, such as item 18 “Thoughts got stuck in my head”, and 
item 25 “My worries overwhelmed me” seemed to assess a similar but more distressing 
cognitive process related to excessive or repetitive worrying. These two items also had 
higher item-total correlations (0.79 and 0.76 respectively) and more negatively skewed 
endorsement frequencies (i.e. “Never” and “Rarely” were chosen more frequently), 
expected and desirable qualities for items assessing psychological symptoms. For these 
reasons, the two alternative items were considered superior and item 1 was discarded in this 
first stage of analysis.  
 
Item 2 – “My anxiety stopped me from doing things”    
This item showed the 15th highest item-total correlation (0.71). Its distribution of 
endorsement frequencies indicated that 14.6% of women scored “3 = sometimes” or higher 
on this item. This item is clearly an indicator of a behavioural component of anxiety, related 
to avoidance of specific places or situations and more generally to a change of behaviours 
that may negatively impact on a person’s daily functioning, a common feature of several 
anxiety disorders, including Agoraphobia, Panic Disorder, Social Anxiety Disorder and 
Specific Phobia (APA, 2013). The only other items within the 28-item scale capturing a 
behavioural component of anxiety are item 11 “I felt that my anxiety made me act 
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impulsively” and item 19 “I avoided people”. However, the content of these items is rather 
specific and does not appear to significantly overlap with the content of item 2. Furthermore, 
these two items had inter-item correlations with item 2 within the desired range (i.e. r ≥ .20 
and <.80) and consequently did not show redundancy with item 2. Based on the above 
considerations, item 2 was retained at this stage.  
 
Item 3 – I had sudden feelings of panic 
Item 3 was found to have one of the lowest item-total correlations (0.60, 23rd higher). Simply 
based on this relatively low correlation with the total score, item 3 was considered a 
candidate for deletion. Furthermore, an alternative item (item 8 “I felt panicky for no good 
reason”) whose content appeared to measure a very similar facet of anxiety related to 
feelings of panic showed comparable endorsement frequencies but a significantly higher 
item-total correlation (0.71, 14th highest). Item 3 was thus discarded at this stage.  
 
 
Item 4 – I had a racing or pounding heart 
Item 4 was the only item within the 28-item SAAS referring to a physical symptom of 
anxiety. It showed one of the weakest item-total correlations (0.58, 24th highest) and only 
low or moderate inter-item correlations with the vast majority of other items within the scale 
(0.13-0.66) with inter-item correlations above 0.60 with only two other items in the scale, 
item 6 and item 28. Item 4 was consequently not considered for inclusion in a shorter version 
of the SAAS and discarded at the initial stage.  
 
Item 6 – My mind was racing      
This item also showed a relatively weak item-total correlation (0.62, 21st highest). It was 
also found to have the 4th highest mean score (2.55) and was one of the five items for which 
at least 50% of respondents scored “3=sometimes” or above (51.6%). Similarly to what was 
discussed for item 1 in relation to the poor evidence of discriminative ability because of its 
response distribution, item 6 was discarded at this stage.  
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Item 7 – I was much more irritable than usual 
Item 7 also exhibited one of the lowest item-total correlations (0.44, 25th highest) and the 
lowest among items assessing general symptoms of anxiety as opposed to pregnancy-related 
anxiety items. It was also one of the items for which respondents endorsed a response option 
of 3 or above most frequently (61.8%) and had the highest mean score among all items 
(2.77). These observations clearly highlight the lack of discriminative power of this item. 
Considering in particular the distribution of endorsement frequencies, it can be reasonably 
assumed that item 7 tap into a rather common experience of pregnancy and cannot thus be 
considered a reliable indicator of poor mental health, or in particular problematic levels of 
anxiety. This item was thus discarded.  
 
Item 8 – I felt panicky for no good reason     
This item had the 14th highest item-total correlation (0.70) and a mean score of 1.79. As 
previously mentioned, the content of this item seems to overlap considerably with item 3 “I 
had sudden feelings of panic”, which was discarded because of inadequate item parameters. 
Item 8 would appear to enquire about a very similar facet of anxiety when compared with 
item 3. However, item 8 had a higher item-total correlation and the way it is worded makes 
it clear that the feelings of panic are not related to an objective risks (WHO, 1992). For this 
reasons, and for its moderately high item-total correlation, item 8 was retained for potential 
inclusion in the SAAS.   
 
Item 9 – I did not feel like myself  
Item 9 also showed a moderately high item-total correlation (0.70, 16th highest). Inter-item 
correlations were all in the moderate or moderately high range (0.30 – 0.80). At an initial 
examination of its content, this item would appear to enquire about a symptom of general 
distress rather than specific anxiety symptomatology. It was, however, included in the initial 
item pool as it emerged to be a common symptom among women with experience of 
antenatal anxiety who were interviewed as part of the process of scale development, and was 
also subsequently indicated as relevant by experts taking part in the Delphi study. The 
content of other items in the scale was inspected to examine whether any other items were 
similar in content to item 9. Only item 27 “I felt like I was losing control” had arguably a 
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degree of conceptual similarity with item 9, with a slightly higher item-total correlation 
(0.72). However, because item 9 had sufficiently robust psychometric properties and 
appeared to assess a relatively unique facet of the target construct, at this stage it was decided 
to retain it for further consideration, before making a final decision on its inclusion in the 
SAAS.  
 
Item 11 – I felt that my anxiety made me act impulsively  
This item was found to have a moderate item-total correlation (0.67, 17th highest). It also 
had one of the lowest mean scores (1.39, 5th lowest) and an inspection of its endorsement 
frequencies revealed that the vast majority of participants (93.8%) to the pilot study endorsed 
option “1 = never” or “2 = rarely” for this item. Although these responses may be expected 
in a scale assessing psychological symptoms, the proportion of women scoring one of the 
two response options was extremely high. Only 4 out of 62 participants scored higher than 
“2 = rarely” for this item. Simply based on these distribution of responses, and considering 
its only moderate item-total correlation, item 11 did not show sufficient discriminative 
ability in this phase of preliminary psychometric testing and was thus discarded.  
 
Item 12 – I found it hard to focus on anything other than my anxiety  
This item showed a good item-total correlation (0.75, 8th highest) and an average score of 
1.40. Two items were found to correlate strongly (i.e. at least 0.75) with item 12. These were 
item 17 “I felt like I needed help for my anxiety” (0.75), and item 23 “I felt extremely 
anxious” (0.80). These three items would seem in fact to capture an analogous component 
of anxiety related to particularly elevated anxiety feelings and a perceived inability to 
manage these feelings. Two main reasons led to the exclusion of this item. Firstly, the two 
items (17 and 23) correlating strongly with item 12 had both higher item-total correlations, 
specifically the first and third highest correlations with the total score among all items. 
Consequently, these two items showed a closer association with the latent construct than 
item 12. Considering also the similar content of items 12, 17 and 23, including more than 
one of these items in the final, shorter version of the SAAS would almost inevitably lead to 
increased redundancy at the expenses of breadth of construct and content validity (Clark & 
Watson, 1991; DeVellis, 2012). In second place, item 12 is significantly longer than most 
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other items considered at this stage, being composed of twelve words. In scale construction, 
shorter items are almost always preferable as item brevity is associated with increased clarity 
for respondents. Item 17 and 23 have both higher item-total correlations than item 12 while 
also containing fewer words. Item 12 was therefore discarded at this stage of the analysis.  
 
Item 14 – I felt unable to cope 
Item 14 exhibited a good item-total correlation (0.75, 9th highest). Its endorsement 
frequencies were consistent with estimated prevalence for antenatal anxiety (15%), with 
16.1% of respondents (n=10) scoring 3 or above. Inter-item correlations for this item were 
also all in the acceptable range. The item which is closer in content to item 14 is arguably 
item 29 “I felt overwhelmed”. These two items had essentially the same item-total 
correlation, 0.750 and 0.752 respectively. Accordingly, at this stage item 14 was retained as 
it showed a satisfactory psychometric performance and appeared to measure a component of 
general distress not evaluated by other items. Further examination and comparison with all 
other items retained at this stage was required in order to make a final decision.  
 
Item 15 – I felt something awful would happen 
Item 15 was found to have one of the lowest item-total correlations (0.61, 21st highest). Due 
to its comparatively weak correlation with the total score this item was a candidate for 
deletion. Another item with similar content, item 28 “I had a feeling of impending doom” 
showed a significantly higher item-total correlation (0.80, 4th highest). Considering the 
relatively low item-total correlation of item 15, as well as the presence of a similar item with 
better psychometric qualities, item 15 was excluded from further analyses.  
 
Item 17 – I felt like I needed help for my anxiety 
Item 17 was the item with the highest item-total correlation (0.86). As commented earlier, it 
is significant that the item with the highest correlation with the total score enquired about 
the perceived need for support around the respondent’s anxiety symptoms, considering that 
the aim of the full scale was in fact to identify women experiencing problematic anxiety. 
Because of its excellent item-total correlation, this item was obviously considered as a 
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candidate for inclusion in the shortened, final version of the SAAS. However, inter-item 
correlations with the remaining 27 items were also inspected to investigate whether item 17 
showed particularly high correlations with any other item, a possible indication of item 
redundancy (Streiner & Norman, 2008). Two items were found to correlate strongly with 
item 17, namely item 21 “I could not control my anxiety” (0.88) and item 23 “I felt extremely 
anxious” (.80). Notably, these two items also exhibited the second and third highest item-
total correlations. Despite suspect redundancy, at this stage item 17 was retained for further 
consideration based on its excellent item-total correlation.  
Of note, an inspection of the inter-item correlation matrix also revealed that three further 
items showed high correlation (i.e. equal or above 0.75) with item 17. Specifically, these 
were item 12 “I found it hard to focus on anything other than my anxiety” (0.75), previously 
discarded, item 27 “I felt like I was losing control” (0.76) and item 28 “I had a feeling of 
impending doom” (0.76). A closer examination of their content appeared to indicate that 
these items also shared common features with item 17, 21 and 23, all referring to feelings of 
lack of control over particularly distressing levels of anxiety. As discussed in Chapter 6, this 
component of antenatal anxiety concerned with problematic anxiety symptoms that are 
perceived as distressing and interfere with a person’s daily functioning is an essential aspect 
of the target construct. Consequently, it was important to represent this feature of antenatal 
anxiety in the final version of the SAAS. However, including more than one of the items 
discussed above would have almost inevitably led to item redundancy, while narrowing the 
scope of the construct being assessed (Kline, 2000; Streiner & Norman, 2008). Specifically, 
among these five items, based on psychometric considerations it was deemed appropriate to 
select one of the three items with the highest item-total correlations (item 17, 21 or 23), as 
further discussed in this and the following section.  
 
Item 18 – Thoughts got stuck in my head 
Item 18 had the 5th highest correlation with the total score (.79). This item would appear to 
assess the cognitive process of rumination, a common symptom of Obsessive Compulsive 
Disorder related to persistent and recurrent thoughts (APA, 2013). Repetitive thoughts in the 
form of worries are also one of the key features of Generalised Anxiety Disorder (APA, 
2013). Inter-item correlations were examined for this item and showed that the vast majority 
of correlations with other items were between 0.20 and 0.75, indicating that this item tapped 
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into a relatively unique facet of the target construct. Item 18 also had a moderately high 
correlation with item 17 “I felt like I needed help for my anxiety” (0.69), which provided 
further evidence that this item showed good discriminative ability without being redundant. 
It was thus decided to retain item 18 for potential inclusion in the scale based on its robust 
item statistics and relative uniqueness of content. 
 
Item 19 – I avoided people 
This item also showed one of the strongest item-total correlations (0.77, 7th highest) and a 
mean score of 1.71. As noted above, this was one of three items within this preliminary 
version of the SAAS assessing a behavioural symptom of anxiety. The other two were item 
2 “My anxiety stopped me from doing things”, which was retained for further consideration, 
and item 11 “I felt that my anxiety made me act impulsively” which was discarded. Item 19 
and item 2 had a high inter-item correlation (0.74), although not at the level for which 
redundancy can be assumed (i.e. > 0.8). Item 19 is also a key diagnostic criterion of Social 
Anxiety Disorder (WHO, 1992; APA, 2013), in which avoidance of social situations is often 
marked. At this stage, it was thus considered appropriate to retain it for further analysis.  
 
Item 20 – I have felt so anxious that I had thoughts about terminating my pregnancy 
As previously discussed, this item was excluded at the initial stage of analysis as it showed 
no variance, with all 62 participants endorsing option “1=never”.  
 
Item 21 – I could not control my anxiety 
Item 21 exhibited a particularly high item-total correlation (0.84, 2nd highest). The specific 
component of anxiety evaluated by this item was discussed in the section on item 17 “I felt 
like I needed help for my anxiety”. It was noted that both items shared similarities in content, 
related to distressing and uncontrollable feelings of anxiety. As they showed respectively the 
first and second highest item-total correlation in this pilot study, at this stage they were both 




Item 22 – I felt so anxious that I had thoughts of ending my life 
As documented earlier, this item was also excluded at the initial stage of analysis because of 
extremely low variance. Only one out of sixty-two participants scored “2=rarely” and the 
remaining sixty-one scored “1=never”. 
 
Item 23 – I felt extremely anxious 
This item had the 3rd highest correlation with the total score (0.81). However, as previously 
noted, it also showed considerably high inter-item correlations with item 17 “I felt like I 
needed help for my anxiety” and item 21 “I could not control my anxiety”, respectively 0.80 
and 0.87. Because of a high risk of redundancy among these three items, item 23 was 
discarded since it was the one among the three with the lowest item-total correlation.  
 
Item 25 – My worries overwhelmed me 
Item 25 was discussed in previous sections because of its apparent, partial overlap in content 
with item 1 “I worried more than usual” which was discarded, item 14 “I felt unable to 
cope”, and item 18 “Thoughts got stuck in my head “, which were both retained at this stage 
of the analysis. Item 25 had the 6th highest item-total correlation (0.77) and 19.3% of 
participants scored “3=sometimes” or above for this item. This item seems to capture a 
symptom very common in Generalised Anxiety Disorder, an excessive and uncontrollable 
level of worrying. It is also important to note that various studies have indicated that GAD 
is the most prevalent anxiety disorder in pregnancy (Grant et al., 2008; Marchesi et al., 2016; 
Dennis et al., 2017). Another item, item 29 “I felt overwhelmed” enquires about a similar 
feeling without including the cognitive component of worrying. However, item 29 showed 
a marginally lower item-total correlation (0.75) than item 25. At this stage, because of its 
good psychometric performance, distinctiveness of content and centrality in a prevalent 







Item 27 – I felt like I was losing control 
Item 27 showed the 13th highest item-total correlation (0.72). As reported in Item 17, this 
item was discarded because of its high correlations with both item 17 (0.77) and 21 (0.75), 
coupled with a markedly lower item-total correlations compared to these two items.  
 
Item 28 – I had a feeling of impending doom 
Similarly to item 27, this item was discarded for reasons discussed in the paragraph for item 
17. Specifically, although this item had the 4th highest item-total correlation (0.80), it 
correlated highly with both item 17 (0.76) and item 21 (0.78). Furthermore, this item had the 
second lowest mean score (1.31) among all items included in this analysis. A particularly 
low mean score may indicate issues with item response distribution (Furr, 2011). An 
examination of endorsement frequencies showed in fact that only 4 out of 62 respondents 
(6.4%) scored “3=sometimes” or above for this item. This would appear to be indicative of 
poor discriminative performance among respondents and provided a further reason for the 
exclusion of this item.  
 
Item 29 – I felt overwhelmed 
Item 29 showed a relatively high item-total correlation (0.75, 10th). Its mean score was 2.16, 
with more than one third of respondents (35.5%) endorsing the response “3=sometimes” or 
above for this item. Arguably the item closest in content to item 29 was item 14 “I felt unable 
to cope”, which also showed an identical item-total correlation (0.75). Inter-item correlation 
for these two items was high (0.71), but not at the extent that would indicate that one of the 
two items was certainly redundant. For this reason, item 29 was retained at this stage of the 
analysis.  
 
Item 30 – I needed someone to support me with my anxiety  
This final item was found to have the 11th highest correlation with the total score (0.74). 
While this item parameter was adequate, when considering both the item-total correlation 
and its response distribution, item 17 and item 21 showed once again a superior psychometric 
performance. Their inter-item correlations with this item are high (0.73 for item 17 and 0.72 
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for item 21) and only marginally do not reach the criterion for suspected redundancy of > 
0.75. Also in consideration of the remarkably better performance of items 17 and 21 in 
relation to their item-total correlations compared with item 30, this item was discarded.  
 
Sub-analyses on the six pregnancy-related anxiety items  
Initial inspection of the item-total and inter-item correlations for the six pregnancy-related 
anxiety items (item 5, 10, 13, 16, 24, 26) was carried out similarly to all the other items 
discussed above. As discussed in the Data analysis section, however, the six PrA items were 
also analysed as a separate subscale, in order to examine its internal consistency and 
determine which items provided the strongest contribution in relation to their psychometric 
performance in measuring pregnancy-related anxiety symptoms. In relation to the internal 
consistency specific to the six-item subscale, DeVellis (2012) notes that, when a distinct 
construct is considered possible within an item pool (i.e. more than one factor), the internal 
consistency of the items composing the suspected subscale should be examined. When the 
six PrA items were treated as a separate subscale, its internal consistency was found to be α 
= 0.77. This provided an initial confirmation that these items taken together assessed a 
unitary dimension.  
An examination of item-total correlations of the six items with the 28-item scale and within 
this six-item PrA subscale was also considered important in determining the relative 
contribution of each of the items in assessing the dimension of pregnancy related anxiety.  
Table 17 presents the six anxiety items and their item-total correlations, both when 









Table 17 – Corrected item-total correlations for the six pregnancy-related anxiety items 
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All correlations are reported as Pearson’s r.  
 
Following an examination of the item-total correlations reported in Table 17 and of other 
item parameters such as endorsement frequencies and inter-item correlations among the six 
PrA items, three of the six PrA were retained for further consideration. This decision was 
informed both by considerations based on the construct relevance of these PrA items and on 
their psychometric performance, as briefly discussed below.  
At an initial stage of analysis of the six-item PrA subscale, item 5 “I felt detached from 
pregnancy and the baby” was discarded because of its particularly poor psychometric 
parameters. It exhibited the lowest item-total correlation within the PrA subscale, and it was 
the only item that increased the internal consistency of the six-item PrA subscale when not 
considered. Moreover, inter-item correlations with all other PrA items were all surprisingly 
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low (all below 0.25) except than with item 26 (0.46). Conversely, also in the initial phase of 
analysis of subscale it was decided to retain item 26 “I did not feel worthy of being a mother” 
for further consideration. This item showed moderately good item-total correlation both 
within the PrA subscale and when considered as part of the full scale. Moreover, item 26 
had the highest item-total correlation with the full scale among the six PrA items. Its 
endorsement frequencies were also consistent with a measure assessing problematic 
symptoms, with 14.5% of respondents scoring “3 = sometimes” or higher for this item.  
The remaining four PrA items measured two relatively distinct facets of pregnancy-related 
anxiety. Item 10 “I have felt scared about giving birth” and 24 “I have had negative thoughts 
about childbirth” refer to fears and negative thoughts about childbirth, while item 13 “I 
worried about losing my baby” and 16 “I worried that something may be wrong with my 
baby” assess specific worries about the unborn baby. In support of this distinction, item 10 
had the highest inter-item correlation with item 24 among all items (0.59) and item 13 
showed a similar pattern with item 16 (0.69). While these items appear to tap into two core 
facets of pregnancy-related anxiety, in order to avoid redundancy in the final version of the 
SAAS, it was considered appropriate to discard one item from each of these two specific 
components of PrA. Between item 10 and 24, item 24 was preferred for various reasons. 
These items had comparable item-total correlations. However, an inspection of their 
endorsement frequencies revealed that item 10 was scored “3 = sometimes”, “4 = often” or 
“5 = always” by 63% of women taking part in this pilot study. Similarly to other items 
previously discussed, it can be argued that this distribution of responses suggest that some 
level of fear around childbirth is considerably common among pregnant women, and that the 
way in which the question is formulated does not yield sufficient discriminatory power. Item 
24, for comparison, was scored 3 or higher only by 24 % of respondents, suggesting a 
superior discriminative accuracy than item 10. Only item 24 was thus retained at this stage.  
Finally, item 13 “I worried about losing my baby” and 16 “I worried that something may 
be wrong with my baby” were also examined and compared. Similarly to the two previous 
items, item 13 and 16 showed very similar item-total correlation. However, they also showed 
comparable endorsement frequencies. An examination of their content suggested that item 
13 focused specifically on worries regarding the possibility of miscarriage, while item 16 
appeared to assess a broader range of negative thoughts related to the health of the baby. 





Comments provided by study participants  
A free text box was provided at the end of the questionnaire, and study participants were 
asked to indicate whether they found any of the questions unclear or to provide any other 
comments they had about the scale. Before presenting the stage of the selection of 10 items 
for the final version of the scale, it is important to discuss the comments that women 
provided, as they also led to a modification in the time frame assessed by the scale, which in 
this version asked about symptoms experienced in the past week. Below a selection of 
relevant quotes from study participants is reported.  
 
P03 - “If the questions were about the last e.g. 2/3 weeks the answers may have been 
different. The last 7 days I’ve felt less anxious than previously” 
 
P20 – “I feel this questionnaire is too long to be routinely included in antenatal care – the 
midwife appointments are already quite “full”, could it be reduced to ~ 15 questions?” 
 
P32 – “– It is difficult to focus on the past 7 days of pregnancy rather than the past few 
weeks” 
 
P40 – “My anxiety is related to a previous miscarriage” 
 
 
A number of other study participants commented positively on the scale, such as P12: 
“Questions all clear and straightforward” or P34: “My feelings (anxiety) don’t last + I can 
control/realise this is likely normal. I think it would be good to complete a questionnaire like 
this to recognise if I was not coping. I don’t think I have completed any questionnaire about 
my mental health through pregnancy + this would be a good addition to support offered in 
case I needed help.” 
 
A participant commented specifically on two items, item 20 “I have felt so anxious that I 
had thoughts about terminating my pregnancy” and item 22 “I felt so anxious that I had 
thoughts of ending my life”. The comment noted that: “Qs 20 and 22 I thought were very 
confronting and I was much happier responding to say Q23. Do all expectant mothers need 
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to be asked Q20 and 22 or are these more relevant to those noted as having heightened 
anxiety?” (P27). As documented earlier, these two questions were both discarded in the 
initial stage of the item selection process because of zero or extremely low variance.  
 
As a result of the comments provided by women, it was considered appropriate to change 
the time frame assessed by the scale from ‘the past 7 days’ to ‘the past 14 days’ in its final 
version. Based on women’s considerations, and on the observation that anxiety levels during 
pregnancy might significantly vary as a response to specific situations (e.g. a problematic 
scan), a time frame of two weeks was considered more suitable to assess problematic 

















7.5 Final selection of scale items for inclusion in the 10-item SAAS  
As indicated earlier, following the stage presented above in which items were discarded 
based on a number of considerations related to their psychometric performance, content and 
contribution to the assessment of the target construct, a total of 13 items were retained for 
further consideration. Three of the 13 items focused on pregnancy-related anxiety symptoms, 
while the remaining 10 items assessed general symptoms of anxiety. The rationale for aiming 
at a scale containing no more than 11 items was discussed in detail in Chapter 6, where it 
was noted that NICE recommends that exclusively short scales should be used to screen for 
perinatal mental health problems (i.e. less than 12 items). A 10-item scale was considered 
optimal, as it included a sufficient number of items to represent a range of facets of the target 
construct (Cox et al., 1987). In order to select the 10 items for the final version of the SAAS, 
the psychometric performance and content of the 13 items retained at this stage were all 
further examined and discussed with my supervisory team.  
First, it was considered essential to include in the 10-item SAAS at least a small number of 
items specific to pregnancy-related anxiety. The importance of the component of pregnancy-
related anxiety in the construct of antenatal anxiety was documented in the systematic review 
of the psychometric literature on antenatal anxiety and further supported by the qualitative 
interviews presented in Chapter 5. It was consequently considered theoretically and 
empirically important to include items tapping into this dimension of antenatal anxiety in 
the final version of the SAAS. Some authors have observed that a minimum of three items 
are typically required to form a separate dimension or factor within a scale with sufficient 
structural validity  (Kline, 2000; Swalm et al., 2010). As a dimension within a scale cannot 
typically be composed by less than three items, and in consideration of the relevance of the 
dimension of pregnancy-related anxiety as documented in the research literature (Huizink et 
al., 2004; Blackmore et al., 2016) and summarised in this thesis, it was thus decided to retain 
the three PrA items identified above as those with the strongest psychometric performance. 
In relation to the remaining 10 items assessing symptoms of anxiety not specific to 
pregnancy, the following three items were excluded in this final stage of item reduction: 
o Item 9 “I did not feel like myself”:  
As noted earlier, this item appears to assess general distress rather than specific anxiety 
symptomatology. Among the other nine items, the only other items which appeared to 
measure a more generic component of psychological distress were item 14 “I felt unable to 
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cope” and item 29 “I felt overwhelmed”. Item 29 is discussed below. In relation to item 14, 
this item showed a significantly higher item-total correlation than item 9 and, as previously 
discussed, distribution responses more consistent with problematic anxiety symptoms. Item 
9 was thus discarded in this final stage favour of item 14, which showed superior item 
parameters and was consequently retained as a possible indicator of general distress.  
 
o Item 17 “I felt like I needed help for my anxiety”:  
Despite having the highest item-total correlation (0.86) among the 28 items, this item was 
discarded at this final stage of analysis. Item 21, “I could not control my anxiety“, with the 
second highest item-total correlation (0.84) was preferred for two main reasons. As noted 
earlier, the two items also showed a very strong inter-item correlation (0.88), essentially 
indicating that a person scoring high on one of the two items was also very likely to score 
high on the other item. Based on previous psychometric considerations with regard to item 
redundancy, it was thus deemed appropriate to include only one of the two in the final 
version of the scale. The content of item 17, one of the items from the PROMIS anxiety item 
bank, clearly indicated a need for support around problematic symptoms. However, in 
consideration of the well-documented stigma associated with perinatal mental health 
problems (Buist et al., 2015), the wording of this item might have led a proportion of women 
not to answer openly for fear of disclosing their need for support. On the other hand, item 
21 “I could not control my anxiety“, while having only a marginally lower item-total 
correlation, was considered to be less direct. Moreover, item 21 comprised less words than 
item 17, a desirable feature in relation to item clarity and comprehensibility. Item 17 was 
thus discarded in this final stage of item reduction.  
  
o Item 29 “I felt overwhelmed”:  
Item 29, as reported earlier, had the 10th highest item-total correlation (0.75), identical to 
item 14 “I felt unable to cope”. It was considered appropriate to include only one of these 
two items in the final version of the SAAS as a possible indicator of general distress. A 
decision between Item 14 and item 29 was guided primarily by the observation that another 
of the remaining items, item 25 “My worries overwhelmed me”, partially overlapped in 
content with item 29. While feeling overwhelmed was a shared feature of these two items, 
item 25 was considered to be more specific to anxiety symptomatology, with the inclusion 
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of the component of worry, and was thus preferred to item 29. As item 29 was discarded in 
this final stage, it was consequently decided to retain item 14 to represent the component of 
general distress in the final version of the SAAS.  
In conclusion of this chapter, Figure 4 in the next page presents the 10 remaining items which 
were included in the final version of the SAAS. The scale is shown in the format in which it 
was presented to study participants in the psychometric validation study discussed in the 






















Figure 4 - 10-item, final version of the Stirling Antenatal Anxiety Scale (SAAS) 
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Chapter 8   Preliminary psychometric validation of the SAAS  
 
8.1 Introduction  
As discussed in the previous chapter, once a final, 10-item version of the SAAS was 
produced, this was psychometrically tested on a larger sample of pregnant women to 
evaluate a range of psychometric properties. The primary aim of the psychometric validation 
study presented in this chapter was to evaluate the screening accuracy of the final version of 
the SAAS by validating it against a structured diagnostic interview for anxiety disorders. 
One hundred and seventy-four women completed the SAAS and other self-report scales to 
assess depression and anxiety symptoms. Additionally, a subsample of 37 women were also 
assessed using a brief diagnostic interview, which served as the ‘gold standard’ in this 
psychometric validation study. This procedure is documented in detail in the following 
sections. The internal consistency, convergent and discriminant validity, and factor structure 
of the SAAS were also evaluated in this preliminary psychometric validation of the scale. 
The word ‘preliminary’ is used here to indicate that psychometric testing and validation of 
a scale is an ongoing process, in which evidence of scale reliability and validity needs to be 
supported by a number of studies testing the scale in a range of samples selected from the 
intended population of respondents (Abell, 2009; DeVellis, 2012). Consequently, while 
making any final claims regarding the psychometric properties and screening accuracy of 
the SAAS would be premature, the psychometric validation study presented here provided 
preliminary evidence of its psychometric performance in a relatively large sample from the 
target population.  
Two additional scales were also completed by women as part of this validation study. These 
were the GAD-7 (Spitzer et al., 2006) and the Edinburgh Postnatal Depression Scale [EPDS] 
(Cox et al., 1987). The GAD-7 was included for two main reasons. The first, and most 
important, was discussed earlier in the thesis (see section 1.2.2). The GAD-7 (and the ultra-
brief screener GAD-2, consisting of the initial two questions of the GAD-7) are the NICE-
recommended measures to screen for anxiety during the perinatal period (NICE, 2014). It 
was thus considered important to evaluate and compare the screening accuracy of both the 
GAD-2 and the GAD-7 in a sample of pregnant women, particularly in light of the fact that 
there is very limited evidence supporting their screening accuracy for problematic anxiety 
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in perinatal populations (Zhong et al., 2015). A secondary reason was that the GAD-7 was 
used to evaluate the convergent validity of the SAAS. The EPDS, a well-established measure 
of perinatal depression also previously discussed in the systematic review chapter, was used 
to assess the discriminant validity of the SAAS.   
 
8.2 Study aims 
The primary and secondary aims of this preliminary psychometric validation of the SAAS 
are presented here.  
Primary aim:  
To validate and compare the SAAS, GAD-2 and GAD-7 against a gold standard structured 
diagnostic interview for anxiety disorders, by evaluating their screening accuracy and 
determining their optimal cut-off scores in a population of pregnant women.  
 
Secondary aims:  
 To evaluate the internal consistency of the SAAS and the GAD-7 
 To assess the convergent and discriminant validity of the SAAS, GAD-7 and EPDS 
 To examine the factor structure of the SAAS  
 To determine the screening accuracy of the SAAS, GAD-2 and GAD-7 in identifying 
women experiencing an anxiety disorder and/or pregnancy-related anxiety symptoms  
 To evaluate the acceptability and ease of completion of the SAAS in a sample of the 









8.3 Study design  
The COSMIN criteria for evaluating whether a psychometric validation study meets the 
standards for good methodological quality (Terwee, 2007; Mokkink et al., 2010b) were used 
to inform the study design and ensure that the study met the criteria for excellent 
methodological quality in the evaluation of a range of psychometric properties. These criteria 
were previously introduced in the systematic review chapter to assess the methodological 
quality of included studies (4.2.3). Specifically, the Consensus-Based Standards for selection 
of Health Measurement Instruments (COSMIN) checklist (Mokkink et al., 2010b) was used 
in the validation study for this purpose. The four ‘boxes’ of the COSMIN checklist that were 
used to provide evidence of the methodological quality of the study were box B 
“Reliability”, box E “Structural validity”, box F “Hypotheses testing”, and box H 
“Criterion validity”. Each box includes a variable number of items (between 5 and 18) that 
are used to assess the quality of study design in relation to a specific psychometric property 
(Terwee et al., 2012). As in the COSMIN checklist a quality score for each box is determined 
by taking the lowest score of any item in a box (i.e. ‘worse score counts’ approach), the study 
was designed and conducted so that it scored excellent for methodological quality for all the 
items in each of the four boxes evaluated.  
The recruitment and data collection phases of this validation study followed the same 
procedure of the pilot study, with a cross-sectional postal survey method used to collect data 
from study participants. However, this was also a psychometric study of screening accuracy 
and there were thus also some substantial differences. In studies of diagnostic or screening 
test accuracy, the result of the test or scale of interest is compared against the reference 
standard, which can be defined as the best available method for establishing the presence or 
absence of the target condition (Furr, 2011). For the identification of psychological 
symptoms, the reference or gold standard is considered to be a structured clinical interview 
based on well-established diagnostic criteria (Gibson et al., 2009; APA, 2013). The most 
common study design for studies of screening accuracy involves systematic comparisons of 
the results of the index test (i.e. the scale) and those of the reference standard in the same 
subjects, in order to determine  the screening or diagnostic accuracy of the scale under 
investigation (Centre for Reviews and Dissemination [CRD], 2008). The main difference in 
study design between the pilot and the validation study was thus that the validation study 
required a subsample of women who completed the scales to be additionally assessed with 
a structured diagnostic interview. Primarily because of the diagnostic interviews, a number 
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of aspects related to sample size, data collection and analysis differed from the pilot study 
and are thus discussed below in relevant sections. However, the setting, sampling method, 
eligibility criteria, recruitment procedure and part of the data collection process were 
identical in the two studies. Please refer to the corresponding sections of the pilot study in 
Chapter 7 for these aspects of study design.  
 
8.3.1 Sampling, recruitment and data collection  
As noted above, the setting, study eligibility criteria, recruitment procedure and part of the 
data collection process were the same as for the pilot study. A further meeting took place 
with eight Senior Charge Midwives (SCMs) in February 2018, two weeks before starting 
recruitment for this validation study. In this meeting 300 study booklets were distributed 
among four different teams. The results of the pilot study with regard to recruitment were 
discussed. It was also clarified that the recruitment procedure for the validation study was 
identical, with the exception that in this study midwives, when presenting the study to 
pregnant women, were required to include information about the possibility of also being 
invited to take part in a telephone clinical interview. SCMs were asked to share this 
information with all midwives participating in recruitment. Furthermore, copies of the 
information sheet “Information for midwives: How to recruit women into the study” 
(Appendix 13), which included a brief script to explain the study that midwives could use to 
describe the study to women, were also given to SCMs. A number of further study booklets 
were distributed in three subsequent meetings with SCMs over the course of the following 
five months, as further documented later. The sections below discuss considerations related 
to sampling and sample size, which differed from the pilot study, as well as the phase of data 
collection with regard to the structured diagnostic interviews conducted as part of this 
psychometric validation study.  
 
Sampling and calculation of sample size  
As was discussed for the pilot study, the initial intention was to recruit a similar number of 
women representing the three trimesters of pregnancy (i.e. 60-70 women per trimester, target 
n = 200). However, over the course of the pilot study, it became clear that it was not feasible 
to recruit an equal representation of women across the trimesters in the sample. A 
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convenience sampling technique was adopted. The target sample size for this psychometric 
validation study (n = 200, with a subsample of n = 60 assessed via a structured clinical 
interview) was determined in consultation with a statistician while planning the phases of 
data collection and analysis, as further detailed below. A sufficiently large sample size was 
required for the purpose of evaluating the screening accuracy of the SAAS, GAD-2 and 
GAD-7, as certain requirements need to be met in studies of test accuracy (CRD, 2008; Furr, 
2011). A formula proposed by Buderer (1996), specifically devised to calculate sample size 
requirements in studies evaluating the sensitivity and specificity of a screening or diagnostic 
test, was used for the calculation of the target sample size. This method of determining 
sample size requirements takes into account a clinically acceptable precision for the 
estimates of sensitivity and specificity, expected values of sensitivity and specificity and the 
estimated prevalence of the condition (anxiety disorders) in the target sample (pregnant 
women). The screening accuracy of the scales could only be calculated on the subsample of 
women who were assessed both by completing the scale and with the diagnostic interview. 
It was calculated that a subsample of 60 women drawn from an initial sample of 200 study 
participants was sufficiently large, based on an expected prevalence of 50% (i.e. 30 women 
in the subsample expected to have the target condition, as detailed below), expected optimum 
sensitivity and specificity of 90%, a maximum acceptable width of the confidence interval 
of 10% (i.e. confidence intervals for sensitivity and specificity from 85% to 95%), and a 
two-sided significance level of 5% (Buderer, 1996). In order to achieve a prevalence of the 
target condition of 50% in the subsample (i.e. 30 women with an anxiety disorder), it was 
expected that a target sample size of 200 women would have included approximately 30 
women with an anxiety disorder, based on estimated prevalence for anxiety disorders in 
pregnancy of approximately 15% (Heron et al., 2004; Dennis et al., 2017).  It was 
consequently planned to purposively select, for the subsample of 60 women, the 30 women 
with scores in the highest range of the GAD-7 (i.e. 7 or above: Zhong et al., 2015) and a 
further 30 women to represent a range of low and moderate scores on the scale (i.e. 15 with 
scores ranging from 0 to 3 and 15 in the 4-6 score range). GAD-7 scores were used to select 
women to be invited for the diagnostic interview as it was, at this stage, the only validated 
anxiety scale that women completed as part of the study. The decision to maximise the 
presence of study participants with the target condition in this subsample drew on procedures 
commonly used in psychometric validation studies (Cox et al., 1987, Sackett & Haynes, 
2002). The sampling method used to select the subsample also offered the additional 
advantage of minimising the number of women that were assessed with a structured clinical 
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interview, while allowing a statistically valid calculation of sensitivity and specificity by 
using the formula discussed above.  
 
Measures 
Women who participated in the validation study were asked to complete three self-report 
scales, specifically the 10-item SAAS, the GAD-7 and the EPDS. The item set, response 
options and scale format of the SAAS were extensively discussed earlier in this thesis, and 
are thus not repeated here. The rationale for choosing the GAD-2/7 and EPDS as additional 
scales was also provided earlier. Their strengths and limitations were discussed in detail in 
the systematic review in Chapter 4, and subsequently here only a brief reminder of their key 
features is provided. All items of the SAAS, GAD-2/7 and EPDS can be seen in Appendix 
16.  
The GAD-7 includes seven items related to symptoms of Generalised Anxiety Disorder 
(Kroenke et al., 2007). Respondents are asked to indicate how frequently they “have been 
bothered” by each of the symptoms over the past two weeks, with all items scored on a 4-
point Likert scale (0 = not at all, 1 = several days, 2 = more than half the days, 3 = nearly 
every day). Scores range from 0 to 21, with higher scores indicating more severe symptoms. 
The first two questions of the scale are known as GAD-2 and, as previously noted, NICE 
guidelines recommend midwives consider asking these two questions to screen for anxiety 
in perinatal women (NICE, 2014). If a woman scores 3 or above on the GAD-2, NICE 
recommend that the GAD-7 should be used for further assessment. To our knowledge, the 
only study in which the screening accuracy of the GAD-7 was examined in pregnant women 
was conducted by Zhong and colleagues (2015). The authors found that an optimal cut-off 
score of seven or above, notably different from cut-offs of eight or ten identified in the 
general population, yielded good sensitivity (73%) and moderate specificity (67%). This cut-
off score (≥ 7) was thus used in the selection of a proportion of the subsample for the 
diagnostic interview.  
The EPDS is a widely used and well-validated 10-item scale for the assessment of depression 
in the perinatal period (Cox et al., 1987; Murray & Cox, 1994). Although the scale appears 
to contain a 3-item anxiety subscale, the EPDS has very good sensitivity and specificity in 
identifying women experiencing perinatal depression (Howard et al., 2018). The EPDS asks 
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respondents about symptoms of depression experienced in the previous week, with four 
possible response options and a total score range of 0-30.  
The M.I.N.I. International Neuropsychiatric Interview (M.I.N.I.) is a brief, structured 
interview used to ascertain the presence of Axis I DSM-IV and ICD-10 psychiatric disorders. 
It has excellent validity and inter-rater reliability, and it has been validated in a range of 
populations (Sheehan et al., 1998). An average administration of the M.I.N.I is estimated to 
take approximately 15 minutes. The anxiety modules of the MINI PLUS version 5.0 
(Sheehan et al., 1998), which included Panic Disorder, Agoraphobia, Generalised Anxiety 
Disorder, Social Anxiety Disorder, Obsessive-Compulsive Disorder, Posttraumatic Stress 
Disorder and Specific Phobia, were used in this study to determine diagnoses of an anxiety 
disorder. All diagnostic interviews were administered by a researcher, as further detailed 
below.  
Other information collected by all women taking part in the validation study (as shown in 
Appendix 16) included their age, gestational week, score on a single pregnancy-related 
anxiety item, parity status, history of obstetric complications, ethnicity, educational level 
and marital status. The ease of completion and acceptability of the SAAS to women 
completing the scale were also evaluated through two questions, as detailed in the Results 
section.  
 
Recruitment and data collection 
Recruitment took place between February and July 2018, with the last study questionnaires 
returned to the study office in August. The recruitment procedure was equivalent to that of 
the pilot study. Women meeting the inclusion criteria were verbally informed about the study 
by midwives while attending routine antenatal clinics in the Glasgow area. The study pack 
given to potential participants contained documents similar to those used in the pilot study, 
including an invitation letter, information sheet, study questionnaire (consisting this time of 
the SAAS, GAD-7, EPDS, and demographic and obstetric questions) and consent form. 
However, all the study documents were modified to reflect the different study design of the 
validation study (for examples see Appendices 3, 16 and 17). In addition, only for the 
psychometric validation study, the study booklet also contained a reply slip which was used 
to contact the subsample of women who were selected for the clinical diagnostic interviews. 
All women who participated in the study returned completed study questionnaires, consent 
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forms and reply slips by post. Once study booklets were returned to the study office, a 
proportion of women were selected to be invited for the diagnostic interview, according to 
the procedure discussed earlier to represent a range of GAD-7 scores. All interviews were 
telephone-administered and conducted by a researcher from the NMAHP-RU at the 
University of Stirling, who received training to administer the M.I.N.I and was blind to the 
scores of the scales. Contact details of women selected for the interviews were securely 
passed to the researcher, who contacted study participants by email or phone, depending on 
what they indicated in the reply slip, for the purpose of arranging a telephone interview. If a 
woman was still willing to take part in the study at this stage, a mutually suitable date and 
time was agreed. An attempt was made to conduct all interviews within four weeks from 
completion of the scales. In all cases in which this was not possible, the SAAS and the GAD-
7 were re-administered by the researcher at the end of the interview, in order to allow a 
clinically meaningful comparison between scale scores and the diagnostic interview. In the 
majority of cases in which the interview was completed within four weeks, the researcher 
conducting the diagnostic interviews was blind to all the original scale scores. Results of the 
clinical interviews were then securely transferred to the author. Only unique ID numbers 
were used for this purpose.  
 
Further ethical considerations 
With regard to ethical aspects specific to the psychometric validation study, the information 
sheet and consent form given to all women taking part in this final study made it clear that a 
proportion of women taking part in the research would also be contacted and invited to attend 
a brief clinical interview. Although women had already given consent to take part in this 
interview by signing and returning the consent form for the validation study, on the day 
agreed for the interview the researcher who phoned all study participants confirmed consent 
verbally before commencing the interview. The researcher was additionally instructed to 
contact me, with the participant’s permission, if a woman expressed the need for 
psychological support during the interview or disclosed information indicating risk to herself 
or others. In this eventuality, a variety of referral options to appropriate pathways of care 
were available by contacting Elaine Clark (NHS GG&C Perinatal Mental Health service), a 




8.3.2 Plan for data analysis  
A data analysis plan for the psychometric validation study was developed in consultation 
with a statistician. The procedure for data entry was identical to the pilot study, with all study 
data (item scores for the three scales, respondents’ demographic and obstetric information, 
and two questions on the ease of completion and acceptability of the SAAS) initially entered 
onto a Microsoft Excel spreadsheet and subsequently transferred to SPSS software (version 
23). A codebook was developed which listed all variables, specifying their level of 
measurement and indicating what each numeric code for a given variable represented 
(Pallant, 2013). Two dichotomous variables indicated whether women were part of the 
subsample who attended the diagnostic interviews, and whether they were identified as 
experiencing an anxiety disorder or not. Nominal variables (e.g. parity, ethnicity) were 
examined and are summarised narratively and through frequency distributions in the Results 
section. In relation to scale items, there is a long-standing debate on whether items in a Likert 
scale should be treated at the ordinal or interval level. However, for the purpose of both item 
analysis and the calculation of a range of psychometric properties in scale development and 
validation, it is a common and accepted practice to treat Likert items at the interval level 
(Spector, 1992; Bowling, 2009; DeVellis, 2012). In both the pilot and the validation studies, 
all scale items were thus treated as interval variables (‘Scale’ in SPSS). 
 
Data cleaning and missing data 
Before conducting any analysis on the data, a number of quality and accuracy checks on the 
dataset were planned and conducted in SPSS, to check for any clear mistakes in data entry, 
inconsistencies and out-of-range values. For categorical variables, responses were checked 
for unusual or impossible values. For continuous variables, frequency distributions and box 
plots were visually inspected to identify any mistakes in data entry and outliers. As many 
statistical techniques are sensitive to outliers (i.e. cases with values considerably above or 
below most of the other cases), these were examined through histograms and examination 
of the tail distributions, boxplots, and range checks. Some authors advocate removing all 
extreme outliers from the analyses (Williams, 2010), while others suggest that genuine 
outliers (i.e. not clear mistakes in data entry) should be retained or changed to less extreme 
values (Tabachnick& Fidell, 2007). In this study, all outliers were inspected but no evident 
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mistakes in data entry were found and all outliers were consequently considered in the 
analysis.  
With regard to missing data, for all nominal and ordinal variables such as ethnicity and 
educational level, when data were missing this was simply reported in the Results section. 
In relation to item scores, a rule suggested by Wilson & MacLean (2011) was applied. If in 
a scale more than 20% of responses were missing, this was excluded from the analysis. If 
20% or less of responses were missing, the missing score or scores were substituted with the 
median score for that participant on all other items in the scale, and documented in the 
Results as per recommended practice (Mokkink et al., 2010b).  
 
Sample characteristics and respondents’ feedback on SAAS  
Descriptive statistics were used to calculate and summarise respondents’ demographic and 
obstetric characteristics, including measures of central tendency and dispersion, and 
response distributions. Continuous variables such as age and weeks of pregnancy were 
summarised and reported using means, standard deviations and ranges. Categorical variables 
such as ethnicity were inspected by examining frequencies of response distributions, as 
reported in the Results. Responses to the two questions enquiring about the ease of 
completion and acceptability of the SAAS (scored on a 1-10 scale) were assessed using mean 
scores and frequency distributions.  
 
Primary analyses 
Consistently with the study aims, a number of analyses were conducted to examine different 
psychometric properties of the SAAS and the GAD-2/7 (the EPDS was only used to assess 
convergent validity). The primary aim of this psychometric validation study was to assess 
the screening accuracy (i.e. criterion validity) of the SAAS, GAD-2 and GAD-7 in 
identifying women experiencing an anxiety disorder, as determined by M.I.N.I diagnoses. 
Additionally, the screening accuracy of the SAAS and GAD-2/7 in identifying women 
experiencing an anxiety disorder and/or pregnancy-related anxiety was also examined. Other 
important measurement properties assessed in this psychometric validation study included 
the internal consistency of the SAAS and the GAD-7, the convergent and discriminant 
validity of the three scales, and the factor structure of the SAAS, as detailed below.  
206 
 
Screening accuracy  
As briefly noted earlier, in studies of screening or diagnostic accuracy of psychological 
scales, the screening performance of a scale is tested by administering both the clinical “gold 
standard” and the scale to the same subjects recruited from the intended population of 
respondents. The reference standard typically produces a dichotomous outcome (e.g. the 
subject either has or does not have the condition of interest). The outcome of the scale, on 
the other hand, is a continuous variable (i.e. total scale score), and thus a range of possible 
cut-off scores for the scale are considered. Specifically, numbers of true positives (TP: those 
who have the condition as determined by the reference standard, and test positive on the 
scale at a given cut-off), true negatives (TN: those who do not have the condition and test 
negative), false positives (FP: those who do not have the condition and test positive) and 
false negatives (FN: those who have the disease and test negative) are typically calculated 
for a range of cut-off scores (Clark & Watson, 2003, Abell, 2009). For the purpose of 
calculating the parameters above, a number of possible cut-off scores for the SAAS, GAD-
2 and GAD-7 considered. Subsequently, 2x2 contingency tables were populated (CRD, 
2008). These tables are used to describe the relationship between the outcome of the 
reference standard and the results of a scale at a given cut-off score, in terms of proportion 
of TP, TN, FP and FN, as illustrated in Figure 5. 
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A number of 2x2 contingency tables were generated, allowing the calculation of the 
following parameters used to determine the screening accuracy of the SAAS, GAD-2 and 
GAD-7 in identifying women experiencing an anxiety disorder. Sensitivity and specificity 
were the two main outcome measures used to evaluate the screening accuracy of the SAAS, 
GAD-2 and GAD-7. The positive and negative predictive values, other similarly informative 
indexes, were also calculated and reported. Definitions of these parameters of screening 
accuracy and the procedure used to calculate these indexes using 2x2 contingency tables are 
provided here: 
Sensitivity: The proportion of people with the target condition (as diagnosed with the 
reference standard) who have a positive test result (i.e. score above a given cut-off score). 
Sensitivity is also known as true positive rate.  
Specificity: The proportion of people without the target condition who have a negative test 
result. Specificity is also known as true negative rate.  
Positive predictive value (PPV): The probability of having the target condition given a 
positive test result.  
Negative predictive value (PPV): The probability of not having the target condition given a 
negative test result.  
Sensitivity, specificity, positive (PPV) and negative (PNV) predictive values were calculated 
through these simple formulas (CRD, 2008):  
 
                              TP     TN                                    TP TN 
Sensitivity =   _________       Specificity =   _________          PPV =   _________         NPV=   _________ 
 
                         TP + FN                                   TN + FP                            TP + FP                           TN + FN 
 
 
Values of sensitivity, specificity, PPV and NPV are commonly multiplied by 100 to give 
percentages (Kline, 2005). Values closer to 100% for sensitivity and specificity indicate 
better discriminative accuracy. In the psychometric literature, 70% is often cited as a 
minimally acceptable value for both sensitivity and specificity, with values over 70% 
considered good, ≥ 80% very good and ≥ 90% excellent (Furr, 2011). 95% lower and upper 
confidence intervals for all the values of sensitivity, specificity, PPV and NPV were also 
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calculated, using the formula for the standard error of a proportion as indicated by Harper 
and Reeves (1999).  
The Area Under the ROC curve (AUROC), a parameter of overall scale accuracy, was also 
calculated for the SAAS, GAD-2 and GAD-7. The ROC curve provides a graphical display 
of all the possible combinations of sensitivity and specificity as a result of varying the cut-
off score in a scale, and the AUROC provides a single index of overall diagnostic 
performance (Brace et al., 2013). The value of the AUROC can vary between 0.5 and 1, with 
a value of 0.5 indicating that a scale does not differentiate at all between subjects with and 
without the target condition and a value of 1 indicating a perfect scale which screens positive 
all those with the target condition and negative all those without the target condition. A value 
of 0.90 or above is considered excellent, with an AUROC between 0.80 and 0.90 indicating 
good discriminative accuracy, and values lower than 0.80 suggesting only a moderate 
accuracy (Pallant, 2013). Analyses of the AUROC are also particularly useful when 
comparing the screening performance of two or more scales. In this study, the AUROC of 
the SAAS, GAD-2 and GAD-7 were calculated and examined, as discussed in the Results.  
 
Internal consistency of the SAAS and GAD-7  
An initial inspection of item parameters for all SAAS items was conducted using descriptive 
statistics (response distributions, means and standard deviations) to examine the spread and 
patterns of items’ scores, floor and ceiling effects as revealed by excessive item skewedness, 
and to check the overall interrelatedness of items by inspecting the correlation matrix. All 
inter-item and item-total correlations were also inspected. The criteria presented in the pilot 
study to evaluate these parameters were applied (floor/ceiling effect ≥ 90%, item-total 
correlations ≥ 0.30, inter-item correlations ≥ 0.20 and ≤ 0.80).  
Similarly to the pilot study, scale reliability was assessed by examining the internal 
consistency of the SAAS and the GAD-7 as measured by Cronbach’s Alpha. It was noted 
earlier that various authors (Abell, 2009; DeVellis, 2012) indicate that the internal 
consistency of a scale developed for use in healthcare settings to inform clinical decisions 
about individuals should ideally approximate a value of α = 0.90 (Kline, 2005; DeVellis, 
2012). Values of Cronbach’s Alpha much higher than this (α = ~ 0.95) are likely to indicate 
item redundancy (Terwee et al., 2007). Nunnally’s criterion (1978) of α > 0.70 indicating 
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good internal consistency, and α >  0.80 indicating very good internal consistency are also 
often mentioned in the literature (Streiner & Norman, 2008).  
 
Convergent and discriminant validity 
As discussed in the Method chapter, convergent and discriminant validity are two 
psychometric properties that are commonly used to assess the construct validity of a scale 
(Abell et al., 2009). In the COSMIN checklist, these two psychometric properties are 
included under the ‘hypotheses testing’ box.  It is expected that a scale will correlate in the 
moderate to high range with scales purported to measure similar constructs and will have 
lower correlations with scales measuring constructs that are partially or fully unrelated to the 
construct of interest (Furr, 2011). Correlation coefficients were thus used to describe the 
magnitude of the relationship between two or more variables (e.g. respondents’ scores on 
two scales). The widely used recommendations proposed by Cohen (1988) to evaluate the 
strength of correlations were used as follows: small correlation (0.10 – 0.29), medium 
correlation (0.30 - 0.49) and large correlation (≥ 0.50).  
Convergent validity: The correlation between SAAS and GAD-7 scores was calculated to 
test convergent validity. Although the GAD-7 was developed as a measure of a specific 
anxiety disorder (Generalised Anxiety Disorder), it is a popular measure of anxiety which 
has been used to assess a range of anxiety disorders in multiple populations (Spitzer et al., 
2007; Plummer et al., 2016). As both the SAAS and the GAD-7 aim to assess problematic 
anxiety symptoms, a large correlation between the two scales was hypothesised, in the range 
0.60-0.80.  
Discriminant validity: The correlation between SAAS and EPDS scores was examined to 
test discriminant validity. As discussed earlier, the majority of EPDS items assess symptoms 
of depression (although a 3-item anxiety subscale was also identified). The EPDS was 
chosen as a well-established measure of perinatal depression, with the hypothesis that the 
two scales measured partially overlapping but distinct constructs. However, considering the 
evidence regarding the 3-item anxiety subscale within the EPDS, and the well-documented 
comorbidity between anxiety and depressive symptoms, a medium to large correlation was 
hypothesised between the two scales, in the range 0.40-0.60. The correlation between the 
EPDS and the GAD-7 was also calculated.  
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Pearson’s r (Pearson product-moment correlation coefficient) is often reported in the 
psychometric literature as measure of the correlation between two scales (Pallant, 2013) and 
it was thus the primary choice for reporting scale correlations. However, this correlation test 
assumes that the data approximate the normal distribution and should not be used if this 
assumption is not met (Brace et al. 2013). Considering that scales measuring psychological 
symptoms are often characterised by a positively skewed distribution of scores (i.e. most 
people report few or no symptoms), the assumption of normality was assessed by calculating 
the Kolmogorov-Smirnov statistic. Normality is determined by a value of more than .05, 
indicating a non-significant result (Pallant, 2013). If total scores were found to be not 
normally distributed, Spearman’s correlation (rho or rs), the non-parametric equivalent of 
Pearson’s r, was planned to be used. Spearman’s correlation is based on the conversion of 
scores into ranked variables and is thus affected to a much lesser degree by outliers and non-
normal distributions (Brace et al., 2013).  
 
Factor analysis (Structural validity) 
The rationale behind a range of data reduction techniques commonly known as factor 
analytic techniques or factor analysis was discussed in Chapter 4. Factor analysis is generally 
used to reduce variables that share common variance, such as items in a scale, into sets of 
clusters, known as components or factors (Bartholomew et al., 2011). The factor structure 
of a scale is an important aspect of validity, as it provides evidence of whether a scale is 
unidimensional (i.e. measures a single factor or latent construct) or multidimensional. In the 
case of the SAAS, the proposed construct of antenatal anxiety was hypothesised to be 
unidimensional, and factor analysis was carried out to provide evidence in support or against 
this hypothesis (i.e. to test its structural validity). The family of techniques known as factor 
analysis includes a number of exploratory and confirmatory techniques. Factors can also be 
described in terms of percentage of the total variance explained by each factor (eigenvalues) 
and by individual item loadings on one or more factors (coefficients of item loadings can 
vary between -1 and +1). Principal Factors Analysis, a type of exploratory factor analysis 
recommended when the aim is to evaluate theoretical predictions such as latent constructs 
(Tabachnick & Fidell, 2007; Wilson & McLean, 2011), was used to explore the factor 
structure of the SAAS.  
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Two tests were initially conducted to assess the suitability of the data for factor analysis, the 
Kaiser-Meyer-Olkin (KMO) measure of sample adequacy and Bartlett’s test of sphericity 
(Pallant, 2013). A sample size above 100-150 is generally considered to be sufficient for 
factor analysis (DeVellis, 2012; Tabachnick & Fidell, 2007). However, the KMO statistic 
was calculated to ensure that the sample was sufficiently large. For this purpose, a KMO 
value of > 0.60 is generally considered suitable for factor analysis (Williams et al., 2012). 
Pallant (2013) indicates that factor analysis is also appropriate if the Bartlett’s test of 
Sphericity is significant (p < 0.05).  
In order to assess the factor structure of the SAAS, factors were extracted based on a 
combination of two rules, widely used in the research literature to determine the smallest 
number of factors providing a satisfactory account of the interrelationships among a set of 
items (Kline, 2005; Pallant, 2013). Kaiser’s criterion, also known as the eigenvalue rule, is 
frequently used to determine how many factors should be retained (Brace et al., 2013). An 
eigenvalue is essentially a measure of the amount of variance captured by a single factor, 
and the rule indicates that factors with an eigenvalue less than 1 should not be retained in 
the factor solution (DeVellis, 2012). Another approach is the scree test (Catell, 1966), which 
involves the visual inspection of a scree plot (generated in SPSS) providing a graph of the 
eigenvalues of all the factors considered in the data set. Only factors above the point of 
inflexion (corresponding to the elbow of the plot) should be retained in a factor solution 
(Brace et al., 2013). Guidelines for exploratory factor analysis recommend that these two 
methods are considered in combination (Costello & Osbourne, 2005) and were thus both 
considered in this study. When more than one factor is identified, factors are rotated, using 
statistical procedures that do not modify the underlying solution, but increase the 
interpretability of clusters of item loadings (Pallant, 2013). In this study, a direct oblimin 
approach to rotation was planned if more than one factor was identified, as it is the 
recommended approach to factor rotation when possible factors are expected to be correlated 
(Williams et al., 2010). Item loadings on factors were also inspected, as they provide an 
indication of the strength of the association between an item and a given factor (Child, 2006). 
The conventions proposed by Tabachnick and Fidell (2007) were used to evaluate the 
strength of item loading coefficients:  
• 0 – 0.44 = poor 
• 0.45 – 0.54 = fair 
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• 0.55 – 0.62 = good 
• 0.63 – 0.70 = very good 
• > 0.70 = excellent 
 
8.4 Results 
A total of 178 pregnant women returned by post completed questionnaires. Four 
respondents, however, did not complete the consent form (n = 3) or the reply slip (n = 1) and 
were thus not included in the analysis. All the results reported here refer to the remaining 
174 women who completed questionnaires, consent forms and reply slips. The response rate 
was difficult to assess. As with the pilot study, it was not feasible for midwives to record all 
study packs that were handed out. A total of 750 study packs were given to midwives 
between February and July 2018. If all packs were handed to women the response rate would 
be 23.2%, slightly higher than for the pilot study. However, this may not be completely 
accurate. Recruitment was stopped after six months because of time constraints of the PhD, 
and once it was determined that the sample size was sufficient to conduct factor analysis. 
The initial recruitment target (n = 200) was only marginally not achieved (84%). It was not 
possible to assess whether there were differences between women who returned 
questionnaires and those who did not (i.e. response bias). However, the representativeness 
of the sample was examined based on information on respondents’ age, parity, ethnicity and 
education, as discussed below.  
With regard to missing data, two participants missed one item each from the SAAS (item 5) 
and the GAD-7 (item 6). As missing items were less than 20% of the total number of items 
in a scale in both cases, item values were replaced with the median score for that scale. Four 
participants did not answer the two questions on ease of completion and acceptability of the 
SAAS. Furthermore, one participant did not complete any EPDS items. Thus, only 173 cases 
were included in the calculation of discriminant validity. All demographic and obstetric 
information was completed, with the exception of one woman who missed the ‘Education’ 
question. The very small proportion of missing data, far below the commonly accepted rate 
of ≤ 5% (Furr, 2011), would appear to indicate that the questionnaire was adequately 
designed and formatted. Outliers were inspected by histograms, boxplots, and range checks. 
As mentioned earlier, while a number of outliers were observed, none were removed from 
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the analysis as no clear mistakes were identified and it was considered important to retain 
cases with extreme responses (Tabachnick & Fidell, 2007).  
 
Subsample for the diagnostic interview 
Thirty-seven women from the original sample were assessed with a structured diagnostic 
interview. The initial recruitment target of n = 60 was thus only partially reached (62%). A 
total of 71 study participants were invited to participate in the diagnostic interview. All 
women who were initially selected for the clinical interview and that eventually did not take 
part were contacted by phone (n = 27) or email (n = 7). However, a substantial proportion of 
those women did not answer the phone (n = 21), on four attempts on different days) or did 
not reply to two emails in two consecutive weeks (n = 5). A time and date for the telephone 
interview was arranged with eight women, but they did not answer the phone. Of the 37 
women who were interviewed, eleven met the criteria for M.I.N.I diagnoses of anxiety 
disorder. Of those, four met the criteria for GAD, two for Posttraumatic stress disorder, two 
for OCD, one for Panic Disorder and two for multiple anxiety disorders. To ensure 
meaningful comparisons between the results of the scale and the structured diagnostic 
interview, the SAAS and GAD-7 were re-administered to women attending the diagnostic 
interviews, if a period of more than four weeks had passed since they first completed the 
scale (n = 4).  
 
8.4.1 Demographic and obstetric characteristics of the sample  
The mean age of the 174 women who participated in the study was 31.1 years (range 19 – 
43). This was consistent with recent statistics indicating that 30.1 is the average age at which 
women in Scotland give birth (NHS Information Services Division [ISD], 2017). 54% of 
participants were in their first pregnancy (n = 94) while the remaining 46 % (n = 80) were 
in their second or subsequent pregnancy. Compared with maternity statistics both at the 
Scottish and UK level, with respectively 43% and 42% of first births in 2017 (Office for 
National Statistics [ONS], 2017; NHS Information Services Division [ISD], 2017), women 
at their first pregnancy were somewhat over-represented in this sample. Among women who 
had previously given birth, almost one third reported at least one experience of pregnancy 
214 
 
or birth complication (n = 24), consistently with the literature presented in Chapter 2. The 
mean gestational week of respondents at the time of completion of the questionnaire was 
28.4 weeks, with a fairly similar representation of women in the second and third trimester 
of pregnancy, as illustrated in Table 18.  
 
Table 18 – Mean, standard deviation (SD) and range for age and gestational week of 























15 - 40 
Of which:    Frequency 
   (n = 174) 
 % 
15 – 21 weeks  31   18 
22 – 28 weeks 55 32 
29 - 35 weeks 52 30 
36 or more weeks 36 21 
 
 
Socio-demographic data collected by study participants also included information in relation 

















White Scottish 142 81.6% 83.9% 
White – Other British 7 4.0% 7.8% 
White – Any other white  
ethnic group 
9 5.2% 3.9% 
Asian/Asian British 8 4.6% 2.6% 
  Black/Black British/African/ 
  Caribbean 
2 1.1% 0.7% 
Mixed/multiple  
ethnic group 
3 1.7% 0.4% 
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115 66.1% 45.2% 
Single 
 
19 10.9% 35.4% 
Cohabiting  
 




1 0.6% 8.1% 
Other 3 
(all engaged) 





With regard to ethnic origin, the sample in this study included a slightly lower proportion of 
‘White Scottish’ and ‘White – Other British’ and a slightly higher proportion of ‘White – Any 
other white ethnic group’ and ‘Asian/Asian British’ compared to the 2011 census. This is 
arguably likely to result from migration to Scotland in recent years, and the fact that the 
sample was recruited in an urban area. The sample appeared, however, to represent 
adequately well the Scottish female population. Figures limited to women of childbearing 
age, which would have allowed more appropriate comparisons, were not available.  
Notably, the sample was considerably more educated than the average of people living in 
Scotland, with a total of 67.1% of women reporting ‘Level 4 or above’ as their highest level 
of qualification. While this is not uncommon among research participants (Bowling, 2014), 
it is a potential limitation of the study that needs to be considered. In relation to marital 
status, the questionnaire included the response category ‘Cohabiting’ and ‘Other’. These 
were, however, not included in the 2011 Scotland census. If ‘Single’, ‘Cohabiting’ and 
‘Other’ are considered as a single category as in the census, their proportion in the sample 
is similar to national-level statistics. As it could arguably be expected, married women were 
over-represented in this sample.  
 
Women were also asked a single question to assess their general level of pregnancy-related 
anxiety symptoms. Specifically, women were asked: “From 1 to 10, how do you feel about 
your pregnancy and about giving birth?” with anchor points being “1= completely calm” 
and “10= extremely anxious”. The mean score was 4.6 (SD 1.91). Scores to this single, 
pregnancy-related anxiety question were also used for secondary statistical analyses to 
establish the screening accuracy of the SAAS, GAD-2 and GAD-7 in identifying women 
experiencing an anxiety disorder and/or elevated levels of PrA. Specifically, scores of 7 or 
above were considered indicative of probable pregnancy-related anxiety. This score was 
chosen based on the observation that 18.4% of women scored at or above this cut-off for this 
question, consistently with prevalence estimates for pregnancy-related anxiety reported in 






8.4.2. Ease of completion and acceptability of the SAAS  
The ease of completion and acceptability of the SAAS were evaluated with two questions, 
as described in the Data analysis section. Four women did not complete the two questions. 
Out of the remaining 170 study participants, 103 assigned the maximum score of 10 both for 
ease of completion and acceptability for use in routine antenatal care (61% of the sample). 
The mean scores for both questions (ease of completion: 8.93; acceptability: 9.48) indicated 
that the SAAS was considered very easy to complete and entirely acceptable for use in 
routine antenatal care by the vast majority of women who participated in the study. The 
proportion of women assigning a score < 7 was 10.6% (n = 18) for ease of completion and 
4.7% (n = 8) for acceptability. The very high mean score for acceptability is of note, as 
developing a scale that was acceptable to the target population was considered critical at all 
stages of the scale development process.   
 
8.4.3 Screening accuracy of the SAAS, GAD-2 and GAD-7 versus the M.I.N.I  
As discussed earlier, it was clearly important to evaluate the screening accuracy of the SAAS 
in identifying women experiencing an anxiety disorder, as this was part of the primary aim 
of this programme of work. It was also of considerable importance to assess the screening 
accuracy of the GAD-7 and the GAD-2 (considered also as a separate scale), both because 
they are the NICE-recommended measures to screen for perinatal anxiety in antenatal care 
(NICE, 2014), and in consideration of the scarce evidence available to support this 
recommendation in perinatal populations (Nath et al., 2018). As also previously noted, NICE 
recommends that the two questions of the GAD-2 should be initially asked, and that women 
scoring a total of 3 or above should be either administered the GAD-7 (but a cut-off score is 
not recommended) or referred for further assessment. The sensitivity, specificity, positive 
and negative predictive values of the three scales (based on M.I.N.I diagnosis) at different 
cut-off points were calculated, and are presented in Table 20, 21 and 22 in the next pages. 






Table 20 – Sensitivity, Specificity, Positive and Negative Predictive Values for the 
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(72% - 96%) 
 
95% confidence intervals in parentheses  
 
At a cut-off score of 8 or above, the SAAS showed excellent sensitivity (91%) and very good 
specificity (85%) in this sample. A different cut-off score of 12 or above maximised 
specificity (92%) at the expenses of the true positive rate (i.e. sensitivity, 73%). Both cut-off 
scores thus resulted in good to excellent values of sensitivity and specificity. While 
sensitivity and specificity should both be at least above an acceptable level (> 70 %), a 
number of authors (Zimmerman & Mattia, 2001;: Streiner & Norman, 2008; Furr, 2011). 
have pointed out that there are many instances in clinical settings in which it might be 
preferable to prioritise one of the two indexes over the other (i.e. either maximise the 
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proportion of true positive cases identified or the proportion of true negative cases). This 
important point is further elaborated in the final Discussion chapter (Chapter 9).  
 
Table 21 – Sensitivity, Specificity, Positive and Negative Predictive Values for the 
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Table 22 – Sensitivity, Specificity, Positive and Negative Predictive Values for the 
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≥  3 
 
27% 








(61% - 89%) 
 
 
      76% 














      74% 
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The GAD-7 showed very good sensitivity (82%) and excellent specificity (96%) at a cut-off 
of 7 or above. As noted earlier, however, NICE does not specify a cut-off score for the GAD-
7 in its guidance on mental health in the perinatal period (NICE, 2014), which may lead to 
assume that the cut-off recommended for the general population (≥ 8: NICE, 2011) should 
be used. In this sample, however, this cut-off considerably reduced the sensitivity of the 
measure. A similar, but arguably more significant problem was found with regard to the 
optimal cut-off score for the GAD-2 of 2 or above. This cut-off yielded good sensitivity 
(73%) and excellent specificity (96%). However, NICE explicitly recommends a cut-off 
score of 3 or above in perinatal populations (2014). The sensitivity at this cut-off score was 
significantly poorer in this study (27%), indicating that a substantial proportion of women 
with an anxiety disorder were missed at a cut off of ≥ 3 (i.e. had GAD-2 scores of 2 or 
below).  
 
Analysis of the AUROCs 
ROC curves were generated for the three subscales. As previously discussed, the Area Under 
the ROC Curve (AUROC) provides a single summary measure of the ability of a scale or a 
test to discriminate between subjects with and without a specific target condition, and is thus 
particularly useful in comparing the screening accuracy of different scales (Bland, 2000; 
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Pallant, 2013). The three ROC curves for the SAAS, GAD-7 and GAD-2 are presented in 
Figures 6, 7, and 8.  
 
Figure 6 – Receiver Operating Characteristic curve for the SAAS  












Figure 7 – Receiver Operating Characteristic curve for the GAD-7  
       
Figure 8 – Receiver Operating Characteristic curve for the GAD-2 
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The test for the ROC curves conducted in SPSS were all statistically significant (p < 0.05). 
The AUROC for the SAAS was 0.94 (95% CI: 0.86-1), well above the threshold of 0.90 
indicating excellent discriminative ability (Bland, 2000). The AUROC thus confirmed the 
particularly good screening accuracy of the SAAS, as indicated by values of sensitivity and 
specificity. The AUROC for the GAD-7 was 0.93 (95% CI: 0.85-1), only marginally lower 
than the SAAS. The two scales both showed in fact very good to excellent sensitivity and 
specificity to the optimal cut-off points. Finally, the AUROC for the GAD-2 was 0.88 (95% 
CI: 0.75-1), a value appearing to confirm the poorer discriminative accuracy of this ultra-
brief scale in an antenatal sample compared to the GAD-7 and the SAAS. The relatively 
large confidence intervals of the values of sensitivity, specificity, PPV, NPV and AUROCs 
are arguably the result of the relatively small sample (n = 37, with 11 M.I.N.I diagnoses of 
anxiety disorders) used for the calculation of the screening accuracy of the three scales, a 
potentially important limitation of this study which is further considered in the Discussion 
chapter.  
 
Screening accuracy of the SAAS and GAD-2/7 in identifying women with an anxiety disorder 
and/or pregnancy-related anxiety symptoms  
The SAAS, consistently with the construct definition of antenatal anxiety proposed in 
Chapter 6, was designed to screen for a range of problematic anxiety symptoms during 
pregnancy, including symptoms of anxiety disorders and symptoms of pregnancy-related 
anxiety. However, the ‘gold standard’ used in this study (i.e. M.I.N.I) only provided 
evidence of the screening accuracy of the SAAS in identifying women with an anxiety 
disorder. Consequently, it was deemed important to assess its screening performance, and 
compare it to the GAD-2/7, when both anxiety disorders and pregnancy-related anxiety 
symptoms were considered. As noted above, for this purpose a single question was included 
in the questionnaire to assess the general level of pregnancy-related anxiety symptoms in 
study participants: “From 1 to 10, how do you feel about your pregnancy and about giving 
birth?” with possible scores ranging from “1= completely calm” to “10= extremely 
anxious”.  
In secondary statistical analyses, the sensitivity, specificity, PPV and NPV for the SAAS 
and the GAD-2/7 were thus re-calculated, including among the ‘positive’ cases both women 
with a M.I.N.I-diagnosed anxiety disorder and women scoring 7 or higher to the single 
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pregnancy-related anxiety question, assumed to be an indication of significant PrA 
symptoms. For reasons of brevity, only the most relevant cut-off scores for these parameters 
of screening accuracy are reported for the three scales (Tables 23, 24, 25).  
 
Table 23 – Sensitivity, Specificity, PPV and NPV for the SAAS in identifying women 
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Table 24 – Sensitivity, Specificity, PPV and NPV for the GAD-7 in identifying women 
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Table 25 – Sensitivity, Specificity, PPV and NPV for the GAD-2 in identifying women 
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As evident from these tables, the SAAS showed a superior screening accuracy when both 
anxiety disorders and PrA symptoms were considered (76% sensitivity; 90% specificity). 
Once more, the screening performance of the GAD-2 at the NICE recommended cut-off 
score of  3 or above was particularly poor with regard to its true positive rate (sensitivity: 
18%), with only a moderate performance at the optimal cut-off score of 2 or above (47%). 
Its specificity was excellent at this cut-off point. Similarly the GAD-7, at its optimal cut-off 
scores of ≥ 7, exhibited only moderate sensitivity and excellent specificity. The superior 
accuracy of the SAAS, compared to the GAD-2/7, in screening both for anxiety disorders 
and for pregnancy-related anxiety symptoms may not be particularly surprising when 
considering the constructs measured by these scales. Nonetheless, it provides further 
preliminary evidence to support the use of the SAAS as a brief screening scale for a range 
of problematic anxiety symptoms during pregnancy. At the same time, it suggests that the 
GAD-2 and GAD-7 might not be sufficiently accurate to screen for the whole spectrum of 
problematic anxiety symptoms that women can experience in the antenatal period. These 
findings, further commented in the Discussion chapter, also indicate that the SAAS in this 




8.4.4 Internal consistency  
Cronbach’s Alpha coefficient as a measure of internal consistency was examined for the 
SAAS and the GAD-7. The internal consistency of the GAD-2 was not calculated as it has 
been noted that calculating the internal consistency of a two-item measure is inappropriate 
(O’Brien et al., 2008). For the SAAS, Cronbach’s Alpha was found to be α = 0.88. This can 
be considered an excellent value, which closely approximates the value for clinical 
applications of a scale (α ~ 0.90) often suggested in the literature (Kline, 2005; DeVellis, 
2012). Internal consistency for the GAD-7 was α = 0.87, comparable to the SAAS. This 
considerably high value of internal consistency for the GAD-7 was expected when 
considering that the scale was constructed to asses a single anxiety disorder (GAD) and is 
consistent with previous studies in the general and pregnant populations (Spitzer et al., 2006; 
Zhong et al., 2015). At the same time, such a high Cronbach’s Alpha value for the SAAS 
seemed to support the unidimensionality of the construct measured by the scale, as 
hypothesised in the definition of the construct of antenatal anxiety. This hypothesis could be 
further tested through factor analysis, as presented in a subsequent section.  
Item-total correlations for the SAAS were all above the pre-defined criterion of ≥ 0.30 (range 
0.44 – 0.77). Inspection of the inter-item correlation matrix revealed a range of moderate to 
moderately high inter-item correlations, a desirable pattern for items in a scale (Streiner & 
Norman, 2008; Abell et al., 2009), with correlations all above 0.20 and below 0.80 (range 
0.24 – 0.65). No items, if deleted, improved the value of Cronbach’s Alpha, suggesting a 
unique contribution of each of the item to the total score. As previously discussed, item 
parameters within these ranges contribute to provide evidence of the psychometric 
robustness of the scale (DeVellis, 2012). Inspections of response distributions did not reveal 
any floor or ceiling effect among the 10 item composing the SAAS.  
 
8.4.5 Convergent and divergent validity 
Correlation coefficients were calculated between total scores of the SAAS, GAD-7 and 
EPDS to evaluate convergent and discriminant validity. Prior to this, the assumption of 
normal distribution of scores was assessed by calculating the Kolmogorov-Smirnov statistic, 
which was required to determine whether a parametric or non-parametric test was 
appropriate for the calculation of correlation coefficients. A non-significant result (p > 0.05) 
indicates normality (Pallant, 2013). The Kolmogorov-Smirnov test showed a value of p < 
227 
 
0.01, indicating a violation of the assumption of normality. Consequently, as detailed in the 
Data analysis section, Spearman’s correlation (rho or rs) was used to calculate and report 
correlation coefficients. A significant, positive correlation was found between the SAAS and 
GAD-7 (rs = 0.70, n = 174; p < 0.01). The strength of the correlation indicated a large 
correlation between the two scales, as hypothesised. The correlation between the SAAS and 
the GAD-2 was only marginally lower (rs = 0.68, n = 174; p < 0.01). Subsequently, the 
magnitude of the correlation between SAAS and EPDS scores was examined. The findings 
related to this correlation were somewhat unexpected. There was a significant, positive 
correlation between the two measures (rs = 0.73, n = 173; p < 0.01), which was in strength 
slightly larger than between the SAAS and the GAD-7. While a moderate to large correlation 
was hypothesised between the SAAS and the EPDS, this was expected to be lower than the 
correlation with the GAD-7, which measures a construct arguably more closely related to 
the target construct of the SAAS.   
The correlation between the GAD-7 and the EPDS was also calculated at this stage to 
examine whether the large correlation between the SAAS and EPDS was indicative of 
potential issues with the construct validity of the SAAS. The Spearman’s correlation 
coefficient between GAD-7 and EPDS revealed a correlation coefficient considerably 
similar (rs = 0.70, n = 173; p < 0.01) to the correlation between SAAS and EPDS (rs = 0.73).  
These findings would appear to confirm that the EPDS is not a unidimensional measure of 
depression, as indicated in various studies reported earlier. Furthermore, while the different 
correlations between the three scales (rs range: 0.70-0.73) suggested a considerable degree 
of overlap between the constructs measured, correlation coefficients were not sufficiently 
large to indicate that the scales measured highly similar constructs (a Spearman’s correlation 
coefficient of 0.73 indicates that 53% of the variance is shared between two scales). 
Hypotheses which may contribute to explain these findings are presented in the final chapter 








8.4.6 Factor structure  
Principal Factors Analysis was carried out to examine the factor structure of the SAAS. The 
KMO measure of sample adequacy was excellent (0.902), far exceeding the limit for 
acceptable sample size of > 0.60 (Kline, 2005). Bartlett’s test of sphericity also reached 
statistical significance (X² (45) = 706.90, p < 0.01), thus supporting further the suitability of 
the data for factor analysis. Principal Factors Analysis was thus conducted, and initially the 
magnitude of the eigenvalues were inspected. These are reported in Table 26.  
 














    
1 4.88 48.9%  
2 0.97 9.7% 58.6% 
3  0.80    8% 66.6% 









   85.1% 
    
 
Only factors with eigenvalues above 0.50 are reported 
 
 
As discussed earlier, the eigenvalue rule or Kaiser’s criterion recommends that only factors 
with eigenvalues above 1 are retained. This provided an initial indication of a unidimensional 
structure of the SAAS, with a single eigenvalue above one explaining approximately half of 
the total variance. A second eigenvalue, however, was considerably close to the 
recommended value for retaining factors. Catell’s scree test (1966) was thus also visually 
inspected to examine factors above the point of inflexion, as they are also used to inform the 
decision on which factors should be retained in the factor structure of a scale (DeVellis, 
2012; Brace et al., 2013). The scree plot for the SAAS is presented in Figure 9.  
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Figure 9 – Scree plot generated with Principal Factors Analysis on SAAS scores 
                 
Inspection of the scree plot clearly confirmed that a one-factor solution for the SAAS was 
the most appropriate, as only one factor was found well above the point of inflexion. 
Consequently, based on the recommended combination of the eigenvalue rule and 
examination of the scree plot, a single factor was retained and a one-factor solution for the 
SAAS was proposed. 
Individual item loadings on this single factor were also inspected. 7 of the 10 items included 
in the SAAS showed very good or excellent item loadings ( ≥ 0.63) according to the criteria 
proposed by Tabachnick and Fidell (2007) as detailed earlier. The remaining three items 
exhibited respectively good (item 4: 0.58) and fair item loadings (item 8: 0.51; item 9: 0.48). 
These items were the three pregnancy-related anxiety items included in the scale. While their 
not particularly high item loading coefficients might suggest a sub-component related to PrA 
within the 10-item SAAS, the magnitude of the loadings would not support the hypothesis 






8.5 Final considerations  
In conclusion, the findings presented in this chapter are an early indication that the SAAS 
has very good psychometric properties, and is potentially appropriate as a screening tool for 
use in clinical settings. Its measurement properties will clearly need to be further tested in 
future research studies, as discussed in the final chapter. In this sample, its internal 
consistency close to excellent (α = 0.88) confirmed the reliability of the scale and suggested 
a unidimensional construct, hypothesis that was further supported by the single-factor 
solution identified by the factor analysis. Evidence of the convergent validity of the SAAS 
was also supported by a large correlation coefficient with the GAD-7, as hypothesised a 
priori. The unexpected finding related to the correlation between the SAAS and the EPDS 
do not allow to reach conclusions regarding the discriminant validity of the SAAS. Possible 
explanations for these findings are presented in the final Discussion chapter.  
As documented in the Results, the screening performance of the SAAS in this study was 
close to excellent, both in the identification of women experiencing an anxiety disorder 
(sensitivity: 91%, specificity: 85%) and significant pregnancy-related anxiety symptoms 
(sensitivity: 76%; specificity: 90%), providing evidence in support of the criterion validity 
of the scale. The optimal cut-off score for the SAAS which maximised sensitivity and 
specificity for the identification of anxiety disorders was found to be ≥ 8. The findings also 
indicated that a different, conservative cut-off of  ≥ 12 may be alternatively used if the aim 
is to maximise the specificity of the scale (92% compared to 85 % for ≥ 8) and thus the 
number of true negative cases. This is an important distinction, which is also elaborated 
further in the final chapter. While the SAAS and the GAD-7 showed comparable sensitivity 
and specificity in identifying women experiencing an anxiety disorder at their optimal cut-
off scores (≥ 8 for the SAAS, ≥ 7 for the GAD-7), the SAAS performed significantly better 
in the identification of women experiencing pregnancy-related anxiety symptoms than both 
the GAD-7 and the GAD-2, which showed only poor or moderate sensitivity. Based on these 
preliminary findings, the SAAS might thus provide a superior screening performance than 
the GAD-2/7 in identifying pregnant women experiencing a range of problematic anxiety 
symptoms. The particularly poor screening performance of the GAD-2 at the NICE-
recommended cut-off score of ≥ 3 was somewhat alarming. Finally, a potentially important 
limitation of this study was that the target sample size was not entirely achieved. A note of 
caution is thus appropriate when commenting and interpreting these findings. This is also 
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Chapter 9   Discussion 
 
9.1   Revisiting the study aim and research questions 
In this final chapter, the evidence and findings presented in the thesis are discussed in relation 
to their rigour, limitations and future potential. In light of the findings presented in the five 
experimental chapters, it is initially useful to re-examine the study aim and research 
questions as presented in the introductory chapter and in 3.3.2. This programme of work 
primarily aimed to develop a brief scale with robust psychometric properties. Internal 
consistency, as well as several forms of validity were quantitatively tested. Other types of 
validity (i.e. face, content, and partially construct validity) are not easily summarised using 
statistical parameters, but require careful consideration at all stages of the scale development 
process (Simms, 2008). The methods and procedures used to develop the SAAS provide 
evidence of methodological rigour in the attempts to maximise the psychometric properties 
of the final version of the scale. The following paragraphs summarise the evidence that was 
provided to support the claim that the SAAS has overall desirable psychometric properties. 
The primary aim of the research was the development and preliminary psychometric 
validation of a brief self-report scale specifically devised to screen for problematic anxiety 
symptoms in pregnant women. As noted in Chapter 1 and in other parts of the thesis, the 
scale was also developed with the objective of making it potentially feasible to implement 
in routine antenatal care. The SAAS was thus constructed with the target of producing a final 
version consisting of less than 12 items, a prerequisite for the scale to be considered for use 
as a screening tool in maternity care in the UK (NICE, 2014). For the same reason, the 
acceptability of the scale to the target population was also considered to be of primary 
importance. The scale construction process, and the subsequent phase of preliminary 
psychometric validation, were informed by five distinct studies, specifically aimed to answer 
one or more research questions, as discussed below:   
 Research question 1: What should a construct definition of antenatal anxiety include 
in order to cover the core domains of problematic anxiety symptoms in pregnancy? 
 Research question 2: Which items are the most appropriate to operationalise the 




Two studies were conducted to answer Research Questions 1 and 2. A systematic review of 
the psychometric properties and item content of anxiety scales used in studies with pregnant 
women was initially carried out (Chapter 4). The aim was to identify anxiety symptoms and 
domains showing good or excellent evidence of their psychometric value when used to 
assess general or pregnancy-related anxiety in antenatal populations. The findings from the 
systematic review were complemented by qualitative interviews with women with 
experience of problematic anxiety symptoms during pregnancy (Chapter 5). The affective, 
cognitive, behavioural and somatic content areas of the construct of antenatal anxiety 
identified through the two studies were subsequently combined, using predefined criteria to 
evaluate the relative strength of evidence for each content area to be considered an important 
domain of the target construct. The combination of different sources of evidence (i.e. 
psychometric literature and target population) ensured a comprehensive coverage of the 
range of problematic anxiety symptoms that pregnant women may experience, thus 
contributing to maximise the face and content validity in the initial item pool (Netemeyer et 
al., 2003; Simms, 2008). Furthermore, it can be argued that these two studies also supported 
the construct validity of the final version of the SAAS. As noted in the Method chapter 
(3.1.3), while it is common practice to assess this form of validity by examining convergent 
and discriminant validity with other scales through psychometric testing (DeVellis, 2012), a 
number of authors have proposed that construct validity encompasses all forms of validity, 
and should be evaluated by examining and considering the procedures used throughout the 
scale development process (Simms, 2008; Streiner & Norman, 2008; Abell et al., 2009). 
Based on this approach, evidence in support of the construct validity of a scale begins with 
an accurate, evidence-based definition of the construct of interest, and is further 
demonstrated through the robustness of the research methods used at all stages of scale 
development (Newton, 2012).  
On the basis of the findings from the systematic review and the qualitative interviews, 
definitions of the construct of antenatal anxiety were formulated (6.2), and an initial item 
pool was generated to reflect the proposed construct. The conceptual definition of antenatal 
anxiety delineated the general boundaries of the construct (i.e. anxiety symptoms in 
pregnancy perceived as distressing and/or having a negative impact on individual 
functioning, and experienced for a sufficiently prolonged period of time), while the 
operational definition detailed specific content areas and facets of the construct (e.g. feelings 
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of panic or intense fear; excessive worry about the baby’s health). A clear and well-
delineated definition of the construct, providing the basis for the generation and selection of 
item relevant to its measurement, is also typically used as evidence of content validity of a 
scale (Clark & Watson, 1995; Streiner & Norman, 2008). Notably, in contrast with several 
authors (Huizink et al., 2004; Blair et al., 2011) who have proposed that pregnancy-related 
anxiety should be considered a specific and entirely distinct syndrome (see 2.3.2), the 
definition of antenatal anxiety proposed in this thesis considered pregnancy-related anxiety 
as one of the possible dimensions of the target construct, which may or may not be present 
in women experiencing antenatal anxiety.  
 
 Research question 3: Which items are considered clear, relevant and acceptable by 
the target population and experts, and can thus be used to create a short and 
psychometrically robust self-report scale for the assessment of antenatal anxiety?  
 
The initial item pool of 55 items generated in the previous phase was initially reviewed by 
three MMHS Change Agents, who provided feedback on the clarity and acceptability of all 
items (6.3.3). Their comments were used to modify a small number of items not deemed to 
be sufficiently clear or acceptable. This procedure further contributed to increase the chances 
of developing a scale acceptable to the target population, composed of items clearly worded 
and with good face validity. The mean scores in the psychometric validation study with 
regard to ease of completion and acceptability of the 10-item SAAS indicate that these 
objectives were achieved, as the scale was considered highly acceptable and very easy to 
complete. At this stage, three additional items were also suggested for inclusion in the initial 
item pool by two clinicians with specific expertise in the area, in an attempt to maximise 
further the content validity of the scale. 
The Delphi study presented in Chapter 6 made use of the knowledge and clinical expertise 
of a group of health professionals working in the area of perinatal mental health to 
considerably reduce the number of items in the initial item pool, from 59 to 30. While this 
initial selection of items based on expert opinion served the purpose of producing a shorter, 
preliminary version of the scale for pilot psychometric testing, it also ensured that the face 
and content validity of the resulting scale (as defined in 3.1.3) were considered and enhanced 
(Netemeyer et al., 2003). A sufficiently large number of items were retained at this stage, 
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thus ensuring item coverage of different facets of the construct (i.e. content validity). It is 
also reasonable to assume that items that were considered less important by experts lacked 
sufficient face validity, or were not considered sufficiently relevant to the assessment of 
antenatal anxiety (i.e. lack of content validity). As noted above in relation to construct 
validity, this procedure of item reduction through expert opinion can also be considered to 
contribute to further support claims of this form of validity.  
The pilot study presented in Chapter 7 addressed the second part of Research Question 3, 
related to items to be used to produce a brief and psychometrically robust final version of 
the scale. As noted in 3.2, this stage of pilot psychometric testing is concerned with 
maximising the internal consistency reliability of the scale, while retaining a sufficient 
number of items to reflect all the core domains of the construct of interest in order to 
maximise content validity. The study was thus predominantly based on quantitative analyses 
and items were selected for the final version of the scale by examining a number of item 
statistics, as detailed in Chapter 7. The particularly high internal consistency (α = 0.96) of 
the 30-item version of the SAAS allowed the selection of 10 items which were eventually 
found to retain an excellent level of internal consistency. A brief and internally consistent 
measure for the assessment of the target construct was thus produced. As previously noted, 
the selection of items composing the final version of the SAAS was also partially based on 
considerations related to item content and coverage of a range of facets of the target 
construct, in an attempt to preserve as far as possible content and construct validity in the 
10-item SAAS. The psychometric soundness of this final version of the scale was tested by 
addressing Research Questions 4 and 5: 
 Research question 4: What is the evidence in relation to the convergent and 
discriminant validity, internal consistency and factor structure of the final version of 
the scale?  
 
 Research question 5: How does the new scale perform when compared to the measure 
currently recommended by NICE (GAD-2/7), and to expert assessment using a 
structured diagnostic interview; and what are the optimised cut-off points for 




The 10-item SAAS, along with the GAD-7 and the EPDS, were completed in a second cross-
sectional survey by a sample of pregnant women in their second and third trimester of 
pregnancy. As noted above, the internal consistency of the SAAS was found to be close to 
excellent (α = 0.88), approaching the value that has been recommended for clinical 
applications (Kline, 2005). Despite the inclusion of three pregnancy-related anxiety items, 
the SAAS was also found to have a single-factor structure, consistently with the definition 
of the construct proposed in this thesis (6.2). Although factor analysis often requires 
replication in a number of studies, this preliminary indication would support the hypothesis 
that pregnancy-related anxiety symptoms can be considered a dimension of the more general 
construct of antenatal anxiety.  
Construct validity of the SAAS in this psychometric validation of the scale was evaluated 
through its convergent and discriminant validity, by hypothesising and testing the 
correlations of the scale with the GAD-7 and the EPDS. As noted in Chapter 8, while 
evidence of the convergent validity of the SAAS was supported by a large correlation with 
the GAD-7, the somewhat surprising finding related to the large correlation coefficients 
between the EPDS and the two anxiety measures (rs range: 0.70 - 0.73) which appeared to 
question the discriminant validity of the scales. A possible explanation for these large 
correlations relates to previous findings documenting the existence of a 3-item anxiety 
subscale within the EPDS, as documented in Chapter 4. An alternative hypothesis, not 
incompatible with the previous one, is that the well-documented comorbidity between 
anxious and depressive symptoms, both in the general and in perinatal populations (Staneva 
et al., 2015a), might have resulted in a partial overlap of symptoms and thus of constructs as 
measured by the three scales. This would also be consistent with the tripartite model of 
depression and anxiety by Watson & Clark (1991), discussed earlier in the thesis (2.2). The 
similarly large correlation found between the GAD-7 and the EPDS appears to confirm 
problems with the structural and construct validity of the EPDS (i.e. not a single factor 
assessing depression), as opposed to issues of construct validity of the SAAS. Additionally, 
as discussed in 3.3.1 and briefly noted above, others have argued that a global assessment of 
construct validity should be conducted by examining evidence provided throughout the scale 
development process (Simms, 2008; Abell et al., 2009).  
In relation to the screening performance of the SAAS in the psychometric validation against 
the M.I.N.I., the scale showed good to excellent sensitivity and specificity at two distinct 
cut-off scores, thus providing evidence of very good criterion validity. A cut-off point of  ≥ 
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8 maximised the sensitivity of the scale (91%), and thus the proportion of true positives. 
Using a score of 12 or above as cut-off allowed to maximise the specificity of the SAAS 
(92%), but reduced substantially its sensitivity (73%). Here the implications of choosing one 
cut-off over the other are briefly discussed. It is, however, important to note that the 
potentially important limitation of the relatively small number of women assessed using a 
diagnostic interview (i.e. the ‘criterion’ or gold standard) in this study should be considered 
when interpreting these findings. This limitation is discussed further in 9.2.  
In the context of screening for problematic anxiety symptoms in routine antenatal care, a 
case can arguably be made for both cut-offs. Some have observed that in clinical settings 
such as maternity care, the additional resources associated with the management of women 
incorrectly identified as depressed or anxious (i.e. false positives) are not cost-effective 
(Paulden et al., 2009). A large number of false positives is, moreover, likely to generate 
unmotivated worry in women. If this approach is favoured, a conservative cut-off of ≥ 12 
should be chosen in order to maximise the specificity of the scale, and consequently reduce 
the proportion of false positives. Others, however, have suggested that a two-stage approach 
to universal screening for common perinatal mental health problems may be adopted if the 
aim is to identify as many women as possible that are clinically depressed or anxious (Austin 
& Kingston, 2016). In this case, the SAAS could be used at a cut-off of 8 or above, in order 
to ensure that a large proportion of women experiencing problematic anxiety symptoms are 
identified (sensitivity 91%). In a second stage, a positive score may simply trigger a 
conversation with their midwife (e.g. a woman may be asked if the symptoms reported in 
the scale are something she would like support around), or referral for further assessment, 
depending on the severity of the problem. This approach, however, is likely to increase the 
proportion of false positives at the initial stage of screening. The decision to prioritise 
sensitivity over specificity or vice-versa in the context of screening for common perinatal 
mental health problems is complex, and a number of important factors need to be taken into 
account (Milgrom & Gemmill, 2014). In this section, some brief comments were provided 
to highlight the clinical implications of favouring one parameter over the other. To conclude 
the considerations on the SAAS, notably the scale also performed well in identifying women 
with an anxiety disorder AND/OR pregnancy-related anxiety symptoms, thus providing 
further evidence in support of its criterion validity.  
Finally, the screening performance of the GAD-2 in this study also deserves a further 
comment. As previously observed in the thesis (2.6), the NICE recommendation to use the 
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GAD-2 (NICE, 2014) was exclusively based on evidence of its good screening accuracy for 
anxiety disorders in the general population, as no studies in perinatal populations were 
available at the time of the publication of the guidance. The findings presented in this thesis 
question the decision to rely on psychometric evidence from populations other than perinatal 
women. They also imply that, if the NICE-recommended cut-off score of ≥ 3 is currently 
used in clinical practice, a substantial number of pregnant women experiencing clinically 
significant anxiety symptoms are likely to go undetected (sensitivity 27%). Although the 
same cut-off score yielded an excellent specificity (96%), the particularly poor sensitivity of 
the GAD-2 at this cut-off cannot be overlooked. The psychometric validation study also 
indicated that the GAD-2 and the GAD-7 are not sufficiently accurate to screen for the whole 
spectrum of problematic anxiety symptoms (i.e. including PrA symptoms) that women can 
experience in the antenatal period. 
 
9.2   Strengths and limitations of the research  
The five studies conducted as part of this programme of work had several strengths and 
limitations. Initially, some general strengths of the research, as well as of specific studies 
presented in the thesis, are discussed. A number of other strengths of the research have 
arguably been discussed as part of the previous section. The remaining part of the section is 
focused on several limitations of the research, which are particularly important to consider 
when interpreting and commenting study findings. 
The research presented in this thesis has a number of strengths. Research methods used to 
address sequentially the different research questions were carefully chosen following best 
practice in scale development, as detailed in Chapter 3. The methods and procedures that 
were eventually used to conduct the five studies were thus based on a solid theoretical and 
evidence-based background. A significant strength of the research was the combination of 
different sources of evidence to inform construct definition and the subsequent generation 
and selection of items to measure the target construct with a brief, psychometrically robust 
scale. Sources of evidence included the psychometric literature on anxiety scales used in 
pregnancy, women with experience of the target condition, health professionals with 
expertise in the area of perinatal mental health, and the intended population of respondents 
through pilot psychometric testing of candidate items.   
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Both for the systematic review presented in Chapter 4 and for the qualitative interviews, 
predefined criteria were used to determine the strength of evidence and relevance of specific 
symptoms to the assessment of antenatal anxiety, thus enhancing the credibility of the 
findings. In relation to the qualitative interviews with women with experience of problematic 
anxiety symptoms (Chapter 5), Evans and colleagues (2015) in their review of anxiety 
measures used with pregnant populations found no studies that used interviews with the 
target population to inform tool development. Although several measures have been 
developed to assess anxiety symptomatology during pregnancy, to my knowledge this is the 
first study to incorporate the experience and symptoms of pregnant women with problematic 
anxiety in the tool development phase. A number of authors have indicated that interviews 
with the target population can considerably contribute to strengthen the content validity of a 
measure (Abell et al., 2009; Streiner & Norman, 2008). Similarly, the involvement of 
MMHS Change Agents in relation to the initial review of the item pool for clarity and 
acceptability (Chapter 6), as well as the input provided with regard to the design and outline 
of the scale, have arguably contributed to the potential applicability of the scale to intended 
respondents, both in research and clinical settings.  
In relation to the Delphi study, one clear advantage of involving a panel of experts in the 
item reduction phase of scale development is that, when carefully chosen, they provide a 
wealth of accumulated knowledge in the area of interest, which can be used to select the 
most relevant and appropriate indicators of the target construct (Clark & Watson, 2003). The 
use of a structured diagnostic interview as part of the psychometric validation of the SAAS 
can also be considered a significant strength of this research. Recent systematic reviews of 
psychometric studies in the area of perinatal anxiety (Meades et al., 2011; Evans et al., 2015) 
and my own review (Sinesi, Maxwell, O’Carroll & Cheyne, 2019) concluded that validation 
against a reference standard is still rarely included in the psychometric testing of scales used 
with perinatal populations.  
In relation to the limitations of this programme of work, these can also be discussed by 
considering the different studies that have informed tool development. In relation to the 
interviews with women with experience of problematic anxiety symptoms, while they added 
an important qualitative component to the process of scale development (Hunsley & Mash, 
2008; Streiner & Norman, 2008), the most significant limitation was perhaps that a 
proportion of women who took part in the interview did not have a diagnosis of an anxiety 
disorder. They were rather recruited based on a subjective self-assessment of problematic 
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anxiety during pregnancy, according to the criterion of “self-identified antenatal anxiety” 
detailed in 5.2.2. This might be considered a limitation of this study, although it allowed the 
inclusion of women who had experienced elevated levels of anxiety symptoms during 
pregnancy but were not formally diagnosed. Moreover, according to the definition of 
antenatal anxiety proposed in Chapter 6, anxiety disorders do not represent the whole 
spectrum of problematic anxiety symptoms in pregnancy and thus including women who 
may have not met formal diagnostic criteria was considered important.  
The Delphi study detailed in Chapter 6 made use of expert opinion to aid the process of item 
selection and reduction. While the strengths of this approach in relation to item reduction 
were noted above, it can be argued that the purposive sampling technique adopted in this 
study, which relied on health professionals included in the mailing list of Maternal Mental 
Health Scotland, may have led to the over-representation of some professional backgrounds 
(e.g. clinical psychology; mental health nursing) and the under-representation of others (e.g. 
psychiatry), as illustrated in 6.5. Another potential drawback of this study is that four items 
were suggested for inclusion in the item pool by experts between round one and round two 
of the eDelphi. These four items were consequently only rated in a single round, and thus 
not subject to the iterative process of consensus building typical of Delphi studies. The 
potential limitation related to the small number of items rated only in one round was, 
however, arguably offset by the advantage of retaining a higher number of panellists. 
One of the limitations of both the pilot and psychometric validation study was that the 
response rate was not accurately determined, for the reasons discussed in the previous 
chapter. Although the response rates for the two studies were relatively low (20.6% and 
23.2% respectively), the actual response rate may have thus been higher. Despite the 
relatively low response rate it has to be noted, however, that in relation to the 
representativeness of the sample the only socio-demographic characteristic that considerably 
diverged from the most recent Scottish Census was the level of education. Women who took 
part in the psychometric validation of the SAAS reported significantly higher levels of 
educational attainment that the general Scottish population. Other obstetric and socio-
demographics characteristics were all fairly representative of national-level statistics.  
Perhaps the most significant limitation of the psychometric validation of the SAAS and 
GAD-2/7 against the M.I.N.I was that the target sample size for the diagnostic interviews (n 
= 60) was not achieved (n = 37). This limitation is potentially important, as it arguably had 
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a direct impact on the confidence intervals for the various parameters of screening accuracy. 
The relatively large confidence intervals reported for sensitivity, specificity, PPV, NPV and 
the Area Under the Curve (AUROC) for the three scales (8.4.3) would seem to indicate that 
some caution is needed when interpreting the parameters of screening accuracy reported in 
the study. The target sample size of 60 women to be assessed with a diagnostic interview 
would have provided width of the confidence interval of 10% for the estimates of sensitivity 
and specificity, according to the formula for the calculation of sample size requirements 
(Buderer, 1996) in studies of screening accuracy detailed in 8.3.1. As noted above this target 
was, however, not reached. Furthermore, as only 11 out of the 37 women assessed via a 
structured diagnostic interview were found to have an anxiety disorder, the values of the 
parameters of screening accuracy presented in Chapter 8 were based on a relatively small 
number of cases. As an example, the sensitivity of 91% showed by the SAAS at a cut-off 
score of 8 or above indicated that 10 out of 11 women with a M.I.N.I diagnosis of anxiety 
disorder had a score ≥ 8. It is evident, however, that a difference in the total score of a single 
participant could have caused a significant change in the estimate of sensitivity. A similar 
observation can be made for other parameters of screening accuracy reported in the study. 
The estimates of sensitivity, specificity, PPV and NPV for both the SAAS and the GAD-2/7, 
thus, need to be interpreted with caution. Further testing of the scale in larger samples, with 
a sufficient number of women assessed with a ‘gold standard’ structured diagnostic 
interview, would be highly desirable, as further elaborated in 9.4.  
To conclude this section on the limitations of the psychometric study presented in Chapter 
8, two further limitations that may be considered lessons to be learned for future studies are 
briefly noted. It was evident through the issue of under-recruitment for the diagnostic 
interviews that in a future study, it would be useful to consider inviting at least twice as many 
study participants to interview as needed. This is primarily based on the observation that, 
among the 71 women selected to be invited for interview, only 37 eventually took part. 
Additionally, on reflection, the choice of the EPDS as the scale used to evaluate discriminant 
validity was probably misjudged, when considering the existing evidence for an anxiety 
subscale within the measure.    
 
9.3   Implications for policy and clinical practice 
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Perinatal mental health problems are of major importance as a public health issue (Bauer et 
al., 2014; Austin & Kingston, 2016; RCGP, 2017). Over the last few years, the importance 
of perinatal mental health has been increasingly recognised by a number of national and 
international clinical guidelines (SIGN 2012; NICE, 2014, COPE 2017), key policy and 
strategic documents (NHS England, 2016; Scottish Government, 2017) and health 
professional bodies (RCGP, 2017; Royal College of Midwives [RCM], 2017; Royal College 
of Psychiatrists [RCPSYCH], 2018). In the UK, third sector organisations such as Maternal 
Mental Health Alliance (MMHA) with its Everyone’s business campaign (Ayers & 
Shakespeare, 2015) and Maternal Mental Health Scotland have also contributed to pressure 
national governments to improve perinatal mental health care.  
Recent reports, however, show that the provision of care is patchy (Thompson & Rodell, 
2014; Khan, 2015, MMHA, 2017). An NHS report indicated that in England specialist 
perinatal mental health services are present in less than 15% of all Trusts. Furthermore, 40% 
of Trusts provide no specialist service at all (NHS Improving Quality, 2015). In Scotland, 
only two Health Boards have a Mother and Baby Unit and specialist perinatal mental health 
community teams are only present in seven out of fourteen Health Boards (MMHA, 2017). 
As a result, although women with severe conditions are more likely to be identified, they are 
often referred to general adult psychiatric services which may not be well-equipped in the 
assessment and treatment of perinatal disorders (NICE, 2014). For the most common mental 
health difficulties such as perinatal anxiety and depression, detection rates are estimated to 
be lower than 50% (Bauer et al., 2014; Biaggi et al., 2016).  
The evidence and findings presented in this thesis have potentially important implications 
for service commissioners and future clinical guidelines. Despite the variability in estimates 
of prevalence of antenatal anxiety, the body of research discussed in Chapter 2 highlighted 
that anxiety is a common mental health problem throughout pregnancy, with the most 
conservative prevalence estimates based on formal diagnostic criteria for anxiety disorders 
indicating that approximately 15% of pregnant women experience at least one anxiety 
disorder (Dennis et al, 2017). The specific, adverse impact of antenatal anxiety on maternal 
postnatal mental health (i.e. as a strong predictor of postnatal depression) and on a range of 
birth and child developmental outcomes is also now well-documented in the research 
literature (see 2.4). The preventative opportunities provided by early identification and 
support for women experiencing antenatal anxiety are thus evident, particularly when 
considering the range of adverse health outcomes for mother and child associated with 
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antenatal anxiety. It was also observed that the negative consequences of clinically 
significant anxiety during pregnancy have a considerable social and economic cost, well-
documented in a recent report from the London School of Economics [LSE] and the Centre 
for Mental Health detailed in 2.5 (Bauer et al., 2014). The combined evidence discussed 
above in relation to the high health, social and economic costs associated with poor mental 
health in the perinatal period, including antenatal anxiety, should alert commissioners of 
maternity care services and other key stakeholders to take the appropriate steps to improve 
early identification and support for women experiencing mental health difficulties at this 
time. These may include, for example, the development of a fully integrated care pathway 
in perinatal mental health care, and actions aimed to reduce the stigma associated with poor 
mental health at this time which might, in turn, increase the likelihood of women disclosing 
problems and seeking support.   
The findings presented in Chapter 8 also have potentially important implications for clinical 
practice. Brief screening tools have become increasingly popular in a range of clinical 
settings over the last few decades (First, 2008). There are arguably a number advantages to 
short screening measures such as self-report scales for use in routine maternity care to 
identify women experiencing poor mental health. This type of measures are relatively 
inexpensive, generally acceptable to intended respondents and intuitive to complete 
(Zimmerman et al., 2018). Moreover, standardise information can be gathered and compared 
at different visits, and validated cut-off scores can provide midwives and other health 
professionals with an easy-to-interpret summary related to specific psychological symptoms. 
This, in turn, can trigger a more detailed conversation on the subject, or prompt referral to 
the appropriate pathway of care if required. The most recent NICE guidelines on antenatal 
and postnatal mental health (2014) seem to support this approach, with the inclusion of brief 
scales such as the PHQ-2 and the GAD-2 (with the GAD-7 recommended for further 
assessment) for the identification of common perinatal mental health problems. However, 
the findings presented in Chapter 8 and commented in 9.1 with regard to the screening 
accuracy of the GAD-2 at the cut-off recommended by NICE pose serious questions 
regarding its appropriateness as a first-line screening measure for problematic anxiety in 
routine antenatal care. While the cautionary note regarding the limitations of the 
psychometric validation study discussed earlier need to be considered when interpreting 
these findings, a recent study published only last year on the screening accuracy of the GAD-
2 (Nath et al., 2018) in a pregnant population reported findings consistent with those 
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presented in Chapter 8, but in a considerably larger sample. Nath and colleagues (2018) 
tested the GAD-2 in a British sample of over 500 pregnant women, who were all also 
assessed with a structured diagnostic interview. At the recommended cut-off of 3 or above, 
while the sensitivity and specificity of the GAD-2 in identifying women experiencing 
Generalised Anxiety Disorder were acceptable (sensitivity 69%; specificity 91%), the 
sensitivity of the scale in identifying women experiencing ANY anxiety disorder was poor 
(sensitivity 26%, specificity 91%). Notably, these parameters of screening accuracy for the 
GAD-2 are almost identical to those found in the psychometric validation study presented in 
Chapter 8 at the same cut-off score of  ≥ 3 (sensitivity 27%, specificity 96%).  
When considered together, these findings would strongly appear to indicate that the GAD-2 
does not show sufficient psychometric robustness for the assessment of clinically significant 
anxiety during pregnancy. This, in turn, has important implications for clinical practice 
considering that, as noted earlier, using the GAD-2 at this problematic cut-off score is likely 
to result in a high rate of incorrect classifications, with a high proportion of false negatives. 
Conversely, the findings presented in Chapter 8 indicate that the SAAS may provide a 
suitable alternative, as it was found to be an effective screening measure for a range of 
problematic anxiety symptoms in pregnancy, highly acceptable to the target population and 
sufficiently brief to meet the NICE prerequisite (i.e. less than 12 items) for being considered 









9.4   Directions for future research 
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While the findings regarding the very good screening accuracy of the SAAS can be 
considered promising, further psychometric validation studies testing a range of 
psychometric properties of the SAAS need to be carried out before considering the scale for 
applications in research or clinical settings. Some possible direction for future research are 
briefly outlined in this section.  
Further psychometric testing of the SAAS compared to a unidimensional measure of 
depression would be desirable to provide further evidence regarding its discriminant validity, 
and help clarify the issue of the large correlation between the scale and the EPDS. Factor 
analysis appeared to provide evidence against the distinction between symptoms of general 
anxiety experienced during pregnancy and pregnancy-related anxiety symptom. Future 
studies testing the factor structure of the SAAS in different and ideally larger samples would 
provide further evidence in support or against its structural validity. The test-retest reliability 
of the scale (i.e. the consistency of scale scores in an individual over subsequent 
administrations) was not assessed in this research. However, this is an important form of 
scale reliability, especially for a scale that may be considered for use in clinical settings. The 
evidence indicating that levels of anxiety symptomatology tend to fluctuate during 
pregnancy (Dennis et al., 2017) should, however, be taken into account when assessing the 
test-retest reliability of the SAAS.  
With regard to the screening accuracy of the SAAS, its potential for use in the identification 
of a range of problematic anxiety symptoms in pregnancy was discussed above. Further 
studies testing its screening performance in other, larger antenatal samples, are obviously 
required before the scale can be considered for use in clinical practice. During the last year 
of the PhD documented in this thesis, the NMAHP Research Unit at the University of Stirling 
was awarded (in collaboration with City University, London) a grant from the National 
Institute for Health Research (NIHR) to identify the most accurate and acceptable screening 
scale for the identification of anxiety in routine maternity care.  The significant contribution 
of this thesis to having already undertaken a substantive (published) literature review 
alongside the work to develop and test the SASS resulted in being invited to join the study 
team as a co-applicant. This study will test four self-report scales of anxiety and 
psychological distress in a sample of almost 2,000 women. The screening accuracy of the 
four scales will be evaluated through structured diagnostic interview with over 400 women, 
while a range of other psychometric properties (e.g. structural validity, internal consistency) 
will be assessed on the whole sample. In the final phase of this large, multi-site research, the 
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feasibility of implementation in routine maternity care of the scale exhibiting the best 
screening performance and acceptability to the target population will be tested through cases 
studies in different healthcare services (i.e. maternity services, psychological services and 
primary care) in England and Scotland. Based on the promising findings documented in this 
thesis, the SAAS was included among the four measures (GAD-2/7, SAAS, CORE-10, 
Whooley questions) which will undergo this robust psychometric testing. Consequently, 
over the course of the next three years important evidence will be gathered regarding a range 
















9.5   Conclusion 
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Despite the considerable gaps in the recognition and management of women experiencing 
perinatal mental health problems, significant steps have been taken in recent years to start 
addressing these issues. In England, as a result of the Five Year Forward View for Mental 
Health (NHS England, 2016), the Department of Health has invested £365 million in 
specialist perinatal mental health services for the period 2016-2021 to enable access to 
specialist perinatal mental health care for at least 30,000 additional women a year. Scotland 
has also seen an increased emphasis on improving perinatal mental health care in its recently 
published Mental Health Strategy 2017-2027 (Scottish Government, 2017). As part of this 
strategy, a significant step forward has been the introduction in 2017 of a Scottish Perinatal 
Mental Health Network. The overall aim of this national managed clinical network is to 
improve the identification and treatment of perinatal mental health problems in Scotland, by 
identifying current gaps in current provision of care and advising the Scottish Government 
on service development and pathways of care. The lack of identification of women 
experiencing poor mental health in the perinatal period, however, currently remains a 
significant problem. Antenatal and postnatal care provide critical opportunities for early 
identification and support of women experiencing mental health difficulties at this time. 
While the early identification and management of health problems is recommended in many 
clinical areas, this appears to be particularly important in the area of perinatal mental health, 
in which timely treatment and support can potentially improve health outcomes for both 
mothers and children (Milgrom & Gemmill, 2015). 
The research documented in this thesis has developed a screening scale for the assessment 
of a range of problematic anxiety symptoms during pregnancy that has shown preliminary 
evidence of very good screening accuracy, and is considered very easy to complete and 
highly acceptable to women. The cautionary notes regarding the limitations of the research 
detailed above need to be considered when interpreting these positive findings. 
Notwithstanding this important caveat, in an area typically under-resourced as perinatal 
mental health care has been for many years (Glover et al., 2014), an effective, acceptable 
and easy-to-complete screening tool that may be used by midwives and other health 
professionals to identify pregnant women experiencing a range of problematic anxiety 
symptoms could be a valuable addition, and allow for more efficient targeting of resources 
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Appendix 6   Systematic review: Methodological quality of all included studies 



















































Appendix 7   Anxiety items and domains identified by the systematic review 
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